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ABSTRACT I'll 
Antiviral, cytotoxic T (Tc) cells are essential for recovery from primary 
poxvirus infections. A recombinant vaccinia virus encoding murine IL-2 
(VV-HA-IL2) was previously constructed by others who showed that 
athymic, nude mice, which lack functional T cells, resolved an infection 
with this virus whereas nude mice infected with a control virus not 
encoding IL-2 (VV-HA-TK) developed a disseminated vaccinial disease 
and died. The experiments described in this thesis were designed to 
elucidate immune mechanism(s) which contributed to the recovery of 
nude mice from VV-HA-IL2 infection. 
Investigations into the kinetics of virus replication and clearance in nude 
and normal mice indicated that VV-HA-IL2 was rapidly cleared 
compared to VV-HA-TK, suggesting that the mechanism(s) involved in 
clearance of VV-HA-IL2 were induced rapidly within 1-4 days after 
infection. 
Since IL-2 activates and induces the proliferation of T cells and natural 
killer (NK) cells, ·studies were undertaken to determine if these effector 
populations were involved in the process of rapid viral clearance. 
Tc cell responses could not be detected in nude mice infected with either 
VV-HA-IL2 or VV-HA-TK. The magnitude and kinetics of appearance of 
Tc cell responses in normal CBA/H mice inoculated with VV-HA-IL2 or 
VV-HA-TK were similar. These findings excluded a role for Tc cells in 
the rapid eliminatio~ of VV-HA-IL2. However, splenocytes from nude 
and normal mice infected with VV-HA-IL2 had elevated NK cell activity 
which was 3-fold higher than the activity induced by VV-HA-TK. The VV-
HA-IL2-induced elevated NK cell activity persisted in nude mice for up to 8 
days and in normal mice for up to 3 days after infection. Effectors 
mediating lysis of YAC-1 targets were mainly as-GMl +, Thyl.2+, CD4-
and CD8-. 
Experiments using mice depleted of NK cells with specific antiserum and 
beige mutant mice deficient in cytolytic NK cells provided evidence for a 
causal relationship between VV-HA-IL2-induced NK cells and their role 
in viral clearance. Depletion of NK cells in nude or normal mice greatly 
exacerbated VV-HA-IL2 infection and resulted in significant increases in 
viral titres. 
IV 
A comparison of the kinetics of virus replication in CBA beige mice and 
normal CBA/H mice indicated that VV-HA-IL2 grew to higher titres and 
that virus clearance was delayed in beige mice compared to normal mice. 
VV-HA-IL2 induced strong splenic and ovarian NK cell activity which 
coincided with the rapid clearance of virus from ovaries of normal CBA/H 
mice; CBA beige mice had no detectable NK cell activity in spleens or 
ovaries. Nevertheless, VV-HA-IL2 was cleared more efficiently than VV-
HA-TK in beige mice suggesting that mechanism(s) other than NK cell-
mediated cytotoxicity were involved in rapid clearance of VV-HA-IL2. 
The role of host derived cytokine(s) involved in the IL-2-induced 
mechanism(s) of antiviral activity was investigated. Administration of a 
monoclonal antibody (Mab) to IFN-y inhibited the ability of nude mice to 
clear VV-HA-IL2 and resulted in mortality. This antibody also prevented 
clearance of VV-HA-IL2 in normal mice. However, the induction of NK 
cell responses in nude and normal mice and Tc cell responses in normal 
mice were not impaired by the Mab treatment, suggesting that the effector 
functions of both· classes of cytolytic cells were inhibited in vivo. 
Several lines of evidence indicated that virus-encoded IL-2 induced a 
possible cascade of immunological events which contributed to the rapid 
clearance of VV-HA-IL2 and recovery of T-cell deficient nude mice from 
infection. 
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Introduction and Literature Review 
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1. The immune response to viral infection: An overview 
The mammalian immune system comprises a highly complex and 
efficient immune surveillance network which is believed to have evolved 
in essence to distinguish self from non-self. Host defense against viral 
infection occurs in three distinct but sometimes interacting phases; 
innate resistance that is non-inducible and immediate; an early, 
inducible phase that is largely antigen non-specific; and a late (relative to 
the first two phases) phase that is inducible, highly antigen-specific and 
generates immunological memory (Janeway, 1988, 1989). Natural killer 
(NK) cells and monocytes/macrophages are active participants in the 
innate and early, interferon-inducible phases of the immune response to 
viral infection (reviewed in Welsh, 1986; Trinchieri et al., 1978; Gidlund 
et al., 1978; Mims and White, 1984a; Biron et al., 1989). The alternative 
complement pathway is yet another component of the non-adaptive 
antiviral immune effector phase. These early components exert their 
antiviral function before the generation of antigen-specific immune 
responses, namely antibody and cytotoxic T (Tc) cells. 
Activation of clonally-specific T and B cells is the critical event in the 
generation of cellular and humoral responses which involves numerous 
and complex events not yet fully elucidated. Cell-mediated immunity 
(CMI), the function of Tc cells, is generally believed to be important in the 
process of recovery from most primary viral infections (Blanden, 197 4; 
Mims and White, 1984a; Mims, 1987a) but antibody may be a contributory 
factor. Neutralisation of virus particles by antibody and lysis of infected 
cells by the classical complement pathway and antibody-dependent 
cellular cytotoxicity (ADCC) can become operative once virus-specific 
antibody is produced. Recovery from a primary viral infection is a 
potentially complex process involving multiple factors. Each component 
of the immune system may contribute to the process of recovery but the 
relative importance of any one of them would depend on the type of virus-
host combination. 
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2. Non-adaptive (innate) immunity 
The innate and early inducible phases of the immune system comprise 
NK cells, interferons (IFN s), monocytes/macrophages, the alternative 
complement pathway and some secretory products of macrophages 
(monokines) and T-cells (lymphokines) generally termed cytokines. In 
some instances, the antiviral functions of some of these components are 
influenced by others. The role of other factors such as age of the host, body 
temperature, nutrition, hormonal effects and pH which influence 
resistance to infection will not be discussed. 
2.1. Natural killer (NK) cells 
NK cells are large granular lymphocytes which mediate the lysis of 
certain tumour and virus-infected target cells in a non-1"1HC-restricted 
fashion (Kiessling et al., 1975; Herberman et al., 1975; reviewed in Welsh, 
1986; Ritz et al., 1988). NK cells, unlike T cells, do not express cell-surface 
CD3 or the T cell .antigen receptor (TCR) heterodimers (a and~) (Lanier et 
al., 1983; Ritz et al., 1985; Lanier et al., 1986; Biron et al., 1987; Biassoni et 
al., 1988). Human NK cells express a low-affinity receptor for the Fe 
fragment of immunoglobulin G (IgG) FcyR or CD16 antigen and the NKH-
1 (Leu-19) cell surface marker (Perussia et al., 1984; Fitzgerald-Bocarsly 
et al., 1988). Although murine NK cells share some cell surface antigens 
with T and B lymphocytes and macrophages (Burton et al., 1988), they are 
believed to have arisen from a non-T, non-B and non-myelomonocytic 
lineage (Kumar et al., 1989). Murine NK cells are asialo-GM1 + (as-
GM1 +), Thy-1+, CD3-, CD4-, CDS- and Jlld- (Hackett et al., 1986). They 
also express one or more of the three known NK cell-specific alloantigens, 
NK-1, NK-2 and NK-3 (Hackett et al., 1986; Burton et al., 1988; Burton et 
al., 1989). 
First recognized on the basis of their cytolytic activity, NK cells are known 
to exert various other functions such as the production of cytokines, 
regulatory functions on the adaptive immune system and on 
haematopoiesis and natural resistance against tumours and microbial 
infection (Trinchieri and Perussia, 1984). Only recently has there been 
mounting evidence that NK cells mediate antiviral function in vivo during 
certain viral infections (reviewed in Welsh, 1986). 
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During systemic virus infections, NK cell responses are markedly 
augmented in most virus-host systems (Welsh, 1981; reviewed in Welsh, 
1986). The augmentation appears to be a function of activation 
(MacFarlan et al., 1977; Welsh and Zinkernagel, 1977; Wong et al., 1977; 
Gidlund et al., 1978) and proliferation (Biron et al., 1984), both of which 
are induced by IFN (IFN-a and-~). Peak splenic NK cell activity and 
blastogenesis occur shortly after the peak in splenic IFN levels (Biron and 
Welsh, 1982; Welsh, 1984). The demonstration by Gidlund et al (1978) and 
Grundy et al (1982) that antibody to IFN-a and -P reduced significantly 
virus-induced augmentation of NK cell activity has provided evidence that 
NK cell activation was mediated by virus-induced IFN. Nevertheless, 
viral glycoproteins may also augment NK-cell-mediated lysis (Harfast et 
al., 1980; Alsheikhly et al., 1983; Arora and Houde, 1988) in the apparent 
absence of detectable IFN synthesis (Casali et al., 1981). NK cells only 
exert potent antiviral function in vivo early during infection, coinciding 
with 'the kinetics ~f their activation, and help limit the severity and 
duration of acute viral infection (Bukowski et al., 1984). 
The most convincing evidence for the antiviral function of NK cells comes 
from studies using appropriate reagents to selectively deplete NK cells in 
mice. Administration of antibody to as-GM 1, or NK-1.1 antigens 
enhanced viral replication and pathogenesis in mice during influenza 
virus (Stein-Streilein and Guffee, 1986), vaccinia virus (VV), murine 
hepatitis virus (MHV), murine cytomegalovirus (MCMV), 
encephalomyocarditis virus (ECMV) (Bukowski et al., 1983) coxsackie-B3 
virus (Godeny and Gaunt, 1986) and ectromelia virus (Jacoby et al., 1989) 
infections. Further evidence for NK cell-mediated antiviral activity come 
from adoptive transfer studies. Bukowski et al (1985) found that adoptive 
transfer of normal spleen cells, depleted of T cells and enriched for NK 
cells, or cloned NK cells conferred protection in newborn mice against 
MCMV infection. The protective effects of the transferred cells were 
abolished when mice were treated with antibody to as-GM1. Using 
similar procedures, NK-1.1 +, as-GM1 + NK cells were shown to confer 
protection against herpes simplex virus-1 (HSV-1) infection in mice 
(Rager-Zisman et al., 1987). A recent report (Biron et al., 1989) that 
severe varicella virus infection followed by CMV infection developed in an 
individual with intact cell-mediated and humoral immune functions but 
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otherwise completely lacked CD16+, NKH-1 + NK cells suggests that these 
effectors may be important in the control of some human viral infections. 
Apart from enhanced splenic NK activity, an increase in NK activity and 
cell number is demonstrable in organs which harbour viral replication 
(Welsh, 1978; Doherty and Korngold, 1983; Leung and Ada, 1982; Stein-
Streilein et al., 1983). The accumulation of NK cells at sites of viral 
replication has been attributed to their ability to respond chemotactically 
to IFN-~ and IL-2, two factors that are produced by infected cells and T 
cells respectively (N atuk and Welsh, 1987). Presumably, the 
accumulation of activated NK cells at the sites of virus infection is 
essential for mediating their antiviral function. 
An paradoxical feature of the action of IFN s is that they enhance the 
cytotoxic activity of NK cells while antagonistically protecting target cells 
from NK cell-mediated lysis (Welsh, 1978; Gidlund et al., 1978; Trinchieri 
and Santoli, 1978). The induction of resistance in targets against lysis is 
an active process ·requiring RNA and protein synthesis and therefore cells 
infected with cytopathic viruses that tum-off host RNA and protein 
synthesis are not protected from NK cell mediated lysis. Such a 
mechanism would ensure that only virally infected cells are eliminated by 
NK cells. The insensitivity to NK cell-mediated lysis has been attributed to 
membrane alterations induced by IFN treatment of targets which include 
marked changes in cell surface glycoproteins (Lindahl et al., 1976; Minato 
et al., 1980), glycosphingolipids and sialic acid (Yogeeswaran et al., 1981; 
1982; 1983). Increase in cell surface sialic acid expression on target cells 
has been inversely correlated with sensitivity to NK cell-mediated lysis 
(Yogeeswaran et al., 1982). In particular, IFN-induced upregulation of 
MHC antigens is generally believed to influence NK recognition of targets. 
In a number of studies (Pointek et al., 1985; Harel-Bellan et al., 1986; 
Storkus et al., 1987; Storkus et al., 1989), an inverse relationship between 
the concentration of class I MHC antigen expression on target cell 
surface and target cell susceptibility to NK cell-mediated lysis has been 
observed. This led to the hypothesis that class I MHC antigens deliver a 
negative signal to NK cells (the converse is true for Tc cells). The validity 
of this hypothesis has been challenged by a number of other studies 
(Chervenak and Wolcott, 1988; Dennert et al., 1988; Gorelik et al., 1988; 
Mullbacher and King, 1989) which have failed to demonstrate any 
correlation between increased class I MHC antigen expression and a 
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concurrent decrease in NK cell-mediated lysis. Two other reports (Reiter 
et al., 1988; quoted in Lotzova and Ades, 1989) also support the contention 
that susceptibility of targets to NK cell-mediated lysis is not dependent on 
the concentration of class I MHC antigen per se . Firstly, expression of 
HLA-A2 antigen following gene transfection into the HLA-negative K562 
(NK sensitive) cells did not affect NK cell-mediated lysis (quoted in 
Lotzova and Ades, 1989). Secondly, the demonstration that IFN-treated 
targets were protected from lysis by NK cells without the induction of any 
class I MHC antigen expression (Reiter et al., 1988) clearly suggests that 
other factors may also influence susceptibility. 
NK cells do not require prior sensitization or antigen presentation to be 
activated. They are not restricted by class I nor class II MHC antigens 
and it is conceivable that they may recognize a number of different 
ligands or some relatively common cell surface change, in view of their 
ability to lyse a wide range of targets. One such ligand appears to be P2-m 
(Mullbacher and ~ng, 1989), a molecule which is non-covalently attached 
to class I MHC antigen molecules expressed on the cell surface and in 
most cases is required for the surface expression of the class I antigens. 
However, class I MHC-unassociated (free) P2-m is known to be present on 
the cell surface (Solheim and Thorsby, 197 4), presumably via inositol 
linkage. Mullbacher and King (1989) used the HLA-negative K562 cells 
which otherwise express P2-m to address the role of this ligand in NK 
recognition. IFN-y treatment of these cells increased P2-m expression 
and there was a concurrent increase in susceptibility to NK cell-mediated 
lysis. It is relevant that another cell line, Daudi, which expresses neither 
P2-m or class I antigen was not susceptible to NK cell-mediated lysis even 
after treatment with IFN-y. Mab to human P2-m was shown to inhibit 
NK cell-mediated lysis of K562 targets. In addition, mouse embryo 
fibroblasts, which express little or no class I MHC and P2-m molecules, 
infected with a recombinant VV encoding human ~2-m had moderately 
increased concentrations of cell surface P2-m and concurrently exhibited 
increased susceptibility to NK cell-mediated lysis. These authors 
concluded that class I MHC-unassociated P2-m serves as a ligand for NK 
cell-mediated lysis. While class I MHC and P2-m expression must be co-
regulated to some extent, it is possible that there could be variations in the 
ratios of the two different molecules in different cell classes, thus 
allowing the possibility that free P2-m would be available as a ligand for 
NK cell recognition. It is well documented that adenoviruses specifically 
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interfere with the expression of cell surface class I MlIC antigens (Eager 
et al., 1985; Burgert and Kvist, 1985; Andersson et al., 1985; Paabo et al., 
1986), but not P2-m (Eager et al., 1985). The reduced expression of class I 
MHC antigens on adenovirus-infected cells has indeed been shown to 
reduce the efficiency of Tc cell recognition (Anderson et al., 1987). 
Whether or not NK cell-mediated lysis of adenovirus-infected targets is 
enhanced because of the availability of class I MHC-unassociated P2-m is 
not known but the hypothesis that P2-m may be a ligand for NK cells can 
be readily tested using adenovirus-infected cells. 
Infection with lymphocytic choriomeningitis virus (LCMV) efficiently 
induces IFN production and NK cell activation in mice. However, all the 
available evidence indicates that NK cells do not play any role in providing 
protection against this virus (Welsh and Kiessling, 1980; Welsh et al., 
1984; Bukowski et al., 1983). LCMV does not shut-off host RNA and 
protein synthesis and hence IFN-treated, LCMV-infected cells, like 
uninfected cells, are rendered resistant to NK cell-mediated lysis 
(Trinchieri and Santoli, 1978; Trinchieri et al., 1981; Bukowski and 
Welsh, 1985; Welsh et al., 1981; de Fries and Golub, 1988). While IFN-
induced target cell protection would ensure that uninfected cells are not 
lysed indiscriminately, it would also prevent elimination of non-
cytopathic viruses. 
2.2. Mononuclear phagocytes · 
The mononuclear phagocyte system consists of blood monocytes and 
tissue macrophages which are strategically placed in the various body 
compartments. They are not merely scavenger cells, phagocytosing and 
degrading infectious material but possess both intrinsic and extrinsic 
antiviral properties which may determine the outcome of an infection 
(Mims and White, 1984b). Their essential role as antigen presenting cells 
(APCs) in the induction of antigen-specific immune responses will be 
discussed in section 3.2.4. Macrophages have virucidal, cytotoxic, 
cytostatic and cytokine secreting potentials and these depend on the 
genetics and age of the host and the state of differentiation and activation 
of the cells (Morahan, 1980). Additionally, macrophages from different 
sites in the body may display quite distinct antiviral properties (Rodgers 
and Mims, 1981), as may subpopulations from any given site which may 
differ in susceptibility to infection (Stueckemann et al., 1982). 
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It has been clearly established that susceptibility to infection with a 
number of viruses is dependent on the outcome of virus-macrophage 
interactions (Mims, 1964). For instance, the inability of blood monocytes 
to take up polio virus type I favours persistence of viraemia. Non-
pathogenic viruses like the CL strain of VV or sublethal doses of 
influenza virus are destroyed by macrophages when injected 
intravenously into mice. Infection of mice with myxoma virus (a natural 
rabbit pathogen) and rats with ectromelia virus (a natural mouse 
pathogen) also result in abortive infection of macrophages and infection 
does not proceed. In some instances, uptake of virus and passive transfer 
to hepatic cells can occur as in the case of Rift Valley fever virus (Mims, 
1957). When liver macrophages are productively infected, release of 
progeny leads to the infection of hepatic cells as can be seen in mousepox 
(Mims, 1959) and probably in man with variola and yellow fever viruses. 
The studies by Roberts (1963) with avirulent and virulent strains of 
ectromelia virus produced strong evidence that virulence was associated 
with the ability of virus to productively infect macrophages. After 
intravenous injection, the avirulent strain of virus infected liver 
macrophages with much greater difficulty and macrophages yielded 
significantly fewer virnl particles than in the case of the virulent strain. 
The ability of ectromelia virus to infect hepatic parenchyma cells is a 
prerequisite for the pathogenesis of mousepox and is dependent on the 
susceptibility to infection of the liver macrophages; these in turn transmit 
infection to adjacent hepatocytes (Mims, 1959). Once growth in hepatic 
parenchymal cells was established, no differences between the avirulent 
and virulent mousepox virus strains could be detected (Roberts, 1963). 
Thus, in an infectious process where the outcome depends on the race 
between virus growth in liver parenchyma on the one hand, and the 
immune response on the other, a delayed initiation of viral replication in 
a major target organ is crucial for the recovery process. 
Monocyte/macrophage depletion in mice may be achieved by treatment 
with silica. This approach has been used quite extensively to evaluate the 
antiviral role of mononuclear phagocytes in vivo (Allison, 1976). Adult 
mice survive i.v. or i.p. injections with HSV-1 but elimination of 
macrophages with silica resulted in lethal hepatitis (Zisman et al., 1970). 
Furthermore, clearance of yellow fever virus from the circulation of 
silica-treated mice was significantly delayed (Zisman et al., 1971). A 
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large proportion of virus inoculated i.p. is inactivated by peritoneal 
macrophages and hence a substantially higher dose of virus is needed to 
establish infection if inoculated through the i.p. than i.v. route (Mims, 
1964). However, following i.p. treatment with silica, much lower doses of 
Friend virus, SFV and ECMV were required to establish infections 
(Zisman et al., 1970; Larson et al., 1972). 
Studies by Bang and Warwick (1960) suggested that the genetic difference 
in susceptibility of two strains of mice to MHV infection operated at the 
macrophage level. Haller ( 1981) showed that macrophages from various 
strains of mice exhibit differences in susceptibility to influenza virus 
infection. Resistance is dependent on the presence of the Mx gene, the 
expression of which is controlled by IFN-a. 
Other antiviral functions of macrophages include ADCC (MacFarlan and 
White, 1983; Smith and Sheppard, 1982) and the participation in delayed 
type hypersensitivity reaction mediated by T cells (see section 3.2. 7 .). 
Most macrophages produce IL-1 (Oppenheim et al., 1979) and there has 
been .. one report (van Damme et al., 1987; Billau, 1987) on the antiviral 
activity of IL-1 which is thought to be mediated through the secretion of 
IFN-p. IL-1 also participates in the inflammatory response as an inducer 
of inflammatory mediators (Mizel et al., 1981), acute phase proteins 
(Stzein et al., 1981) and fever (Murphy et al., 1980) which could all 
contribute to antiviral mechanisms. 
2.3. Antiviral factors 
2.3.1 The interferons 
The production of interferons (IFNs) is a regular feature of virus 
infection~. Apart from their role in NK cell activation and proliferation, 
the IFN s are perhaps the best characterized family of proteins with 
known antiviral activity both in vivo and in vitro. 
There are three antigenically distinct species of IFN s, namely alpha IFN 
(IFN-a), beta IFN (IFN-~) and gamma IFN (IFN-y). The type of IFN that 
is induced is dependent on the infecting virus and the interacting cell 
involved (Stanton and Baron, 1984). Both IFN-a and -~ are produced by 
leukocytes (T,B, null and macrophages), epithelial cells and fibroblasts 
following viral infection whereas IFN-y is produced mainly by activated 
9 
T cells after antigen-specific stimulation (Interferon nomenclature, 1980). 
Mitogens can also induce T cells to secrete IFN-y and NK cells are known 
to produce IFN-y (Randa et al., 1983; Sandvig et al., 1987; Young and 
Ortaldo, 1987). Under appropriate experimental conditions, mice with 
severe combined immunodeficiency (SCID) with no functional T- and B-
cells and athymic, nude mice can produce this cytokine (Bancroft et al., 
1987; Wentworth and Ziegler, 1987). 
IFNs are the earliest of the known mammalian inducible host-defense 
mechanisms and become operative within hours of infection. The 
induction of an antiviral state in uninfected cells is related to the capacity 
of IFNs to induce the production of a number of enzymes which may play 
important roles in the regulation of viral and cellular macromolecular 
synthesis and degradation (reviewed in Revel and Chebath, 1986; 
reviewed in Pestka and Langer, 1987). The ability of one or more of these 
enzymes to render any cell resistant to infection is dependent on the type 
of cell, the virus and the type of IFN. These parameters would determine 
the effectiveness of such a mechanism to limit viral spread. 
Earlier studies by Gresser and others (1976) suggested that IFN.;a and -~ 
contributed to antiviral function in vivo. They demonstrated that 
administration of antibodies to IFN-a and/or -P increased the severity of 
infections with HSV, Moloney sarcoma virus (MSV), vesicular stomatitis 
virus (VSV), Newcastle disease virus (NCDV) and ECMV in mice but 
infection with influenza virus was unaffected. In the light of these 
findings, it was thought that influenza virus was insensitive to the 
antiviral action of IFN s. However, there is a distinct possibility that the 
anti-IFN antibody administered i.p. or i.v. may not have reached the 
tracheobronchial epithelium (site of influenza virus replication) in 
adequate concentrations to affect local IFN activity. A point of relevance 
in this regard is the finding that influenza virus inoculated i.n. in mice 
was not affected by NK-cell depleting antibody given i.v. but infection was 
significantly exacerbated if antibody was administered intranasally 
(Stein-Streilein and Guffee, 1986). It therefore seems that viruses 
differing in the preferred site of replication (different organs) may require 
different antibody treatment procedures to demonstrate the antiviral 
activity of IFN or other components of the immune system. 
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A recent report by Leist et al. (1989) highlights the possible antiviral role of 
IFN-y in vivo. Administration of anti-IFN-y antibody enhanced titres of 
VSV and VV in normal mice. Similarly, titres of LCMV were 
significantly increased in nude and normal mice treated with IFN-y 
antibody. Antiviral Tc cell responses to VV and VSV were not affected by 
antibody treatment but anti-LCMV Tc cell response was severely 
impaired. The impaired Tc cell response to LCMV was thought to be 
partly due to 'high-dose immune paralysis' phenomenon previously 
postulated by Hotchin (1971). Similar studies by Wille et al. (1989) led 
them to suggest that the impaired anti-LCMV Tc cell response was not 
due to enhanced LCMV titres in anti-IFN-y antibody treated mice, but 
rather, the anti-IFN-y antibody inhibited the generation of Tc cell 
response. The general findings of both groups are similar, i.e. treatment 
with anti-IFN-y antibody resulted in increased LCMV titres and impaired 
the Tc cell response, but they differ in the interpretation of their respective 
results. The crucial point is increased LCMV titres and impaired Tc cell 
response always go together. The question then is "what is cause and 
what is effect?" The two possible explanations are: i) titres of LCMV 
increase because Tc cell response is impaired by treatment with anti-
IFN-y, ii) Tc cell response is impaired because anti-IFN-y antibody 
inhibited clearance of LCMV which consequently affected Tc cells. If the 
former explanation were true, then Tc cell responses to VV and VSV 
should also have been impaired, but they were not. The latter explanation 
seems more likely because LCMV titres in T cell-deficient nude mice 
increased significantly following anti-IFN-y antibody treatment (Leist et 
al., 1989). Adoptive transfer of LCMV-immune Tc cells into virus-infected 
and IFN-y antibody-treated mice should provide the evidence consistent 
with the above argument. 
To address the role of IFN-y in antiviral immunity, Kohonen-Corish et al. 
(1990) inserted the murine IFN-y (Mu-IFN-y) gene into VV genome. The 
recombinant virus, designated VV-Mu-IFN-y, was found to be highly 
attenuated in athymic nude mice and euthymic normal mice. Nude mice 
survived an infection with VV-Mu-IFN-y but not with a control 
recombinant VV not encoding Mu-IFN-y or another recombinant VV 
encoding human IFN-y (IFNs are strictly species specific). VV-Mu-IFN-y 
was cleared from ovaries of normal mice by day 4 pos"t-infection whereas 
between 6-8 log10 PFU of the control viruses were recovered from ovaries 
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at day 5. The mechanism of rapid VV-Mu-IFN-y clearance was not 
mediated by antibody, NK cells or anti-VV Tc cells. The available 
evidence suggested that virus-encoded murine IFN-y most likely 
contributed to viral clearance through direct antiviral activity. Based on 
these observations, the authors raised the possibility that the major 
function of immune Tc cells (known to produce IFN-y) was to focus the 
secretion of antiviral cytokines like IFN-y at sites of viral infections. 
While this speculation has some basis, it is clear that IFN-y has other 
known functions which could potentially contribute to the process of virus 
clearance. Apart from its capacity to induce an antiviral state in 
uninfected cells, IFN-y can activate mononuclear phagocytes to increase 
their virucidal capacity as well as upregulate the expression of class I 
MHC antigen expression (see below) on targets which could increase the 
sensitivity of Tc cell recognition. The kinetics of VV-Mu-IFN-y clearance 
in that study suggests the possibility that virus-encoded IFN-y, produced 
early in infection, may have activated mononuclear phagocytes which 
contributed to virus clearance. Data presented in Chapter 5 is consistent 
with this argument. The role of IFN-y in antiviral immunity will be 
discussed further in section 3.2.5.1. and Chapter 5. 
Apart from their direct antiviral function, IFNs also play an important 
role in immunoregulation which could determine the outcome of a viral 
infection or disease. All the three species of IFN s upregulate the 
expression of class I MHC antigens and ~2-m, but IFN-y is the most 
potent and is the only IFN that upregulates the expression of class II 
MHC antigens. IFN-induced expression of class 1 MHC antigens and ~2-
m on virus-infected cells may contribute to antiviral mechanisms 
possibly by enhancement of Tc (Bukowski and Welsh, 1985; King et al., 
1986) and possibly NK (Mullbacher and King, 1989) cell recognition. 
Additionally, IFN-y-induced expression of class II MHC antigens on 
some cell types such as macrophages and Langerhans cells has possible 
immunological implications particularly with regard to antigen 
presentation (reviewed in Janeway et al., 1984). Thus, if the basal level of 
the cell-surface histocompatibility antigens is below the threshold 
concentration normally required for efficient T cell responses, then the 
IFN-induced increase in levels of class I and class II antigens could 
represent an important component of the host response to virus 
infections. It should be emphasized that the threshold level may vary in 
different experimental systems. 
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2.3.2. Tumour necrosis factors-a and -~ 
The production of TNF-a, first described as a factor that caused necrosis 
of tumours (Carswell et al., 1975), is triggered by a variety of stimuli 
including viruses (Aderka et al., 1986; Wong and Goedde!, 1986). 
Although macrophages are the principal TNF-a producers (Carswell 
et al., 1975), mast cells (Young et al., 1987) and activated T cells 
following mitogenic stimulation (Turner et al., 1987) may also produce 
this cytokine. 
Recently, TNF-a was shown to have intrinsic antiviral activity on some 
cell types in vitro (Kohase et al., 1986; Mestan et al., 1986; Wong and 
Goedde!, 1986), and to act synergistically with the antiviral activity of 
IFN-a, -~ and-yon a variety of cell types against a number of RNA and 
DNA virus infections (Wong and Goedde!, 1986; Mestan et al., 1988; Reis 
et al., 1989). Furthermore, TNF-~ can selectively lyse virus-infected but 
not uninfected cells in vitro (Aderka et al., 1985). This mode of action is 
believed to be related to the known increased cytocidal activity of the 
cytokine in cells treated with inhibitors of cellular RNA or protein 
synthesis. This suggests that only viruses that shut-off host RNA or 
protein synthesis would make infected targets susceptible to lysis. Wong 
and Goedde! (1986) have also shown that TNF-a inhibits replication of 
some RNA and DNA viruses in the absence of an apparent contribution of 
endogenous IFNs. They further demonstrated that TNF-~ (lymphotoxin) 
also possessed antiviral activity in vitro which could be greatly enhanced 
in synergy with TNF-a. It is interesting to note that each of the soluble 
mediators described so far have intrinsic antiviral properties which can 
be amplified by the synergistic interactions with another of these factors. 
The precise in vivo antiviral role of TNF-a and -b have not been elucidated. 
2.4. The alternative complement pathway 
The alternative or properdin pathway of the complement system is 
essentially a bypass system for the classical pathway and may not require 
the presence of antibody (reviewed in Hirsch, 1982). 
Several viruses or virus-infected cells, including Sindbis, VSV, measles 
and RSV (Smith et al., 1981; reviewed in Hirsch, 1982) directly activate the 
alternative complement pathway. Because this pathway is antibody-
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independent, it can be activated immediately after viral invasion, before 
antigen-specific immune responses have been generated. Evidence for a 
precise role for complement in antiviral function in humans is lacking. 
3. Adaptive Immunity 
3.1. The major hist.ocompatibility complex (MHC) 
The murine major histocompatibility gene complex (H-2) comprises the 
K, I and D regions (Klein, 1975; Snell et al., 1976; reviewed in Klein, 1986). 
The Kand D regions encode the class I (Kand D) glycoproteins whereas 
the I region encodes the class II (Ia) glycoproteins . The class I antigens 
are expressed virtually on all somatic cells but class II antigen 
expression is limited to certain cell types like B cells (Sachs and Cone, 
1973), dendritic cells (Steinman, 1981), some populations of macrophages 
(Beller and Unanue, 1981) Langerhans cells (Freilinger et al., 1981) and 
intestinal epithelial cells (Parr and McKenzie, 1979). The MHC gene 
products restrict the activities of T cells with specificity to foreign 
antigens. 
3.2. T Lymphocyt.es 
Thymus derived (T) lymphocytes may be distinguished from bone marrow 
or bursa derived (B) lymphocytes by the presence of antigens recognizable 
by monoclonal antibodies (Mab). In man these are the OKT, CD4 and CDS 
antigens and in mice the Thy-1, Ly and Qa antigens (reviewed in 
McKenzie and Potter, 1979; Sutton et al., 1989). Although the Thy-1 
antigen is expressed by all T cells, it is not exclusively a T-cell antigen 
since some nonhaematopoietic cells (Reif and Allan, 1964; reviewed in 
Mckenzie and Potter, 1979) and NK cells (Hackett et al., 1986) are Thy-1+. 
T cells have been classified into subsets according to surface antigen 
expression and function. The two main subsets of peripheral T cells in 
the mouse are Lyl +2-3- (Lyl) and Ly1-2+3+ (Ly2,3). Using antisera 
directed against Lyl and Ly2, T cells mediating DTH and involved in T-B 
cell collaboration were found to be of the Lyl +2- phenotype whereas most 
Ly1-2+ T cells had a cytotoxic function (Kisielow et al., 1975; Cantor and 
Boyse, 1975). With the advent of more sensitive methods like flow 
cytometry, Ly2,3 T cells were found to express low levels of the Lyl 
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molecules (Mathieson et al., 1979; Ledbetter et al., 1980) and therefore Lyl 
is not a suitable marker for differentiating T lymphocyte subsets . 
Subsequently, a Mab which recognized an antigen designated L3T4 was 
found to be expressed solely on Lyl +2- T cells (Dialynas et al., 1983a, b). 
Using the CD nomenclature, the antigenic determinant defined by L3T4 
has been designated CD4 while the Ly2 antigen has been designated CDS. 
The CD4+ T cell population includes subsets that mediate helper/inducer 
functions (Th), DTH (Td) and in some instances cytotoxicity. Recently, Th 
cells have been further subdivided into Thl and Th2 on the basis of 
different patterns of cytokine secretion and function (Mosmann et al., 
1986; reviewed in Mosmann .and Coffman, 1989). The Thl subset 
mediates DTH and corresponds functionally to Td. The Th2 subset is 
involved in helper functions. CDS+ T cells mediate cytotoxic (Tc) 
functions. Suppressor T (Ts) cells may be CD4 + or CDS+ and regulate the 
antigen-specific immune response by inhibiting the effector functions of 
Th, Td, and Tc (G_ershon and Kondo, 1970; Germain and Benacerraf, 
1981; reviewed in Klein, 1986) and will not be discussed here . 
. 
The majority of peripheral CD4 + and CDS+ T cells in the mouse express 
the a~-TCR but a small proportion of T cells express the yo-TCR and are 
mainly CD4-, CDS- (Brenner et al., 1986; Bank et al., 1987; reviewed in 
Brenner et al., 1988; Janeway et al., 1988; Bluestone and Matis 1989). It is 
not known if yo-TCR+ T cells have any antiviral function. The TCR 
heterodimers (a~ or yo) are usually associated with other molecules of the 
CD3 complex (reviewed in Clevers et al., 1988). 
3.2.1. Antigen recognition and MHC-restriction of T cells 
The induction of an antigen-specific immune response is dependent on 
antigen recognition by clonally-specific T and B cells. T and B cells 
"perceive" antigens in completely different ways. 
Antigen-specific B cells recognize and bind to epitopes dependent upon 
protein or carbohydrate structure via surface immunoglobulin (slg) 
(Wigzell and Makela, 1970; Greaves and Hogg, 1971; reviewed in 
Benjamin et al., 1984). Two classes of protein B-cell epitopes are known. 
Conformational epitopes are defined as those which are dependent on the 
native spatial conformation of protein whereas sequential epitopes are 
those dependent only on the amino acid sequence of the corresponding 
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peptide segment (Sela et al., 1967; Sela, 1969). However, B-cell binding to 
either class of epitopes is not different. These epitopes are regarded as 
topographic, i.e. they are composed of structures on the protein surface. 
The antibody synthesized following B cell activation binds to protein 
antigen based on its original conformation as originally "perceived" by 
sig on the B cell. 
T cells, on the other hand, recognize antigen only when it is presented on 
the surface of other cells in association with appropriate class I or class 
II MHC molecules, a phenomenon known as MHC restriction. Antigen 
recognition requires intracellular degradation of protein (antigen 
processing), association with MHC molecules and presentation to T cells 
by antigen presenting cells. Recent evidence suggests that foreign 
antigens recognized by T cells are processed intracellularly into short 
peptides (Shimonkevitz et al., 1983) prior to association with MHC 
molecules. Hence, peptides derived from processed antigen in APCs or 
target cells (Babbit et al., 1985; Townsend et al., 1986a) bind to the MHC 
molecules and the peptide-MHC molecule complex is presented on the 
surface of these cells. 
3.2.2. Antigen processing 
At least two distinct pathways of antigen processing exist (reviewed in 
Morrison et al., 1986a, b; Braciale et al., 1987a; Long, 1988; Long, 1989). 
These pathways, depending on the nature of antigens, i.e., endogenous or 
exogenous, determine whether antigen is recognized by class I- or class 
II-restricted T cells. Class I MHC antigens are restriction elements for 
CDs+ T cells and class II MHC antigens are restriction elements for 
CD4 + T cells. 
The primary requirement for entry of antigen into the class I pathway of 
processing and presentation is a cytoplasmic localization. In addition to 
cellular proteins undergoing normal degradation, this requirement may 
also be met during viral infection. Class I-restricted T cells recognize 
peptides derived from endogenous viral protein synthesis (Townsend et 
al., 1986a, b; Braciale et al., 1987a, b). Such peptides complex with de novo 
synthesised and/or recycling class I MHC molecules before presentation 
on the surface of APCs or target cells. Most somatic cells express class I 
molecules and all class I-bearing cells are thought to be capable of 
antigen presentation although some lack "signal 2" for primary T cell 
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activation (Andrus et al., 1980; Lafferty et al., 1980; Lafferty et al., 1983; 
Lafferty, personal communication) (see section 3.2.4.) 
For exogenous antigens presented in the context of class II MHC 
molecules, intact antigens enter the cell by means of endocytic vesicles 
either by pinocytosis or receptor-mediated endocytosis. Endocytosed 
antigen is degraded in acidic lysosomes. The resulting peptides are 
complexed with class II MHC molecules and then expressed on the 
surface of Ia+ APCs (reviewed in Schwartz, 1985; Germain, 1986). Thus, 
the antigens processed and presented by Ia+ APCs, e.g. B cells, dendritic 
cells and macrophages, are only seen by class II-restricted T cells. There 
may be exceptions to this rule as demonstrated by the observation that 
some exogenous antigens can be presented by class I molecules (Staerz, 
1987; Yewdell et al., 1988). Fusion of non-infectious influenza virus with 
cell membrane causes viral proteins to enter the class I pathway of 
antigen processing (Yewdell et al., 1988) 
The generally accepted concept that CD4 + and CDS+ T cells recognize 
processed forms of protein antigens together with MHC molecules is 
consistent with evidence that both types of cells share a common pool of 
TCR V genes (reviewed in Kronenberg et al., 1986; Davis and Bjorkman, 
1988) which belong to the immunoglobulin supergene family. The 
reasons for CD4 + T cells being class II MHC-restricted and CDS+ T being 
class I MHC-restricted therefore probably resides in the fact that CD4 
binds to class II MHC and CDS binds to class I MHC and that this binding 
is usually required for T cell activation (Doyle and Strominger, 1987; 
Ratnofsky et al., 1987). 
Because T cells have only one receptor (TCR) that accounts for both 
antigen and MHC specificity (Dembic et al., 1986), the association of 
peptide (usually of 6-20 amino acid residues) and the MHC molecule 
becomes a crucial factor in the initiation of the immune response. It 
should be emphasised here that the specificity of T cell recognition is 
governed by the peptide-MHC molecule complex (epitope) and not the 
peptide alone. 
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3.2.3. MHC restriction of Th and Tc cells 
In the induction of an antibody response, antigen-specific B cells interact 
with antigen-specific Th cells (Mitchison, 1971). This interaction is MHC-
restricted (Kindred and Shreffier, 1972; Katz et al., 1973). Antigen bound 
by the B cell is internalized and processed as by other APCs and displayed 
on the surface in association with class II MHC molecules. The antigen-
specific, class II-restricted CD4+ Th cells that recognize peptide plus 
MHC are triggered to produce B cell growth factors which result in the 
clonal expansion of antibody producing B cells. The importance of MHC 
restriction was also demonstrated in macrophage-Th cell interactions 
(Rosenthal and Shevach., 19.73). 
The subsequent demonstration by Zinkernagel and Doherty (1974) that 
virus-immune Tc cells killed infected targets only if the effector and target 
cell types shared the same class I MHC (KID) antigens not only indicated 
that Tc cells were MHC-restricted but also the provided a basis for 
understanding the role and in vivo significance of MHC encoded antigens 
and the function of Tc cells in antiviral immunity (reviewed in 
Zinkernagel and Doherty, 1979). 
3.2.4. T-cell activation 
The development of the adaptive-immune response to viral infection 
requires the activation of B, Th and Tc cells. This results in the clonal 
expansion of these antigen-specific lymphocytes and their differentiation 
to acquire effector function manifested either by secretion of bioactive 
molecules (e.g. cytokines or antibody) or the development of cytotoxic 
function. This review will be confined to activation of T cells only. 
The most crucial event in T cell activation is the interaction of the 
TCR/CD3 complex with the antigen-MHC molecule complex. If this 
binding achieves the required threshold load, protein kinase C activation 
is triggered in the T cell and production of inositol 1,4,5-triphosphate then 
mobilizes intracellular calcium. This is followed by the secretion of T cell-
derived factors (cytokines) involved in proliferation, differentiation and 
activation of lymphocyte subsets (see below). There is evidence that CD4 
and CDS molecules participate as crucial accessory molecules in the 
interactions of T cells with the APCs (Gabert et al., 1987). Their 
contribution is particularly important when the binding between peptide-
' 
I 
I 
' 
I 
' 
I 
I 
I 
I 
I 
I 
I 
I 
18 
MHC complex and TCR is of low affinity. Other molecules like ICAM-1 
and LF A-1 also participate as accessory molecules in the binding of T 
cells to APCs (Dustin et al., 1988). 
3.2.4.1. Th cell activation 
The antigen-specific activation of Th cells is dependent upon two distinct 
but interdependent APC signals. APCs are required to process and 
present antigen to Th cells. This function is normally a property of an Ia+ 
subpopulation of macrophages, dendritic cells and B cells. Binding of the 
TCR, by the peptide-Ia molecule complex constitutes the first signal. The 
second macrophage-derived T cell activating signal (co-stimulatory 
signal) is provided by interleukin-I (IL-1) (Aarden et al., 1979) that is 
apparently produced by all macrophages (Oppenheim et al., 1979) though 
not all Th cells require IL-1 (Kurt-Jones et al., 1987; Greenbaum et al., 
1988; Weaver et al., 1988). The nature of other possible co-stimulators in 
T-cell activation by APCs such as B cells and dendritic cells is currently 
unknown. One of the major functions of IL-1 in T-cell activation is 
induction of the synthesis and secretion by T cells of the T-cell growth 
factor, IL-2, and expression of the IL-2 receptor (IL-2R) ( Smith et al., 
1980a; Larsson et al., 1980; Waldman, 1986; Smith, 1988; Weiss, 1989). 
Secretion of IL-2 and expression of IL-2R by T cells occur for a finite time 
interval after TCR binding to epitopes on APC and IL-1 action. The 
subsequent utilization of IL-2 dictates the progression of only the 
responsive (and hence antigen-specific) T cells from the Go to G1 and 
eventually the S phase of the cell cycle (Stern and Smith, 1986). The 
ultimate determinant of the magnitude of any response, however, is a 
function of the concentration of T cell epitopes (peptide-Ia complexes) on 
APCs (Matis et al., 1983) which trigger the cascade of events outlined 
above. 
3.2.4.2. Tc cell activation. 
Most of the inferences made regarding requirements for induction of Tc 
cell responses have been drawn from observations of alloreactive Tc cell 
generation in vitro. Also, the primary and secondary T cell activation 
requirements may be different (Lafferty et al., 1980). 
Initiation of CDS+ Tc cell activation requires binding of the TCR to peptide-
class I MHC molecule complexes on APCs or target cells as the first 
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signal. Earlier studies (Wagner et al. 1973; Bach et al. 1976; Larsson et al. , 
1980) have suggested that at least 2 signals are necessary for the 
generation of alloreactive Tc cells from precursors. The co-stimulatory 
signal may be provided by IL-1 in the case of AP Cs but it is not clear if 
non-lymphoreticular cells can provide such a signal or if indeed IL-1 is 
the only such signal required. That the second signal be provided by IL-2 
is widely accepted (Wagner et al., 1980a; Smith et al., 1980b; Lafferty et al., 
1980; Lafferty et al., 1983). However, there have been indications that a 
third signal may be involved for Tc cell activation (Farrar et al., 1981; 
Raulet and Bevan, 1982; Falk et al., 1983; Kanagawa, 1983; Wagner and 
Hardt, 1986). Farrar et al (1981) proposed that induction of Tc cell 
response involves a linear cell-factor interaction in which IL-1 
(macrophage derived) stimulates T cells to produce IL-2, which in tum 
stimulates T cells to produce IFN-y. IL-2 alone can induce proliferation 
and differentiation but IFN-y may be important to acquire cytolytic 
function. That the third signal may be IFN-y was also suggested by a 
number of other reports (Simon et al., 1979; Klein and Bevan, 1983; 
Giovarelli et al., 1988; Siegel, 1988). According to Klein and Bevan (1983), 
IL-2 is a requisite signal not only for the development of Tc effector 
function but also for the production of IFN-y, and that Tc effector function 
and IFN-y release are closely associated immunologic events. Because 
generation of alloreactive Tc cell responses could be ablated by antibody to 
IFN-y (Simon et al., 1986; Siegel, 1988; Giovarelli et al., 1988), these reports 
suggested that IFN-y is neccessary for the induction of cytolytic activity 
but some others (Bucy et al., 1988) do not share this view. 
Tc cell activation can occur without CD4+ Th-Tc cell interaction (Mizuochi 
et al., 1985; reviewed in Singer et al., 1987) and the helper function in the 
generation of allogeneic Tc cell responses can be provided by a CD4-CD8+, 
lymphokine secreting population of T cells. Anti-VY Tc cell responses 
can be generated in vitro in the absence of CD4 + T cells but in the 
presence of IL-2 secreting CDS+ T cells (Mizuochi, 1989) (see section 
3.2.6). There are indications that IL-4, IL-5 and IL-6 may also be involved 
in Tc cell activation as demonstrated in vitro. IL-4 and IL-5 are known B-
cell stimulatory and differentiation factors (Kishimoto, 1988). Virus 
infection stimulates the production of IL-6 (IFN-~2), a cytokine that is 
produced by fibroblasts, endothelial cells, monocytes/macrophages, T and 
B cells (Mizel, 1989). In vitro, this cytokine is known to stimulate T cell 
proliferation, induce IL-2R expression and induce the generation of Tc 
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cell responses. Whether IL-4, IL-5 and IL-6 are involved in Tc cell 
generation in vivo is yet to be elucidated. 
3.2.4. Cytokines and regulation of the immune response 
Apart from the cytokines described above, a variety of others including 
IL-3, IL-5, IL-7 ', TNF-a and -P, and colony stimulating factors (CSF) 
regulate the proliferation, differentiation, maturation and activation of 
lymphoid and non-lymphoid cells involved in the immune response 
(Mizel, 1989). Activation of cytokine gene expression is rapid and 
transient. The inflammatory response that requires cell proliferation and 
activation may be restricted to the site of cytokine production, since these 
soluble factors appear to be released in small amounts in a rather 
localized space in the vicinity of interacting cells so that effective 
concentrations only occur near the site of production (Poo et al., 1988). In 
addition, the production and activity of cytokines are tightly regulated. 
The triggering of cytokine production in the process of T cell activation in 
viral infections is a function of epitope (formed by a complex of viral 
peptide and MHC) concentration (Sinickas et al., 1985). Hence, 
elimination of virus (antjgen) will eliminate the trigger and lead to 
termination of the response. 
3.2.5. Cytot.oxic T (Tc) cells 
Cytotoxic activity of a T lymphocyte is triggered by binding of the TCRs to 
epitopes on the target cells (or by binding of mitogen to the T cells). Once 
this occurs, the Tc cells can lyse any cell displaying the relevant epitope in 
the near vicinity. Tc cell responses can be made to allogeneic or 
xenogeneic cells, to syngeneic cells bearing chemically modified 
determinants or to virus infected or transformed cells (reviewed in 
McKenzie and Potter, 1979; reviewed in Klein, 1986). Tc cells have clearly 
demonstrable antiviral function in vivo. The classical antiviral Tc cells 
are CDS+ and recognize viral peptides on the surface of infected cells in 
association with self class I MHC molecules (Zinkernagel and Doherty, 
1974; Blanden et al., 1975; reviewed in Zinkernagel and Doherty, 1979; 
Swain and Dutton, 1980; Townsend et al., 1986a, b). Recently, the 
existence of class II MHC-restricted, CD4 + Tc cells have been described 
but their importance in antiviral immunity is unclear (Meuer et al., 1983; 
Misko et al., 1984; Morrison et al., 1986a, b; Jacobson et al., 1984). 
21 
3.2.5.1. Classical CDS+ Tc cells 
The importance of class I MHC-restricted antiviral Tc cells in recovery 
from primary viral infections is well recognized (reviewed in Blanden, 
1974; McMichael et al., 1983; Mims and White, 1984a). In retrospect, the 
relative importance of cellular versus hum.oral immunity in the human 
primary response to poxviruses (and viruses in general) was evident in 
the observations of patients with immune deficiency diseases (Fulginiti 
et al., 1968). Patients with congenital or acquired aggammaglobulinemia 
could be successfully vaccinated against smallpox and recovered from 
measles and other childhood viral diseases. In contrast, thymus-
deficient children developed severe generalized vaccinial infections 
following vaccination and were not helped by transfusion of immune 
globulin. Such observations could not be interpreted fully prior to the 
definition of lymphocyte subsets and their functions. 
Among the most definitive demonstrations of the antiviral effector 
functions of Tc cells are the models of host defense to primary viral 
infections in mice (Blanden, 1971b; Zinkemagel and Welsh, 1976; Yap and 
Ada, 1978b; Yap et al., 1978; Reddhase et al., 1987). 
In a series of crucial experiments, Blanden (1970; 1971a, b) established an 
essential role for T cells in recovery from mousepox, a generalised viral 
infection in mice. An important event in the recovery process was the 
recruitment of mononuclear phagocytes into foci of infection by 
specifically activated antiviral Tc cells. Based on these studies, a 
mechanism whereby Tc cells exerted antiviral function in vivo was 
suggested (Blanden, 1971b). Firstly, by virtue of their cytolytic capability, 
antiviral Tc could halt virus spread by destruction of infected cells before 
assembly of progeny virus. Secondly, the recruitment of mononuclear 
phagocytes by the antiviral Tc cells and their subsequent activation would 
allow the destruction of virus~infected material by phagocytosis. Finally, 
effector Tc cells may secrete IFN at sites of infection, thus protecting other 
cells in the immediate vicinity from being infected. Subsequent studies by 
Blanden and Gardner (1976) indicated that the kinetics of generation of 
splenic anti-ectromelia virus Tc cell activity were similar to transferred 
protective activity. They raised the possibility that the effector T cell 
populations that lysed virus-infected targets in vitro could be identical to 
those which conferred protection in vivo. 
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The in vivo protective effect of antiviral Tc cells is absolutely dependent on 
the transferred immune Tc cells and the recipient sharing at least the K 
or D regions of the H-2 gene complex, but H-2I region-compatible T cells 
do not confer any significant level of protection (Kees and Blanden, 1976; 
Zinkernagel and Welsh, 1976; Ertl et al., 1977; reviewed in Zinkemagel 
and Doherty, 1979). Using H-2 mutant mice, the fine specificity of the 
MHC restriction of T-cell mediated antiviral protection was shown to 
correspond to that of Tc cells (Kees and Blanden, 1976). 
The direct involvement of Tc cells in antiviral immunity through their 
ability to destroy infected host cells is strongly suggested by numerous in 
vitro and in vivo experimental systems (Blanden and Gardner, 1976; Ada 
et al., 1976; Zinkemagel and Althage, 1977; Koszinowski and Ertl, 1976; 
Zinkemagel et al., 1977; Yap and Ada, 1978a, b; Yap et al., 1978; reviewed 
in Zinkernagel and Doherty, 1979; Lukacher et al., 1984). Mullbacher and 
Ada (1987) have discussed evidence in favour of the cytolytic function of Tc 
cells in vivo but there is no direct evidence to demonstrate the in vivo 
killing of virus-infected cells in solid tissues. Recently, Liu and 
Mullbacher (1989) demonstrated that transferred alloreactive Tc cells kill 
host macrophages in the peritoneal cavity by programmed cell death 
(apoptosis), one mode of killing exercised by Tc cells. Thus, it may be 
possible to demonstrate antiviral Tc cell- mediated lysis of infected cells by 
apoptosis in solid tissues. It should be emphasised that Tc cell-mediated 
lysis can occur by a number of ways and apoptosis is only one of them. 
The question of whether Tc cells exert antiviral function in vivo through 
cytolytic activity still remains controversial and will not discussed 
further. What warrants consideration, however, is the the role of 
cytokines, particularly IFN-y, in Tc cell-mediated antiviral function in 
vivo. 
Both alloreactive and antiviral CDS+ Tc cells produce IFN-y when 
stimulated appropriately in an antigen-specific and MHC-restricted 
manner (Glasebrook et al., 1981; Morris et al., 1982; Klein et al. , 1982; 
Prystowsky et al., 1982; reviewed in Mosmann and Coffman, 1989). The 
availability of cyclosporine A (CsA) which inhibits the synthesis and 
secretion of cytokines like IL-2 and IFN-y by Tc cells but not the cytotoxic 
activity (Andrus and Lafferty, 1982; Prowse et al., 1985; Schiltknecht and 
Ada, 1985a, b, c; Hodgkin et al., 1987; Noble and Steinmuller, 1989; 
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Granelli-Piperno, 1990) has provided an excellent tool for the analysis of 
the physiological function of Tc cells in vivo. 
In a series of experiments, Schiltknecht and Ada (1985a, b, c) established 
that in CsA-treated mice, influenza virus could not be cleared and 
persisted at very high titres; specific immune responses were delayed or 
of lesser magnitude (antibody and Tc cell responses) or apparently absent 
(DTH response), compared to untreated controls (Schiltknecht and Ada, 
1985a). CD4+ T cells obtained from CsA-treated, virus-infected mice could 
transfer DTH to recipient mice infected a few hours earlier with influenza 
virus, suggesting that anti-influenza Td cells were generated in mice 
treated with CsA but the effectors could not function in vivo (1985b). 
Similarly, in adoptive transfer experiments with anti-influenza Tc cells, 
transferred cells did not reduce virus titres in CsA-treated animals, 
unlike untreated controls (Schiltnecht and Ada, 1985c). Equal numbers of 
the transferred cells were shown to reach 1 ungs in both groups. These 
findings led them to suggest a role for lymphokine release by Tc in vivo for 
antiviral protection. Their suggestions were consistent with an earlier 
report by Taylor and Askonas (1983) who described the in vivo antiviral 
functions of two influenza virus-specific T-cell clones. Only the clone that 
produced IFN-y on exposure to influenza virus-infected syngeneic targets 
in vitro reduced lung virus titres in vivo. This was despite the fact that a 
smaller number of cells of the IFN-y-producing clone reached the lungs 
compared to the other clone. However, data obtained by yet another group 
(Lukacher et al., 1984) suggested that it was the direct cytolytic activity 
and not lymphokine production which was critical for the expression of 
antiviral function by Tc cells in the influenza model. Based on these 
findings, Schiltknecht and Ada (1985c) postulated that that the 
lymphokines secreted by T cells in vivo may have an indirect role. The 
secretion of IFN-y by Tc cells could enhance the expression of class I MHC 
antigens on infected lung cells which would make them more susceptible 
to lysis. 
The relative importance of IFN-y-induced upregulation of MHC antigens 
for the expression of Tc cell function in vivo is exemplified by a recent 
study using alloreactive Tc cells. Lafferty and colleagues (Prowse et al., 
1985) previously established that islet graft destruction by primed CDS+ T 
cells is CsA sensitive, and therefore islet rejection is a cytokine-dependent 
process. To further address the role of cytokines in Tc cell-mediated graft 
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rejection, they (Hao et al., 1990) used an alloreactive CDs+ Tc cell clone 
which produced IFN-y and TNF-P but not IL-2 or IL-3. The clone, known 
to transfer allograft immunity was found to be sensitive to CsA in vivo, 
suggesting that IFN-y and/or TNF-P may be involved in allograft 
rejection. Thus, mice transplanted with pancreatic islets rejected the 
graft when the alloreactive Tc cell clone was transferred but failed to do so 
if treated with CsA. However, pretreatment of the islet tissue with IFN-y 
prior to grafting was shown to increase class I lvllIC antigen expression 
on the islet tissue and CsA could no longer block the destruction of these 
islets in vivo by the transferred alloreactive Tc cells in 11 of 15 mice. The 
authors concluded that the cytokine dependence of islet allograft rejection 
was due, at least in part, to the activity of IFN-y which acts by increasing 
MHC antigen de~sity on the target tissue, rendering it sensitive to a 
cytotoxic attack. This finding is consistent with the postulation of 
Schiltknecht and Ada (1985c) but the possibility that IFN-y may also 
contribute to allograft rejection or antiviral function by other means 
cannot be excluded .. Other potential roles of IFN-y in antiviral immunity 
will be addressed further in Chapters 5. 
A recent study (Ruby and Ramshaw, submitted) has provided evidence 
that anti-VV CDS+ Tc cell function in vivo is dependent on IFN-y. Normal 
CBA/H mice treated daily with a Mab to IFN-y following infection with 
VV were unable to clear virus, which resulted in 100% mortality from an 
otherwise sublethal infection. In another VV-infection model, transfer of 
CDS+, anti-VV Tc cells to infected mice reduced VV titres by 4 log10 PFU 
within 3 days. However, the antiviral activity of transferred anti-VV Tc 
cells was completely abrogated in recipient mice which had been infected 
with VV and treated with anti-IFN-y Mab, indicating that IFN-y was a 
crucial component of Tc cell-mediated clearance of VV. 
The importance of Tc cells in control of viral infections has been further 
demonstrated using athymic nude mice. Due to a lack of functional T 
cells, these mice usually succumb to viral infections and die (Ertl et al., 
1977; Grundy and Melief, 1982; Yap et al., 1979). Influenza virus-infected 
nude mice can be saved by transfer of immune Tc cells (Yap et al., 1979) 
but not immune serum (Yap and Ada, 1979). Recently, Ramshaw and 
colleagues (1987) have shown that such T-cell deficient mice can 
successfully resolve an infection with recombinant VV encoding murine 
IL-2. Further investigations revealed that the recovery was not T-cell 
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mediated and suggested a possible involvement of NK cells (Karupiah et 
al., 1990) and IFN-y. The mechanisms of recovery of nude,from infection 
./ 
with the IL-2-encoding VV mice will be addressed in the later chapters. 
As discussed, classical ens+ antiviral Tc cells only recognize epitopes 
consisting of a complex of class! MHe with a peptide derived from viral 
antigen expressed in the cytosol (Townsend et al., 1985; Townsend et al., 
1986a, b; Morrison et al., 1986a, b; Braciale et al., 1987a; reviewed in 
Townsend and Bodmer, 1989). Because these class I molecules are 
expressed virtually on all somatic cells, any infected cell can be 
eliminated by the appropriate virus-specific Tc cells. However, MHe 
class II-restricted en4+ Tc cells do exist and their possible physiological 
role is discussed below. 
3.2.5.2. CD4+ MHC class II-restricted Tc cells 
The existence of class II MHe-restricted, en4 + Tc cell responses have 
been reported for influenza virus (Fleischer et al., 1985; Lukacher et al., 
1985; Morrison et al., 1986a, b), HSV (Schmid, 1988; Yasuka and Zarling, 
1984), EBV (Meuer et al., 1983; Misko et al., 1984) and measles virus 
(Jacobson et al., 1984). Whereas influenza virus infection elicits both 
class I- and class II-restricted Tc, the Tc response to measles virus is 
primarily class II- restricted. In all of the above studies, cloned en4 + Tc 
cells have been used. A cloned anti-influenza en4+, class II-restricted 
line with Tc activity was even shown to provide protection in mice against 
lethal influenza infection (Lukacher et al., 1985). While the above finding 
provides definitive evidence for an antiviral function, the relative 
importance of class II-restricted Tc in comparison to class I-restricted Tc 
cells during a normal (or experimental) infection would vary in different 
virus-host combinations and different target organs. From the studies of 
Lukacher et al (1985) it is not clear how class II-restricted Tc cells would 
directly eliminate virus-infected cells that only express class I MHe 
antigens. 
3.2.6. Helper T (Th) cells 
en4 + T cells are generally designated helper (Th) cells but this 
terminology is inappropriate. This subset of T cells mediates a variety of 
different functions, one of which is to provide 'help ' to antigen-specific B 
cells and ens+ Tc cells for activation. It is now evident that Cn4 + T cell 
help is not mandatory for the generation of CDS+ antiviral Tc cell 
responses. The 'help' provided by CD4 + T cells is through secretion of 
cytokines involved in-lymphocyte activation. It is also clear that CD8+ T 
cells can produce cytokines and hence provide helper functions for the 
generation of Tc cell responses (Andrus et al., 1984; Mizuochi et al., 1985, 
1989). 
Since most viral antigens are T-dependent (Bums et al., 1975), the 
generation of virus-specific immune responses requires interaction 
between CD4+ Th cells and APCs. CD4+ Th cells recognize an epitope 
formed by a complex of viral peptide on APCs with class II l\'1HC molecule 
(Unanue and Allen, 1987; Unanue and Cerottini, 1989). The TCR binding 
to this epitope initiates activation of CD4 + Th cells followed by diverse 
cellular interactions that result in antigen-specific B cell activation and 
development of inflammatory reactions. 
B-cell activation is induced by cytokines· secreted by CD4 + Th cells. These 
cytokines, namely IL-4, IL-5 and IL-6 are involved in B-cell growth and 
differentiation and an~body isotype switching (reviewed in Kishimoto, 
1985; O'Garra et al., 1987; Kishimoto, 1988; revievved in Mosmann and 
Coffman, 1989). IL-4 and IL-5 are only produced byCD4+ Tcells of the Th2 
subset which also utilize IL-4 as an autocrine growth factor. CD4 + Thl 
cell-derived cytokines such as IL-2 and IFN-y are also involved in antigen-
specific B cell responses. T cell help is essential for the generation of 
antigen-specific IgA and IgG antibody responses. The role of antibody in 
antiviral responses will be briefly dealt with in section 3.3. 
Inflammatory responses are mediated by CD4 + T cells of the Thl subset 
which secrete IL-2 and IFN-y and utilize IL-2 as an autocrine growth 
factor (Mosmann et al., 1986; Mosmann and Coffman, 1989; Bottomly, 
1988). Some of these clones lyse antigen-specific, class II MHC-restricted 
targets (Bottomly, 1988). The role of CD4+ inflammatory T (Td) cells in 
antiviral immunity will be discussed in section 3.2. 7. 
Reports on the requirements for CD4+ T cell help in the generation of 
antiviral Tc cells are controversial. A number of in vitro and in vivo 
studies suggest that T cell help is necessary for the generation of antiviral 
Tc cell responses to poxviruses, influenza virus, Sendai virus (SV) and 
VSV (Pang et al., 1976; Ashman and Mullbacher, 1979; Brenan and 
Mullbacher, 1981; Ciavarra, 1990). From experiments with radiation 
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chimaeras, T cells differentiating in an H-2-compatible, but H-2I-
incompatible thymic environment were found to be completely 
unresponsive to VV (Zinkernagel et al., 1978). This was interpreted to 
mean that participation of Th cells was a necessary requirement for anti-
VV Tc cell generation and hence the need for I-region compatibility. 
These views were not favoured by Bennink and Doherty (1978), who, based 
on their own data, suggested that T cell help was not required for the 
generation of anti-VV Tc cell response. 
Studies performed using Mab to selectively deplete CD4 + T cells in vivo 
have provided but somewhat conflicting findings. In one such study, 
Buller et al (1987) demonstrated that CD4+ T cell depletion did not affect 
the Tc cell response to ectromelia and VV. Furthermore, CD4+ T cell-
depleted mice recovered from infection with ectromelia virus which was 
lethal for athymic nude mice. Using similar approaches, CD4+ T cells 
were found to be unnecessary for the generation of antiviral Tc cell 
responses to HSV (Nash et al., 1987), LCMV (Ahmed et al., 1987) and 
influenza virus (Liu and Mullbacher, 1989). In the case of HSV1depletion 
of CD4+ T cells was, in fact, found to enhance the anti-HSV Tc cell 
response (Nash et al. 1987). 
Two other recent reports on the role of CD4 + T cells in antiviral Tc cell 
generation suggest that Th function may be important. CD4+ T cell 
depletion was shown to impair Tc cell responses to Moloney Sarcoma 
virus (MSV) (Weyland et al., 1989), LCMV and VV (Leist et al., 1989). 
While the reasons for differences between these ( Leist et al., 1989) and the 
earlier reports (Buller et al., 1987; Ahmed et al., 1987) in the case of Tc cell 
responses to VV and LCMV are not clear, it is interesting to note that 
administration of exogenous IL-2 to CD4 + T cell-depleted mice either 
partially (Leist et al., 1989) or completely (Weyland et al.,1989) restored the 
antiviral Tc cell responses. These findings are consistent with the idea 
that 'help' provided by CD4 + Th cells is in the form of IL-2. Indeed, in the 
absence of CD4 + Th cells, IL-2-producing CDs+ T cells were found to be 
sufficient for the optimal generation of anti-VV Tc cell response 
(Mizuochi et al., 1989). It is not clear whether IL-2 is the only factor 
necessary. In this regard, Liu and Mullbacher (1989) found that in the 
absence of CD4 + T-cells, 'help' could be delivered in vitro by B cells with 
no requirement for cell to cell contact and in the apparent absence of IL-2 
or IL-4, but the precise mechanisms are not known. Furthermore, a 
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recent report by Ciavarra (1990) indicates that the generation of a 
secondary VSV Tc cell response in vitro in the absence of CD4 + T cells 
could not be replaced by addition of exogenous IL-2 to the culture. 
Addition of IL-2 was reported to induce cytotoxic cells which had the 
characteristics of LAK cells but not antiviral Tc cells. 
Clearly, the above findings demonstrate that the contribution of CD4+ T 
cells in the induction of antiviral Tc cell responses was not always 
mandatory and may vary in different virus infection models, suggesting 
that CD4 + T cells may not be crucial for the expression of antiviral 
function by CDS+ Tc cells. There is strong evidence (Nash et al., 1987), 
however, that CD4+ T cells mediating DTH (Td) are necessary for the 
control of HSV infection in skin even in the presence of CDS+ Tc cells (see 
below). 
3.2. 7. T cells and delayed type hypersensitivity (Td) 
Delayed type hypersensitivity (DTH) is a T cell-mediated inflammatory 
reaction characterized by mononuclear cell infiltration. In response to a 
viral infection, virus-specific T cells proliferate and release cytokines 
which attract macrophages to the site of viral replication and in tum 
induce them to proliferate (Liew, 1982). The classical T cells (Td) that 
mediate DTH are CD4+ and hence class II MHC-restricted. However, 
DTH is not exclusively a CD4 + T cell-mediated function. Several lines of 
evidence indicate that class I MHC-restricted CDS+ T cells can mediate 
DTH functions (Zinkemagel, 1976; Ada et al., 1981; Lin and Askonas, 
1981). 
Recent studies using cloned CD4 + Th cells and CDs+ alloreactive Tc cells 
provide a basis for understanding why both CD4+ and CDS+ T cells are 
capable of mediating DTH reactions (Mosmann et al., 1986; Bottomly, 
1988; Mosmann and Coffman, 1989). Based on distinct cytokine secretion 
patterns, cloned CD4 + Th cells may be divided into two subsets. Thl 
clones secrete IL-2 and IFN-y but not IL-4 or IL-5, and mediate DTH 
functions. Th2 clones, on the other hand, secrete IL-4 and IL-5 but not IL-
2 or IFN-y and provide help for B cell responses. Furthermore, Thl 
clones but not Th2 clones, produce TNF-~ and lyse targets in an antigen-
specific and MHC-restricted manner (Bottomly, 1988). Additionally, some 
alloreactive CDS+ Tc cell clones have a cytokine secretion pattern similar 
to that of Thl clones. One of the cytokines produced by Thl clones and 
alloreactive CDS+ Tc cell clones, IFN-y, has been implicated as an 
essential mediator of DTH and in the migration of leukocytes into 
inflammatory sites (Issekutz et al., 1988). Hence, it is conceivable that 
both CD4+ and ens+ T cells may mediate DTH reactions in a viral 
infection. However, the crucial question concerns the importance of such 
a response in antiviral immunity. Is DTH essential for the control of a 
viral infection? Perhaps the following examples may illustrate its relative 
importance. 
Leung and Ada (1981) showed that class I MHC-restricted CDs+ T cells 
that included cells with Tc and Td activity, could protect mice against 
lethal influenza virus infection whereas class II MHC-restricted CD4 + T 
cells with Th and Td activity exacerbated the disease and accelerated the 
death of mice. Transfer of CD4 + T cells with DTH activity but 
undetectable Tc activity was not protective (Liew and Russel, 1983), while 
transfer of CD4+ T cells with Tc activity provided protection in mice 
against lethal influenza infection (Lukacher et al., 1985) .. Both CD4+ and 
CDS+ T cells appear to mediate DTH activity (Leung and Ada, 1981) but 
the Tc component may be more important for influenza virus clearance in 
vivo. Furthermore, a cloned influenza HA-specific, class I-restricted Tc 
cell line, (Lin and Askonas, 1980) that conferred protection in mice 
following adoptive transfer in vivo, and had the capacity to lyse influenza-
infected targets in vitro, was subsequently shown to confer DTH skin 
reactivity to influenza virus (Lin and Askonas, 1981). The same clone also 
produced IFN-y after exposure to influenza virus-infected cells in vitro 
(Morris et al., 1982). Based on the other reports (Leung and Ada, 1981; 
Lukacher et al., 1985) it is tempting to speculate that the Tc component 
was probably more important but the possibility exists that both functions 
(cytotoxicity and DTH) of the clone contributed to antiviral mechanisms. 
Also, although IFN-y is part of the DTH component, the possibility that 
this lymphokine contributed to direct antiviral activity and increased the 
efficiency of cytotoxic function cannot be excluded. 
In the studies performed to demonstrate that antiviral Tc cell induction 
and generation do not require the participation of CD4 + Th cell (Buller et 
al., 1987; Nash et al.,1981; Ahmed et al., 1987; Liu and Mullbacher, 1989), 
few have reported the pathological findings or data on viral titres. The 
relative importance of CD4 + T cells in the process of recovery from a viral 
infection is exemplified by the report of Nash et al (1987) which 
demonstrated that CD4 + T cells were not mandatory for the generation of 
anti-HSV Tc cell response. But the depletion of CD4 + T cells in mice 
resulted in a delay in clearance of RSV from the skin despite the presence 
of CDS+ antiviral Tc cells and such mice exhibited increased mortality. 
Additionally, in mice depleted of CDS+ T cells but intact CD4+ T cells 
(hence DTH response), virus clearance from the ear was normal whereas 
elimination of virus from the peripheral and central nervous system was 
markedly delayed although no increase in mortality compared to control 
mice was observed. Thus, in the HSV model, both CD4+ and CDS+ T cells 
are important and contribute to viral clearance at different sites of viral 
replication. From the studies conducted by Buller et al (1987), it is evident 
that depletion of CD4+ T cells did not result in death after ectromelia virus 
infection, but the necrotic lesions in spleen, liver and lymph nodes of 
CD4 + T-cell-depleted mice were clearly more severe. This is suggestive of 
a role for CD4+ T cells in limiting viral growth, perhaps in some indirect 
manner. Efficient viral clearance seems to be a function of CDS+ Tc cells 
since depletion of CDS+ T cells in mice (although achieved with difficulty) 
resulted in death after infection with ectromelia virus (Buller et al., 1987). 
Although Tc cells are important in the process of recovery from most 
primary virus infections (Blanden, 197 4), they appear only to halt further 
virus spread, and cannot reduce the number of infectious particles 
already present as was demonstrated for ectromelia (Blanden, 1971b). 
The beneficial effect of Tc cell-mediated lysis is apparent only if infected 
cells are lysed before assembly of progeny virus. Therefore, the advantage 
of a DTH reaction is the recruitment of monocytes. If infectious virus 
were released from infected cells in solid tissues before the generation of 
neutralising antibody or in sites where antibody did not readily penetrate, 
then recruitment of mononuclear phagocytes, which phagocytose and 
destroy infectious material or become unproductively infected, would 
surely help. The importance of DTH reactions in the process of recovery 
from viral infections has been previously questioned (Liew, 1982), but it is 
apparent that the DTH reaction contributes to antiviral mechanisms in 
some infection models. The extent to which it contributes to viral 
clearance from infected tissues may vary with different viruses in 
different tissues of different host species. 
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3.3. Hum.oral responses in antiviral immunity 
Although T-cell-mediated immunity (CMI) plays a crucial role in the 
recovery from most primary viral infections, including poxviruses, 
influenza, herpes-type viruses, CMV, LCMV and measles , an 
appropriate antibody response is important in the recovery from some 
viral infections like yellow fever, polio and coxsackie (Mims, 1987a). 
Humoral responses are particularly important in viral infections that 
produce systemic disease with plasma viraemia. However, virus-specific 
antibody is the first line of defense to reinfection (Oldstone, 1975; Mims 
and White, 1984c; Mims, 1987 a). 
The generation of CMI precedes humoral responses in most primary 
viral infections including poxviruses (Blanden, 1970; Hutt 1975; Pyne, 
1980; Novembre et al., 1989; Mims and White, 1984a; Mims, 1987a), but 
virus-specific antibody could contribute to the termination of infection, 
particularly in the clearance of plasma-borne virus. Virus neutralisation 
can occur by direct ·antibody binding and in the process prevent infection 
of susceptible cells in a number of ways (Della-Porta and Westaway, 1978; 
Possee et al., 1982; Wiley et al., 1981; Taylor and Dimmack, 1985a, b). 
Control of infection can also occur by ADCC and activation of the classical 
complement pathway which is antibody-dependent (MacFarlan et al., 
1977; Shore et al.,1976; Rager-Zisman and Bloom, 1974; reviewed in 
Hirsch, 1982). Antibody-mediated immunity may operate via all the above 
mechanisms during a primary or secondary infection. 
4. Recombinant VV: Live virus vaccines and analysis of the immune 
response to defined foreign antigens 
4.1. General 
Smallpox was among the first diseases shown amenable to prophylaxis, 
the means of prevention having apparently been discovered long before 
the elaboration of the germ theory of infectious disease. Now rendered 
extinct, smallpox has been known for centuries as one of mankind's most 
serious scourges (Fenner, 1985; Fenner et al., 1988a). The eradication of 
smallpox on a global scale was made possible by the extensive use of 
vaccinia virus (VV) vaccines (reviewed in Behbehani, 1983). Routine 
vaccination was stopped in 1980 on the recommendations of the World 
Heal th Organization. 
4.2. Recombinant VV as live virus vaccines 
Within two years of the discontinuation of smallpox vaccination, the 
prospect of live vaccines consisting of genetically engineered vaccinia 
viruses encoding foreign antigens was reported (Mackett et al., 1982; 
Panicali and Paoletti, 1982). Following these first reports, a large number 
of VV recombinants encoding viral, bacterial,protozoan and human 
proteins have been constructed (reviewed in Mackett and Smith, 1986; 
Moss, 1985; reviewed in Moss and Flexner, 1987) and analysed in terms of 
correct synthesis, processing and transport of proteins. This approach 
also has allowed the analysis of immune responses to single defined 
antigens and further to define "protective antigens" from pathogens. 
4.3. Prot.ecti.on 
A number of studies utilizing VV recombinants have provided strong 
evidence that the co-expressed foreign antigens can prime the immune 
system and provide protection in mice, rats, foxes, hamsters, cattle and 
chimpanzees against the appropriate pathogens (Smith et al., 1983; Kieny 
et al., 1984; Moss et al., 1984; Mackett et al., 1985; Blancau et al., 1985; 
reviewed in Mackett and Smith, 1986; Andrew et al., 1987; Elango et al. , 
1987; Koprowski et al., 1987; reviewed in Flexner and Moss, 1987; Bray et 
al., 1989). 
4.4. On the question of safety 
While the potential for developing this approach to vaccination is 
enormous, no compromise can be made on the question of safety. Post-
vaccination complications, both severe and mild, following immunization 
with VV have been well documented (Fenner et al., 1988b). This has been 
despite the availability of information relating to the safety of virus strains 
used during the WHO smallpox eradication program 
Notable in this regard is the demonstration by Buller et al. (1985) that 
deletion of the thymidine kinase (TK) gene of the WR strain ofVV 
effectively reduced virulence but did not affect immunogenicity. In 
contrast, evidence from the work of Andrew and colleagues (1989) has 
indicated that recombinant VV with a TK- phenotype induced lower 
antibody and Tc cell responses than the wild type (TK+ phenotype) VV, 
which replicated to higher titres. While the safety of a vaccine is of high 
priority, reduction of its virulence may also result in reduced 
immunogenicity which is undesirable. 
A rather different approach was taken by Ramshaw and colleagues 
' (1987). They inserted the murine IL-2 gene into a recombinant VV 
genome, which also contained the gene for influenza HA, in order to 
enhance the immune response to VV and the co-expressed foreign 
antigen. They reported the interesting finding that athymic, nude mice 
that lacked functional T cells successfully cleared infection with the IL-2-
encoding virus, but died of disseminated vaccinial disease after infection 
with a control recombinant virus. Soon after this, Flexner et al (1987) 
showed that insertion of the human IL-2 gene into VV genome led to nude 
mice surviving the infection. The role of antiviral Tc cells in mediating 
recovery from primary poxvirus infections is well established (Hirsch et 
al., 1968; Blanden, 1971b; Ertl et al., 1977). Therefore, the finding that 
expression of murine or human IL-2 during an infection with the 
recombinant VV allows the survival of T-cell deficient mice (Ramshaw et 
al., 1987; Flexner et al., 1987), was intriguing. Investigation of this and 
related phenomena is reported in this thesis. 
5. Scope of this thesis 
The demonstration by Ramshaw et al. (1987) that T-cell deficient nude 
mice recover from an infection with recombinant VV encoding murine 
IL-2 had important implications and therefore required a detailed 
analysis of the mechanisms involved. 
The experiments described in this thesis were designed to study the 
immunobiology of infection with the IL-2-encocling VV, designated VV-
HA-IL2, with particular emphasis on the recovery mechanisms in nude 
. 
mice. 
In Chapter 2 , the kinetics of recombinant VV replication in athymic, 
nude and euthymic normal mice are described. Studies on the survival of 
nude mice following infection with VV-HA-IL2 and a control 
recombinant not encoding IL-2 (VV-HA-TK) have been included. Data 
are presented which show that VV-HA-IL2 is cleared more rapidly than 
VV-HA-TK in nude and normal mice and that clearance is not likely to be 
antibody-mediated. 
Chapter 3 examines the possible roles of NK and Tc cells in rapid 
clearance of VV-HA-IL2. The kinetics of viral clearance precede that of Tc 
cell generation in normal mice but coincides with an elevated NK cell 
response in both nude and normal mice infected with VV-HA-IL2. Nude 
mice infected with VV-HA-IL2 had no detectable antiviral Tc cell 
response. 
In view of these findings, in Chapter 4, the possible role of NK cells is 
addressed using NK cell-deficient mouse models. The results were 
suggestive of both NK-dependent and -independent mechanisms involved 
in the rapid clearance of VV-HA-IL2 and survival of nude mice. 
Chapter 5 documents investigations into the role of soluble mediators 
· with antiviral function that could be triggered by virus-encoded IL-2 and 
that may have contributed to the recovery of nude mice from infection 
with VV-HA-IL2. The approach taken was the use of monoclonal 
antibodies in vivo to inhibit the function of the soluble mediators. A 
crucial role for IFN-y was established and evidence is presented 
indicating that IFN-y-mediated macrophage activation may be involved in 
the recovery mechanisms. 
Chapter 6 has been included to illustrate pertinent observations made in 
the course of the work described above which relate to the highly 
productive infection that VV causes in murine ovaries. I have addressed 
these observations with regard to virus virulence, viral tropism and how 
the expression of IL-2 during an infection with VV-HA-IL2 can avert 
ovarian damage and prevent infertility in mice. 
Finally, in Chapter 7 I have attempted to evaluate the data described in 
this thesis. 
CHAPTER2 
Studies on the Kinetics of Recombinant VV Replication and Clearance in 
Nude and Normal Mice 
INTRODUCTION 
Ramshaw and colleagues (1987) reported that athymic nude mice infected 
with the IL-2-encoding recombinant virus, VV-HA-IL2, resolved the 
infection successfully whereas nude mice given the control virus, VV-
HA-TK, developed a progressive vaccinial disease and died. VV-HA-IL-2 
given i.v. or s.c. in the foot-pad to nude mice was cleared by 11 and 15 days 
respectively. VV-HA-TK given in the foot-pad of nude mice induced a 
severe necrotic lesion which remained unresolved even 30 days post-
infection. All nude mice given VV-HA-TK i.v. died within 15 days after 
infection. 
In order to study the IL-2-induced mechanism(s) of recovery of nude mice 
from VV-HA-IL2 infection and the immunobiology of infection with the 
recombinant virus, an investigation of the kinetics of viral replication and 
clearance in athymic nude was an essential starting point. Although the 
rates of VV-HA-TK and VV-HA-IL2 clearance from foot-pads of normal 
euthymic CBA/H mice has been shown previously (Ramshaw et al., 1987) 
to be comparable, viral replication/clearance in the organs of these 
immunocompetent mice required investigation. 
This chapter descibes studies on the kinetics of replication and clearance 
of the recombinant vaccinia viruses in nude and normal mice. Mortality 
in nude mice infected with different doses of the wild type virus, VV-WR, 
and the recombinants VV-HA-TK and VV-HA-IL2 has also been 
included. In addition, experiments were carried out to establish that IL-2 
was produced in vivo during an infection with VV-HA-IL2. 
MATERIALS AND METHODS 
Mice. 
Mice raised under specific pathogen-free conditions were used at 4-10 
weeks of age. Athymic nude (nu/nu) mice of the CBA background were 
obtained from the Walter and Eliza Hall Institute, Melbourne. Euthymic 
CBNH and athymic Swiss outbred nude mice were obtained from the 
Animal Services Section of the John Curtin School of Medical Research. 
Viruses. 
A brief description of the recombinant VV used throughout this study is 
necessary to understand the work described in this chapter and the 
proceeding chapters. The neurovirulent, L929 cell-adapted WR strain, 
(Wokatsch, 1972), designated VV-WR, was used to construct the 
recombinants (Ramshaw et al., 1987). The murine IL-2 encoding 
recombinant, VV-HA-IL2, and the control virus VV-HA-TK, were both 
constructed from a previously described recombinant VV-PR8-HA6 
(Andrew et al., 1986), which encodes the haemagglutinin (HA) of 
influenza A/PR/8/34 virus. VV-PR8-HA6 will be referred to as VV-HA. 
A HindIII map ofVV-WR is shown in Fig. la with insertion points at Eco 
RI (E) and BamHI (B) sites in the J and F regions respectively (Fig. lb). 
The influenza HA gene, under the control of the vaccinia 7 .5-kD promoter 
(P7 _5), was inserted into the vaccinia TK gene in the J region at the EcoRI 
site (Fig. le) since this allowed the selection of recombinant virus by virtue 
of its TK- phenotype (Mackett et al., 1982). VV-HA-IL2 was constructed by 
insertion of the HSV TK gene plus a chimaeric promoter-IL-2 fragment 
into the Hindlll F region at the BamHI site of VV-HA (Fig. le). The 
insertion of HSV TK, under the control of a promoter (PF) derived from 
the the HindIII F fragment of VV DNA, and the IL-2 gene, under the 
control of P7_5, resulted in a TK+ phenotype. Since the RSV TK gene was 
also used as a selectable marker for virus construction, the control 
recombinant virus VV-HA-TK encoding HSV TK but not IL-2 was 
similarly constructed (Fig. ld). The genome arrangements of the 
recombinant viruses were analysed by restriction endonuclease digestion 
and hybridization with the appropriate DNA probes (Ramshaw et al., 
1987). In vitro, both recombinant viruses had comparable rates of 
replication. High levels of biologically active IL-2 were detected in the 
supernatants of VV-HA-IL2-infected murine, primate and human cells 
but not with VV-HA-TK. 
Virus stocks were prepared from infected CV-1 cells [(0.01 plaque forming 
units (PFU)/cell] grown in 2 litre Schott-acid washed roller bottles. 
Titrated stocks were stored in 100µ1 aliquots in sterile vials at -70 °C. 
Before use for immunization, virus stocks were diluted in 2 ml of gelatin 
saline to contain the desired PFU and sonicated at 50 watts for 2x5 
seconds using a Branson Sonifier (Branson Sonic Power Company, 
Danbury, CT., USA). 
Cell lines. 
CV-1, a cell line derived from African green monkey kidney (Jensen et 
al., 1964) and 143B, a human osteosarcoma cell line (Rhim et al., 1975) 
were maintained in Eagle's minimum essential medium (E:MEM) (Gibco, 
Grand Island, NY, USA) supplemented with antibiotics and 5% heat 
inactivated (56°C for 30 minutes) foetal calf serum (FCS) (Flow 
Laboratories, North Ryde, Australia). 
Virus titration. 
Organs removed from mice infected with VV-HA-TK or VV-HA-IL2 were 
stored individually in 1 ml of phosphate buffered saline (PBS) at -70 °C. 
Organs from individual mice were homogenized and a 100 µl volume of 
the homogenate was incubated with an equal volume of trypsin (1 mg/ml) 
in gelatin saline for 30 min at 37°C. After neutralization of the trypsin 
with 800 µl of saline containing 5% FCS, serial 10-fold dilutions were 
made and the virus titrated as plaques grown on human 143B cell 
monolayers in 6 well Linbro plates (Flow Laboratories, Inc, McLean, VA). 
Virus was adsorbed for 1 h before the cell monolayers were overlaid with 
EMEM containing 2.5% FCS. After a 2 day incubation period at 37 °C in a 
humidified atmosphere containing 5% CO2 in air, monolayers were fixed 
and stained with 0.1 % crystal violet in 20% ethanol for 5 min, dried and 
plaques counted. 
Assay for IL-2. 
The presence or absence of murine IL-2 in cell culture supernatants and 
sera of mice infected with VV-HA-IL2 or VV-HA-TK was determined 
using the murine IL-2-dependent T-cell line CTL-L. The procedure has 
been described in detail elsewhere (Gillis et al., 1978). Briefly, presence of 
IL-2 was assessed by CTL-L cell proliferation and uptake of 3H-thymidine 
in the presence of serial 2-fold or 3-fold dilutions of sera. 
Monoclonal antibody (Mab) t.o murine IL-2 
A rat anti-mouse hybridoma line, S4B6.3 l, which is a subclone of the 
originally described clone, S4B6 (Mosmann et al., 1986), was obtained 
from DNAX Research Institute of Molecular and Cellular Biology, Palo 
Alto, CA., USA. The clone secretes Mab (IgG2a subclass) to murine IL-2. 
The Mab was obtained as ascites, grown in pristane-primed outbred nude 
mice and used after partial purification by ammonium sulphate 
precipitation. The precipitate was dissolved in PBS and dialysed 3 times 
against PBS at 4°C , filter sterilized and stored at -20 °C. This Mab was 
used to neutralize the activity of IL-2 in vivo as described in Results. 
RESULTS 
Mortality in outbred nude mice given VV-WR or VV-HA-TK but not VV-
HA-IL2. 
Groups of female outbred nude mice were injected i.v. with varying doses 
of the wild type virus VV-WR or the recombinant viruses, VV-HA-TK and 
VV-HA-IL2. Mice that received 106 or 107 PFU ofVV-WR developed 
severe pox lesions on the skin between days 3 and 6, exhibited weight loss 
(data not shown) and weakness and died between 6 and 10 days after 
infection (Table 1). The mean time to death (MTD) in nude mice given 
VV-HA-TK was dose-dependent in that mice given 5xl05 PFU of virus 
had a MTD of 23 days (Table 1) whereas mice given 107 PFU of virus had a 
MTD of 14.8 days (p< 0.01, Students T-test). The wild type virus appeared 
more virulent than the control recombinant virus since nude mice that 
received VV-WR developed disease signs and died earlier than mice that 
had received the same dose of VV-HA-TK (Table 1). Nevertheless, 
infection with VV-WR or VV-HA-TK in outbred nude mice resulted in 
100% mortality. In contrast, all mice that had been infected with either 
107 or 5xl07 PFU ofVV-HA-IL2 appeared healthy with no signs of disease 
over the entire observation period of 21 days. 
Mortality in inbred CBA nude mice. 
The observations made with outbred nude mice were consistent with 
those seen in inbred CBA nude mice. All of the CBA nude mice that were 
inoculated i.v. with 107 PFU of VV-HA-IL2 survived the infection with no 
overt disease. There was 100% mortality in mice given 106 or 107 PFU of 
VV-HA-TK with MTD of 13.6 and 11.2 days respectively (Fig. 2). 
Kinetics of recombinant VV replication in organs of nude mice 
Female outbred nude mice were infected i.v. with 107 PFU of VV-HA-TK 
or VV-HA-IL2 and the kinetics of viral replication and clearance in 
organs of mice was determined over a 13 day period. 
In ovaries of infected mice, VV-HA-TK and VV-HA-IL2 titres were 
comparable 0.5, 1 and 2 days after infection (Fig. 3). Both recombinant 
viruses replicated very rapidly in ovaries with mean virus titres 
increasing from 3 log10 12 hours after infection to 5 log10 by day 1 and 
reached about 6 log10 PFU on day 2. VV-HA-TK titres increased very 
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rapidly, reaching a mean peak titre of 9 log10 on day 5. About 8 log10 PFU 
of VV-HA-TK remained in ovaries from day 5 onwards till day 13. In 
contrast, VV-HA-IL2 titres dropped sharply after the second day of 
infection with only 3 log10 PFU remaining on day 5 when the VV-HA-TK 
titre was 9 log10. The IL-2-encoding recombinant virus was not detected 
in ovaries of nude mice after the sixth day of infection. 
Both the recombinant viruses seeded lungs with comparable mean viral 
titres 0.5, 1 and 2 days after infection (Fig. 3), suggesting that the rates of 
replication in vivo were also comparable during the first 2 days of 
infection. After 2 days, marked differences were apparent in viral titres. 
VV-HA-TK increased from 4.8 log10 PFU on day 2 to about 6.5 log10 PFU 
on day 3 and persisted thereafter at about 6 log10 PFU until day 13 when 
mice started dying. On the other hand, VV-HA-IL2 titres did not increase 
beyond the 3rd day of infection, when mean lung titre was about 5 log10 
PFU. Viral titres decreased rapidly thereafter and could not be detected 
in 1 ungs after the 6th day of infection. 
The replication of these recombinant viruses in spleens and brains of 
nude mice sho_wed somewhat a different pattern. VV-HA-IL2 was 
detected in spleens 12 hours after infection but could not otherwise be 
recovered from spleens or brains (Fig. 3). VV-HA-TK persisted in the 
spleens with mean titres between 3-4 log10 PFU except for the 4th day of 
infection when mean titre was a little over 5 log10 PFU. VV-HA-TK was 
recovered from brains only after the 4th day of infection, reaching a peak 
of 6 log10 PFU on day 10 and persisting at close to this level on the 13th day 
after infection (Fig. 3). 
The delayed appearance ofVV-HA-TK (5 days after infection) in the brain, 
together with its rate of apparent replication, suggested that the virus was 
being seeded from other organs, such as the ovaries and lungs when peak 
titres were demonstrable (Fig. 3). The absence of VV-HA-IL2 in mouse 
brains after infection may be attributed not only to its intrinsic inability to 
maintain replication in the brain, but also to the more efficient clearance 
of this virus in comparison with VV-HA-TK. 
Kinetics of viral replication in normal CB.A/H mice. 
Female CBA/H mice between 6-8 weeks of age were infected i.v. with 107 
PFU of VV-HA-TK or VV-HA-IL2. Groups of 4 mice were sacrificed on 
the days indicated (Fig. 4), their ovaries, lungs, spleens, and livers 
removed and virus titres in these organs determined. 
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In all organs, mean VV-HA-TK and VV-HA-IL2 titres were comparable 1 
day after infection. 
Compared to the other three organs, VV replicated most efficiently in 
murine ovaries (Fig. 4). VV-HA-TK replicated rapidly with titres 
increasing from 4.8 log10 on day 1 to reach a maximum of about 8.6 log10 
on day 3. Although clearance ofVV-HA-TK from ovaries was apparent by 
the 4th day of infection, the control virus was detectable at day 10 post-
infection. VV-HA-IL2 reached only 5.3 log10 on day 2 and thereafter was 
cleared more rapidly from ovaries than VV-HA-TK; no virus was 
recovered after· the 6th day of infection. 
In the lungs, VV-HA-TK reached a peak titre of 4.9 logio PFU on day 3 
and declined thereafter to undetectable levels on day 6 after infection. 
Mean peak VV-HA-IL2 titre in the lungs (4 log10) was recorded on the 2nd 
day, and virus was cleared by the 5th day post-infection. 
Although neither virus replicated in spleens or livers as much as in the . 
ovaries, VV-HA-IL2 was cleared from both these organs earlier than VV-
HA-TK (Fig. 4). 
Infection with VV-HA-IL2 does not result in systemic circulation of IL-2. 
In order to study the immune mechanism(s) induced by IL-2 which 
contributed to nude mice survival and the rapid clearance of VV-HA-IL2 
in nude and normal mice, it was of interest to establish whether this 
lymphokine was present in the serum of infected mice 
Sera collected from nude mice given 107 PFU of VV-HA-IL2 or VV-HA-TK 
i.v. 12 hours after infection and thereafter everyday until day 13 contained 
no detectable IL-2 as assesed by 3H-thymidine incorporation into the IL-2 
dependent T-cell line CTL-L (data not shown). Similarly, no murine IL-2 
was detected in sera of normal CBA/H mice between 1-10 days after i.v. 
infection with 107 PFU VV-HA-TK or VV-HA-IL2. 
a 
The effect of anti-IL-2 Mab treatment on viral titres and survival of nude 
• mice 
Data presented above demonstrated that IL-2 was not detected in sera of 
mice infected with VV-HA-IL2. It was therefore important to establish 
that IL-2 was indeed produced in vivo during an infection with VV-HA-
IL2. 
Groups of 11 outbred nude mice infected i.v. with 107 PFU ofVV-HA-IL2 
or VV-HA-TK were simultaneously treated with Mab to murine IL-2. The 
rationale for this approach is as follows. Firstly, treatment with the Mab 
to IL-2 should reduce the activity of IL-2 produced in vivo during infection 
with VV-HA-IL2. Secondly, if the highly attenuated phenotype of VV-HA-
IL2 is due to the influence of and/or mechanism(s) induced by virus-
encoded IL-2, then treatment with the antibody should increase the 
severity of infection. 
Results presented in Table 2 indicate that this is indeed the case. All 7 
mice infected with VV-HA-IL2 and treated with the Mab to IL-2 died, 
whereas mice given virus alone survived. Antibody-treated nude mice 
infected with VV-HA-TK all died with a MTD of 7.3 days which was not 
significantly different (p> 0.05) from those given VV-HA-TK only. 
Furthermore, five days after infection, mean titres of VV-HA-IL2 in 
ovaries and lungs of mice treated with the Mab were significantly higher 
(p< 0.001) than untreated controls (Table 3). Marginal increases were 
apparent in VV-HA-TK titres in ovaries and lungs of mice treated with 
the antibody, but were not significantly higher than controls. 
These results are consistent with an important role for IL-2-induced 
immune mechanism(s) in rapid viral clearance and survival of nude 
. 
mice. 
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DISCUSSION 
The MTD in inbred CBA or outbred Swiss nude mice infected with VV-
HA-TK was dose-dependent. Outbred nude mice given 5x1Q5 PFU ofVV-
HA-TK exhibited a delay in the onset of signs of disease like weight loss 
and pox lesions on the skin compared to mice given higher doses of virus, 
but 100% mortality was nevertheless observed. 
Although all nude mice given varying doses of VV-HA-TK eventually died 
from disseminated vaccinial disease, VV-HA-TK was less virulent than 
the wild type virus, VV-WR. Nude mice given VV-WR died twice as fast 
as mice given similar doses of VV-HA-TK. Deletion or insertional 
inactivation of the VV-WR TK gene is known to reduce virus virulence 
(Buller et al., 1985). VV-HA-TK possesses a TK+ phenotype via expression 
of the HSV TK gene. However, the HSV TK is not as efficient as the 
vaccinia TK since VV-HA-TK expresses only about 10% of the enzyme 
activity of VY-WR.raising the possibility that this is the cause of reduced 
virulence (Coupar et al., 1987). On the other hand, it is also possible that 
insertion of the HSV TK gene into the F region of the Hind III fragment 
resulted in reduced virulence. Nevertheless, VV-HA-TK caused 100% 
mortality in nude mice. 
Insertion of the murine IL-2 gene into the vaccinia genome resulted in 
the most marked 'attenuation' observed here as indicated by the absence 
of mortality in nude mice infected i.v. with 5xl07 PFU ofVV-HA-IL2. 
Also, VV-HA-IL2 was cleared more efficiently than VV-HA-TK by T-cell 
deficient nude mice, thus enabling them to survive the infection. The 
difference in clearance efficiency was more marked in nude mice than in 
normal mice. 
Two important inferences were made from experiments involving the use 
anti-IL-2 Mab to inhibit the function of IL-2 in VV-HA-IL2 infected nude 
mice. This resulted in 100% mortality from an otherwise sublethal dose 
of virus. Firstly, it was established that IL-2 was indeed produced in vivo. 
Secondly, the highly attenuated phenotype exhibited by VV-HA-IL2 was 
not because of 'attenuation' per se due to insertional inactivation but 
rather due to the IL-2-induced mechanism(s) of rapid viral clearance in 
the host system. 
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The inability to detect IL-2 in sera of mice infected with VV-HA-IL2 
suggested that the lymphokine was operating locally at the sites of virus 
infection. 
Investigation of the kinetics of VV-HA-IL2 clearance from infected nude 
or normal mice showed that the mechanisms involved in IL-2-mediated 
clearance of virus were induced and operated rapidly within 1-4 days after 
infection. This suggested strongly that cell-mediated immune 
mechanism(s) may have been involved. The rapid clearance of VV-HA-
IL2 compared to VV-HA-TK also excluded a role for humoral immunity 
as previously reported (Ramshaw et al., 1987). 
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Figure 4. lunetics of recombinant vaccinia virus replication on organs of normal CBAJH mice. 
Female CBNH mice between the ages of 6 to 8 weeks were infected i.v. with 107 PFU of VV-HA-IL2 or VV-HA-TK and on 
the days indicated organs were removed to determine virus titres. Data shown are the geometric means of 4 individual 
organs per day for each group+ SEM. The sensitivity of virus detection in the assay system employed is above 100 PFU 
indicated by the horizontal dotted line. 
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Table 1. 
Mortality in nude mice given different doses of wild type or recombinant 
• • • V3CC1Dl8 VIrUSeS. 
Virus (Dose)a No. of mice % Mortality MTD (death on day p.i.) 
VV-WR 7 100 8.9 (8,8,9,9,9,9,10) 
(106 PFU) 
VV-WR 7 100 7.4 (6,7,7,7,8,8,9) 
(107 PFU) 
VV-HA-TK 7 100 23.0 (17,18,22,24,26,26,28) 
(5xl05 PFU) 
VV-HA-TK 7 100 17.8 (15,16,16,17,19,20,22) 
(106 PFU) 
VV-HA-TK 7 100 15.6 (12,12,13,16,17,19,20) 
. (5xl06 PFU) 
VV-HA-TK 7 100 14.8 (12,12,12,15,17,17,19) 
(107PFU) 
VV-HA-IL2 7 0 
(107PFU) 
VV-HA-IL2 7 0 
(5xl07 PFU) 
a Age and sex matched outbred nude mice were infected i.v. with the 
indicated doses of virus. No morbidity or mortality was observed in 
groups that received VV-HA-IL2 beyond the 30 day observation period. 
Table 2. 
The effect of anti-IL2 Mab treatment on the survival of nude mice infect.eel 
with VV-HA-IL2 or VV-HA-TK. a 
No of Virus Anti-IL-2 Mab % Survival 
Ill.ice treatlll.ent 
7 VV-HA-IL2 
7 
7 
7 
VV-HA-IL2 
VV-HA-TK 
VV-HA-TK 
+ 
+ 
100 
0 
0 
0 
MTDh 
(death on days p.i. )c 
6.9 (5,5,6, 7 ,8,8,9) 
7.6 (6,7,7,7,8,8,lO) 
7.3 (6,6,7,7,7,9,9) 
a Four to 5 week old outbred nude Ill.ice were injected i.v. wi~h 107 PFU 
VV-HA-IL2 or VV-HA-TK. On days O (day of infection), 1, 2, 3 and 4, 
Ill.ice were given i.p. approxiillately 500µg of anti-IL-2 Mab(+) and 
controls were left untreated (-). Mortality was Illonitored in all groups. 
Nude Ill.ice treated with anti-IL-2 Mab only all survived. 
b Mean tiille to death. 
c Numbers in parentheses indicate the days on which individual Ill.ice 
died. 
Table 3. 
The effect of anti-IL-2 Mab treatment on VV-HA-IL2 and VV-HA-TK 
titres in nude mice. 
Virus infection and 
treatment a 
VV-HA-TK 
VV-HA-TK + anti-IL-2 
Mab 
VV-HA-IL2 
VV-HA-IL2 + anti-IL-2 
Mab 
~10 virus titres + SEM 
. 
ovanes 
8.3+0.1 
8.8+0.2 
3.0+0.1 
7.8+0.4 
lungs 
6.3+0.1 
6.7+0.3 
3.3+0.1 
5.6+0.2 
a Four to 5 week old mice were infected with virus and treated with anti-
IL-2 Mab as described for Table 2. On day 5 post-infection, mice were 
sacrificed and virus titres in lungs and ovaries were determined. 
h Data shown are the geometric means of 4 individual organs per group + 
SEM. 
c Increase in titre highly significant (p < 0.001; Students T-test) compared 
to untreated group infected with VV-HA-IL2 only. 
CHAPTER3 
Tc cell and NK cell responses in nude a d normal mice infected with 
recombinant VV 
INTRODUCTION. 
Cytokines identified to date, including IL-2, have all been shown, at least 
in vitro, to have multiple biological activities. IL-2 is pivotal for the 
generation and regulation of an immune response (Smith, 1988). It has 
direct stimulatory effects on T cells (Morgan et al., 1976), B cells (Mingari 
et al., 1985), monocytes (Holter et al., 1987), organ-derived macrophage 
precursors ( Baccarini et al., 1988), and NK cells (Hefeneider et al., 1983). 
Because of its pleiotropic effects on various lymphoid and myeloid cell 
populations, both in vivo and in vitro, IL-2 may have numerous 
immunomodulatory effects in immunodeficient or immunocompetent 
mice infected with VV-HA-IL2. These may be narrowed, however, when 
considering immune mechanisms induced in response to viral infection 
as in the present context. 
The experiments described in this chapter were designed to elucidate 
mechanism(s) influenced or induced by IL-2 (during infection with VV-
HA-IL2) which may contribute to the process of rapid viral clearance in 
nude and normal mice. The role of humoral immune mechanisms has 
been excluded for reasons discussed in the preceding chapter. 
Theoretically, the expression of IL-2 during infection of normal mice with 
VV-HA-IL2 may have resulted in enhanced Tc cell responses or 
accelerated their generation. Such modified responses could have 
contributed to the rapid clearance of VV-HA-IL2. Reports that nude mice 
given allogeneic cells plus IL-2 can develop allospecific Tc cells (Wagner 
et al., 1980b) suggested that antiviral Tc cells might be induced in VV-HA-
IL2-infected nude mice. 
Although young adult, athymic, nude mice lack functional T cells, they 
are detectable in aged nude mice by 4-6 months of age (Gillis et al., 1979; 
Hunig and Bevan, 1980; Maryanski et al., 1981; MacDonald and Lees, 
1984; Chen et al., 1984). The expression of alloreactivity by nude T cells is 
well established (Hunig and Bevan, 1980; Hale, 1980; Maryanski et al., 
1980) though the precursor frequency of alloreactive Tc cells in nude mice 
is very low compared to that seen in normal mice. The existence of 
functional T cells in athymic mice has been taken as evidence that some T 
lymphocytes can develop via an extra-thymic pathway. 
Another possibility is that activation of NK cells by IL-2 could contribute to 
antiviral immunity (Weinberg et al., 1986; Bukowski et al. 1988). This 
applies to both nude and normal mice infected with VV-HA-IL2. 
More recently, there have been reports that administration of IL-2 in mice 
or the exposure of lymphoid cells to IL-2 in vitro, results in the generation 
of LAK cells (Rosenberg et al., 1985; Merluzzi et al., 1984; Mazumder and 
Rosenberg, 1984; Thompson et al., 1986). Adoptive transfer of cultured 
LAK cells to MCMV-infected mice substantially reduced virus titres 
(Bukowski et al., 1988). While precursors of LAK cells from nude mice 
appear to be NK cells (Hasui et al. 1989), those from normal mice are 
mainly NK cells and some T cells (Kalland et al., 1987; Lotzova and 
Heberman, 1987). 
The induction of Tc and NK cell responses in nude and normal mice 
infected with VV-HA-TK or VV-HA-IL2 was investigated using a kinetic 
approach. By using a panel of LAK cell sensitive (NK cell insensitive) 
targets, the induction of LAK cell activity was assessed. Finally, the 
phenotypes of the various cytolytic populations induced by VV in nude and 
normal mice were analysed. 
MATERIALS AND METHODS 
Mice. 
As described in Chapter 2. 
Viruses. 
As described in Chapter 2. 
Cell lines. 
L929 (H-2k), a continuous fibroblast line from C3H mouse (Sanford et al., 
1948), YAC-1 (H-2a), a line derived from Moloney leukemia virus-induced 
lymphoma in A/Sn mouse (Kiessling et al., 1975), P815 (H-2d), a 
mastocytoma line derived from DBA/2 mouse (Potter and Dunn, 1957), 
and EL-4 (H-2h), a lymphoma line derived from C57BU6N mouse (Gorer, 
1950), were all maintained in Eagle's minimum essential medium 
(EMEM) (Gibco, Grand Island, NY, USA) supplemented with antibiotics 
and 5% heat-inactivated FCS (Flow Laboratories, North Ryde, Australia) 
and used as targets in cytotoxicity assays. 
Antibodies. 
The following Mabs and antiserum were used at the dilutions indicated 
for in vivo cell depletion with complement: anti-Thy-1.2, clone F7D5 
(Serotec Ltd., Blackthorn Bicester, England) at a dilution of 1:1000; anti-
CD4, clone RLl 74 (Ceredig et al., 1985) and anti-CDS, clone 31M 
(Sarmiento et al., 1980) kindly provided by Dr. R. Ceredig (John Curtin 
School of Medical Research) at dilutions of 1:10; and rabbit anti-ganglio-
tetraosylceramide (anti-asialo-GM1 or anti-as-GM1) (Wako Pure 
Chemicals Industries, Osaka, Japan) at a dilution of 1:50 (1:25 or 1:10 for 
some experiments). Low toxicity rabbit complement (C) (Cedarlane 
Laboratories, Ltd., Canada) was used at a final dilution of 1:10. 
Preparation of effect.or cells from spleens for cytot.oxicity ~ays. 
Single cell suspensions from pooled spleens were obtained by gently 
pressing minced spleens through stainless steel mesh with syringe 
plungers. Erythrocytes and dead cells were removed by Ficoll-Paque 
(Pharmacia, Uppsala, Sweden) density gradient separation and the 
remaining cells at the inter-phase were removed, washed 3 times with 
II} 
EMEM supplemented with 5% heat-inactivated FCS, 10 mM HEPES buffer 
and antibiotics (complete medium). After the final wash, cells were 
resuspended in complete medium at the desired concentrations. 
Depletion of effect.or cell suspensions with antibody and complement.. 
Effector cells suspended in 1 ml of EMEM at the appropriate 
concentrations, were treated with antibodies for 30 min at 4°C, washed 
once and resuspended in 1 ml of EMEM containing rabbit C. After 
incubation for 45 min at 37°C, the cells were washed twice and 
resuspended in 2 ml of EMEM without further adjusting the 
concentrations. 
Cyt.ot.oxicity assays. 
Target cells were labelled with 51Cr (about 50µCi for 2xl06 cells) for 1 h at 
37°C in a humidified atmosphere containing 5% CO2 in air, washed 3 
times in complete ·medium and resuspended at a concentration of 2xl05 
cells/ml for use as targets. For virus-infected targets, L929 cells were 
infected with VV-WR at 20-40 PFU/cell during the 1 h labelling period. 
The standard chromium release assay was carried out in triplicate in U-
bottom microtitraticn plates (2xl04 target cells plus the appropriate 
number of splenocyte effector cells) for 4 h with YAC-1 targets and 6 
hours for L929 (infected or uninfected), EL-4 and P815 targets, at 37°C in a 
humidified atmosphere of 5% CO2 in air. 51Cr release from targets was 
measured in a Packard Auto-Gamma counter and specific lysis was 
calculated using the formula 
% specific lysis = experimental release - spontaneous release x 100 
maximal release - spontaneous release 
Spontaneous release ranged from 6-10% for YAC-1 cells, 8-12% for L929 
cells, and 7-15% for P815 and EL-4 cells. 
RESUL'IS 
Tc cell responses in nude mice. 
To investigate the possibility that IL-2 expressed during infection with 
VY-HA-IL2 induced anti-viral Tc cell responses in nude mice, inbred 
CBA nude mice were infected i.v. with 106 PFU of VY-HA-TK or VY-HA-
IL2 and the kinetics of Tc cell generation and cytolytic activity were 
monitored. Splenocyte populations were obtained from groups of 4 mice 
infected with VY-HA-TK or VY-HA-IL2 1, 2, 3, 4, 5, 6 and 8 days 
previously and their ability to lyse uninfected or VY-infected H-2-
compatible (L929) targets was assessed. 
Splenocyte effector cells obtained from nude mice 1-8 days after infection 
with VY-HA-IL2 lysed uninfected and VY-infected L929 targets and the 
level of cytolysis was consistently 3-fold higher than that seen with VY-
HA-TK-induced effectors (Table 1). The lysis of uninfected or infected 
targets by VY-HA-TK-immune effectors was higher than lysis by effectors 
obtained from unimmunized control mice. Although VY-infected targets 
were lysed slightly more efficiently by splenocytes from VY-HA-TK or VY-
HA-IL2 infected mice, the levels of cytolysis of uninfected or infected 
targets were not significantly different. The peak cytolytic activity was 
observed at 5-6 days after infection. The finding that uninfected targets 
were lysed by the effector cell populations indicated that lysis was not 
caused by virus-specific Tc cells. 
Phenotypic analysis revealed that CD4 + or CDS+ T cells in the splenocyte 
population were not responsible for the lysis of VY-infected or uninfected 
targets (Table 2), since treatment with anti-CD4 or anti-CDS monoclonal 
antibody and C did not abrogate the cytolytic activity. However, treatment 
with anti-Thy-1.2 or anti-as-GM1 and C resulted in a 3-fold reduction of 
the cytolytic activity of 6-day immune, VV-HA-IL2-induced effectors. On 
the contrary, while most of the cytolytic activity of 6-day VY-HA-TK-
immune effectors was eliminated after treatment with anti-as-GM1 and 
C, these effectors were more resistant to treatment with anti-Thy-1.2 and 
C. Splenocytes obtained from nude mice 2 days after infection with VY-
HA-TK or VY-HA-IL2 bore similar phenotypes to 6 day-immune 
splenocyte effectors that mediated lysis of uninfected or infected L929 
target cells (data not shown). Thus, the IL-2 expressed during infection 
51 
with VV-HA-IL2 did not induce the generation of classical antiviral CDS+ 
Tc cells in nude mice. 
Tc cell responses in normal CBA/H mice. 
In the preceding chapter, it was established that in normal mice, VV-
HA-IL2 was cleared a few days earlier than VV-HA-TK. Thus, the 
possibility that IL-2 secreted in vivo during infection with VV-HA-IL2 
accelerated the generation of Tc cells or perhaps enhanced Tc cell 
responses in normal mice was investigated. 
The kinetics of Tc cell generation and activity in normal CBA/H mice 
given VV-HA-TK or VV-HA-IL2 were examined. Splenocytes were 
obtained from groups of 4 mice infected i.p. with 107 PFU of VV-HA-TK or 
VV-HA-IL2, 1, 2, 3, 4, 5, 6 and 8 days earlier, and the ability of effectors to 
lyse uninfected or VY-infected L929 targets was determined. 
Both VV-HA-IL2- ·and VV-HA-TK-induced effectors lysed uninfected as 
well as infected L929 targets from as early as 1 day after infection (Table 
3). The lysis of uninfected L929 targets by VV-HA-IL2-immuµe 
splenocytes was about 3-fold higher than lysis caused by VV-HA-TK-
immune spleen cells, p_eaked at days 2-3 after infection, and declined to 
control (unimmunized) levels after the 5th day. Lysis of virus-infected 
targets over and above uninfected targets by VV-HA-IL2-immune 
cytotoxic Tc was demonstrable on the 4th day after infection, peaked at 
days 5-6 and persisted on day 8 after infection. However, some of the 
cytolytic activity on VY-infected targets on days 4 and 5 may be attributed 
to non-specific cytolysis, as illustrated by lysis of uninfected targets on the 
same days. 
The cytolytic activity of splenocytes from mice given VV-HA-TK on 
uninfected L929 targets was about 3-fold higher than the activity exhibited 
by unimmunized control splenocytes on the first and second days after 
infection. Cytolytic activity dropped to below controls levels by the 5th day 
of infection (Table 3). Antiviral Tc cell responses in normal mice given 
VV-HA-TK appeared on the 3rd day after infection, peaked at day 6 and 
were still strong on the 3th day. That lysis of virus-infected targets by 2-
day-immune splenocytes from normal mice infected with VV-HA-TK or 
VV-HA-IL2 was not due to classical CDS+ Tc cells was confirmed by 
phenotypic analysis. Treatment with anti-CDS antibody and C did not 
m 
affect the cytolytic activity. Six-day immune splenocytes CVV-HA-TK or 
VV-HA-IL2), however, were sensitive to both anti-CD8 and Thy-1.2 and C 
(Table 5) thus confirming that the lysis of H-2-compatible, virus-infected 
targets was mediated by classical Tc cells. The above data established 
that IL-2 produced during infection with VV-HA-IL2 in normal mice did 
not accelerate the generation of Tc cells or enhance their response in 
comparison to infection with VV-HA-TK. 
NK cell responses. 
The lysis of uninfected L929 target cells by splenocytes from mice 
immunized with VV-HA-IL2 was consistently about 3-fold higher than 
lysis due to VV-HA-TK-induced effectors on days 1, 2 and 3. This was 
true for nude mice (Table 1), with greater cytolytic activity observed over a 
period of 8 days after infection, and normal mice (Table 3). Since NK cells 
are known to be part of the early response to infection (reviewed in 
Welsh., 1981), further characterisation of NK responses was undertaken. 
Splenocytes from CBA nude mice infected i.v. with 106 PFU of VV-HA-IL2 
exhibited elevated (3-fold) cytolytic _activity on YAC-1 target (classical NK 
targets) cells compared to splenocytes from VV-HA-TK-infected mice or 
uninfected controls (Table 6). This elevated cytolytic activity persisted for 
at least 6 days after infection. 
In normal mice infected i.p. with 107 PFU ofVV-HA-IL2, NK cell activity 
(lysis ofYAC-1 targets) was also about 3-fold higher for the first 3 days 
than in mice given VV-HA-TK (Table 6). Cytolytic activity decreased to 
below levels of unimmunized controls by day 6 after infection when Tc 
activity peaked (Table 3). In addition, the cytolytic activity on YAC-1 
targets mediated by VV-HA-IL2- and VV-HA-TK-immune effectors 1, 2, 3 
and 6 days after infection correlated with the lysis of uninfected L929 
targets on these days indicated (Table 3). 
Phenotype of effectors from nude or normal CBA mice mediating lysis of 
YAC-1 targets. 
Using the panel of anti-serum and Mab and C, the general finding was 
that effectors mediating lysis of YAC-1 targets were mainly Thy-1.2±, 
CD4-, CDS- and as-GM1+ (Table 7), the phenotype of conventional NK cells. 
However, effectors from VV-HA-IL2-infected mice were more sensitive to 
anti-Thy-1.2 and C and less sensitive to anti-as-GM1 and C than cells 
from mice infected with VV-HA-TK or from uninfected controls. In the 
case of as-GM1, this phenomenon may have reflected quantitative 
differences in expression of the ligand on the cell surface, because more 
effectors could be lysed by increasing the antiserum concentration, 
resulting in reduced levels of YAC-1 target lysis (Table 8). However, some 
cytolytic activity still remained despite the use of higher concentrations of 
antiserum. 
NK cell responses in outbred nude mice. 
The kinetics of NK cell generation and cytolytic activity in outbred nude 
mice (Table 9) were similar to those seen in inbred CEA nude mice 
(Tables 1 and 6). Lysis of YAC-1 targets by VV-HA-IL2-immune 
splenocytes was at least 3-fold higher than that mediated by VV-HA-TK-
immune cells and the elevated activity persisted, being detectable even on 
day 8 after infection. Peak cytolytic activity was observed 5 days after 
infection with VV-HA-IL2 and 3 days after VV-HA-TK. Furthermore, 
phenotypic analysis of 3- and 5-day immune spleen cells indicated that the 
effectors which lysed YAC-1 targets were mainly Thy-1.2±, as-GM1+, CD4-
and CDS- (Table 10). Increasing the concentration of the anti-as-GM1 to 
remove as-GM1+ cells further reduced cytolytic activity on YAC-1 targets 
(Table 8). 
Lysis of P815, EL-4 and L929 targets by VV-HA-IL2-induced splenic 
effector cells from outbred nude mice. 
The ability of VV-HA-IL2-induced effectors to lyse targets such as P815 
and EL4 was tested. These cells are usually regarded as insensitive to NK 
cells. Results obtained using normal mice infected with VV-HA-IL2 or 
VV-HA-TK were variable between experiments, but generally spleen cells 
obtained during the first 3 days after infection caused low but 
insignificant levels oflysis of P815 and EL-4 targets (data not shown). 
However, splenocytes obtained from outbred nude mice given 107 PFU of 
VV-HA-IL2 i.v. caused significant lysis of P815, EL4 and L929 targets, 
though at lower levels than lysis of YAC-1 targets (Fig. 1). Effectors 
obtained from VV-HA-TK-infected nude mice showed significant cytolytic 
activity only on YAC-1 targets. The VV-HA-IL2-induced cytolytic 
splenocytes mediating lysis of PS 15, EL-4 and L929 targets had the same 
phenotype (data not shown) as effectors which lysed YAC-1 targets, i.e., 
as-GM1+, Thy-1.2±, CD4- and CDS-. 
DISCUSSION. 
Young adult, athymic, nude mice lack functional T-cells which are 
normally essential for recovery from primary infection with pox viruses 
(Hirsh et al., 1968, Blanden, 1970; 1971a, b). Therefore, infection with VV 
results in persistence of virus, disseminated vaccinial disease, and death 
(Ramshaw et al., 1987; and Chapter 2 , Table 1). However, when infected 
with recombinant VV encoding murine IL-2, nude mice resolve the 
infection (Ramshaw et al., 1987; and Chapter 2, Table 1). Evidence 
presented in this chapter established that nude mice recover from 
infection with VV-HA-IL2 without detectable Tc cell responses. 
Inbred nude mice infected with VV-HA-IL2 or VV-HA-TK had no 
detectable antiviral Tc cell responses during the first eight days after 
infection. Nude mice given allogeneic cells plus IL-2 were reported to 
mount an alloreactive Tc cell response (Wagner et al., 1980b). Here, IL-2 
was used primarily to expand the small pool of alloreactive T cell 
precursors. Effectors which lysed appropriate targets in vitro were Thy-
1.2+ but no attempt was made to demonstrate the presence of CDS (Ly2) 
antigen. In their studies, Wagner et al. did not include control mice that 
were given only IL-2 although a group given only allogeneic cells failed to 
respond. In the light of current knowledge of the effects of IL-2 on nude 
mouse lymphoid cells, i.e. induction of cytolytic cells which lyse a broad 
range of targets in a non-MHC-restricted fashion (Hasui et al., 1989), and 
the fact that some NK cells also express the Thy-1.2 antigen (Hackett et 
al., 1986), their data will have to be reevaluated. Infection with VV-HA-
IL2 failed to induce detectable anti-VV Tc cell responses in nude mice. 
Virus-encoded IL-2 should theoretically expand a limited pool of 
precursors, if indeed there were any, but they remained undetectable in 
the present experiments. 
Normal mice infected with VV-HA-IL2 or VV-HA-TK generated strong 
anti-VV Tc cell responses, with peak cytolytic activity on days 5-6 as 
reported previously for wild type virus, VV-WR (Koszinowski and 
Thomssen, 1975). However, infection with VV-HA-IL2 did not enhance 
Tc cell responses or accelerate their generation in comparison with VV-
HA-TK. This finding is consistent with earlier reports that the 
expression of IL-2 by recombinant VV enhanced neither the Tc cell 
responses in normal mice (Mfillbacher et al., 1989) nor the proliferative 
responses of Th cells in chimpanzees (van Eendenburg et al., 1989). In 
both reports, however, the rate of clearance of control and IL-2-encoding 
recombinant viruses was not addressed. Although VV-HA-IL2 is cleared 
more efficiently than VV-HA-TK in normal mice, anti-vaccinia Tc cell 
responses were comparable at 5-6 days after infection. 
The enhanced NK activity observed in spleens of mice given VV-HA-IL2 
compared to VV-HA-TK can· be attributed to the well-documented 
augmentation of NK activity by IL-2 in vivo (Hefeneider et al., 1983; Biron 
et al., 1990) and in vitro (Hermy et al., 1981). 
In nude mice, the elevated NK activity in response to infection with VV-
HA-IL2 persisted for at least 8 days after infection. This could be 
attributed to the longer persistence of virus in nude mice than in normal 
mice. Furthermore, normal mice also mount an antiviral Tc cell 
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response which seems to down-regulate the NK. cell response. During 
systemic viral infections, NK. cell responses are markedly augmented and 
this has been generally attributed to IFN-a or -~-mediated activation 
(MacFarlan et al., 1977; Gidlund et al., 1978). From the data presented 
here, it appears that in normal mice, Tc cell activity appears when NK. 
cell activity is on the decline and peak Tc cell activity is evident when NK. 
activity is barely detectable. 
With respect to the killing of the classical NK.-susceptible target, YAC-1, 
the phenotype of splenocyte effectors from infected nude or normal mice 
was as-GM1+, Thy-1.2±, CD4- and CDS-. VV-HA-IL2 induced these cells 
more efficiently than VV-HA-TK and increased their sensitivity to 
treatment with anti-Thy-1.2 plus C. The increase in sensitivity could have 
been due to an expansion of the Thy-1.2+ cell population or induction or 
upregulation of Thy-1.2 expression. This is consistent with earlier 
observations concerning the induction of Thy-1.2 expression on 
splenocytes of nude mice by IL-2 (Wagner et al., 1980b, Lipsick and 
Nathan, 1981). However, it must be emphasized that there was no 
evidence that these Thy-1.2+ cells from nude mice were classical antiviral 
Tc cells as they were CD8-. In the case of nude or normal mice of the CBA 
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(H-2k) strain infected with VV-HA-IL2, there was lysis of H-2k-compatible 
L929 target cells whether or not they were infected with VV-WR. 
In addition, other target cells, such as P815 and EL-4, were lysed by VV-
HA-IL2-induced effector cells obtained from nude mice. These two target 
cell types are generally insensitive to lysis by classical NK cells and 
cytolytic cells which lyse them have been generally designated LAK cells. 
Lysis of P815, EL-4 and L929 targets by VV-HA-IL2-induced killers was , 
however, at far lower levels than lysis of YAC-1 targets, and this, 
incidentally, has been documented to be typical of activated NK cells 
(Bukowski et al., 1988). Since the VV-HA-IL2-induced effectors mediating 
lysis of P815, EL-4 and L929 targets had the same phenotype as effectors 
which lysed YAC-1 targets, they will therefore be referred to as NK, NK-
like or activated NK cells. 
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Figure 1. Lysis of NK sensitive (YAC-1) andNKinsensitive (L929, P815, 
EL-4) targets. 
Six-week old outbred nude mice were injected i.v. with 107 PFU of VV-HA-
TK or VV-HA-IL2 and 5 days later, the ability of splenocytes (pooled from 4 
spleens) to lyse the various targets was tested. VV-HA-IL2-immune 
effectors lysed all 4 targets at significant levels whereas VV-HA-TK-
induced effectors only lysed YAC-1 targets at significant levels. Data 
shown are means of triplicates and SEM were less than 5%. 
Table 1. 
Kinetics ofVV-HA-IL2- or VV-HA-TK-induced cytotoxic T cell activity in 
· splenocyt.e effect.ors of athymic CBA nude mice.. 
Days % specific lysis c 
after 
Immunization a L929 targets L929 + VV-WR targets 
E:Th VV-HA-IL2 VV-HA-TK VV-HA-IL2 - VV-HA-TK 
-immune -immune immune -immune 
1 20:1 1B 11 25 13 
7:1 9 5 12 7 
2:1 4 2 6 3 
2 20:1 23 13 'Z7 16 
· 7:1 12 5 17 6 
2:1 6 3 8 3 
3 20:1 2) 15 34 18 
7:1 17 7 19 10 
2:1 9 4 10 5 
4 20:1 35 23 41 25 
7:1 21 9 26 12 
2:1 12 6 15 8 
5 20:1 54 ID 58 23 
7:1 3) 12 38 15 
2:1 18 8 22 9 
6 20:1 52 25 59 Z7 
7:1 2) 7 33 9 
2:1 ID 3 24 6 
8 20:1 48 22 51 24 
7:1 ~ 6 23 7 
2:1 13 4 15 3 
Unimmunized 20:1 8 11 
control 7:1 4 5 
2:1 1 2 
Table 1, cont. 
a Eight to 10 week old female nude mice were given i.v. 106 PFU ofVV-
HA-IL2 or VV-HA-TK. 
b Effector : target ratio. 
c SEM were less than 5% and have been omitted for clarity. 
Table 2. 
Phenotype of 5-day immune splenocyte effectors from nude mice infect.ed 
with VV-HA-IL2 orVV-HA-TK. 
% specific lysis c 
Treatment a E:Th L929 targets L929 + VV-WR targets 
VV-HA-IL2 VV-HA-TK VV-HA-IL2 - VV-HA-TK 
-immune -immune immune -immune 
C 20:1 44 16 49 19 
7:1 'Zl 9 31 11 
2:1 13 3 15 4 
C + anti-Thyl.2 20:1 2'.) 12 33 13 
· 7:1 15 7 15 8 
2:1 8 1 9 2 
C + anti-CD4 20:1 49 1B 51 a) 
7:1 28 10 ~ 12 
2:1 15 3 15 5 
C + anti-CDS 20:1 46 15 48 18 
7:1 25 8 'Zl 9 
2:1 12 4 13 5 
C + anti-as-GM1 20:1 25 3 ~ 3 
7:1 10 1 13 2 
2:1 4 0 6 1 
a Six-day immune splenocytes were treated with antibody + C as described 
in Materials and Methods. 
b Effector : target ratio. 
c SEM were less than 5%. 
Table 3. 
Kinetics ofVV-HA-~- or VV-HA-TK-induced cytot.ox:ic T cell activity in 
splenocyte effect.ors of euthymic CBNH mice. 
Days % specific lysis c 
after 
Immunization a L929 targets L929 + VV-WR targets 
E:Th VV-HA-IL2 VV-HA-TK VV-HA-IL2 - VV-HA-TK 
. 
-immune -immune immune -immune 
1 20:1 22 14 26 18 
7:1 16 7 18 11 
2:1 6 4 10 6 
2 20:1 &5 12 38 19 
· 7:1 15 7 19 10 
2:1 9 5 8 5 
3 20:1 3'2 8 36 28 
' 7:1 15 6 22 10 
2:1 10 4 9 7 
4 20:1 27 7 49 42 
7:1 13 5 33 22 
2:1 8 3 15 13 
5 20:1 17 3 f57 66 
7:1 8 3 49 41 
2:1 6 1 28 24 
6 20:1 6 3 64 70 
7:1 3 2 46 49 
2:1 4 2 24 2:) 
8 20:1 4 3 55 64 
7:1 2 3 &5 46 
2:1 0 0 18 23 
Uninfected 20:1 8 12 
control 7:1 5 7 
2:1 3 2 
Table 3 cont. 
a Mice were infected i.p. with 107 PFU of virus. 
h Effector : target ratio. 
c SEM were less than 5%. 
Table 4. 
Phenotype of 2-day immune cytotoxic spleen cells from normal mice 
infected with VV-HA-IL2 orVV-HA-TK 
% specific lysis c 
Treatment a E:Th Uninfected VV-WR Infected 
VV-HA-IL2 VV-HA-TK VV-HA-IL2 - VV-HA-TK 
-immune -immune immune -immune 
C 20:1 41 3) 47 a, 
7:1 22 12 'l:l 16 
2:1 10 4 13 7 
C + anti-Thyl.2 20:1 15 12 18 14 
· 7:1 7 7 9 10 
2:1 3 2 4 4 
C + anti-CD4 20:1 38 22 40 25 
7:1 Z3 10 ~ 13 
2:1 9 3 12 6 
C + anti-CDS 20:1 40 19 43 a) 
7:1 24 11 ~ 14 
2:1 10 4 12 7 
C + anti-as-GM1 20:1 19 2 22 3 
7:1 9 0 13 1 
2:1 5 0 7 0 
a Six-day immune splenocytes were treated with antibody+ C as described 
in Materials and Methods. 
b Effector : target ratio. 
c SEM were less than 5%. 
... 
Table 5. 
Phenotype of 6-day immune cytotoxic spleen cells from normal mice 
infected with VV-HA-IL2 or VV-HA-TK. 
% specific lysis c 
Treatment a E:Th L929 targets VY-WR-infected L929 tar ets 
VV-HA-IL2 VV-HA-TK VV-HA-IL2 - VV-HA-TK 
-immune -immune immune -immune 
C 20:1 8 11 ffi 75 
7:1 4 5 48 53 
2:1 1 3 24 ~ 
C + anti-Thyl.2 20:1 3 6 12 15 
· 7:1 2 3 6 7 
2:1 0 2 2 5 
C + anti-CD4 , 20:1 9 •, 12 63 79 
7:1 4 5 46 51 
2:1 2 3 25 3) 
C + anti-CDS 20:1 8 11 10 12 
7:1 5 6 4 7 
2:1 1 4 2 4 
C + anti-as-GM1 20:1 6 9 63 70 
7:1 3 4 45 48 
2:1 0 2 a) 25 
a Six-day immune splenocytes were treated with antibody + C as described 
in Materials and Methods. 
b Effector : target ratio. 
c SEM were less than 5%. 
Table 6. 
Lysis of YAC-1 targets by spleen cells from mice immunized with 
VV-HA-IL2 or VV-HA-TK. 
Days % specific lysis c 
after 
Immunization a 
1 
2 
3 
6 
Unimmunized 
controls 
E:Th 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
Effectors from 
Euthymic CBA/H mice 
VV-HA-IL2 
-immune 
64 
53 
23 
61 
m 
Z2 
54 
44 
2.5 
]2 
6 
3 
28 
13 
6 
VV-HA-TK 
. 
-immune 
46 
3) 
19 
:I) 
ID 
8 
45 
24 
11 
15 
11 
7 
Effectors from 
Athymic CBA/H nude 
. 
mice 
VV-HA-IL2 
-immune 
(32 
45 
'Zl 
56 
43 
32 
56 
. 43 
32 
63 
39 
26 
43 
21 
]2 
VV-HA-TK 
-immune 
46 
'Zl 
14 
50 
ro 
13 
48 
25 
14 
40 
a) 
13 
a Nude mice were infected i.v. with 106 PFU and normal mice i.p. 
with 107 PFU. 
b Effector : target ratio. 
c SEM were less than 5%. 
Table 7. 
Phenotype of cytotoxic spleen cells from mice immunized with VV-HA-IL2 or VV-HA-TK. 
Treatment E:Ta Euth ic CBA/H S lenoc es c 
Unimmunized VV-HA-IL2 VV-HA-TK Unimminized 
Control . Control 
. . 
-immune -immune -immune -immune 
Conly 20:1 ~ 75 ID 43 o7 54 
7:1 11 36 16 21 47 28 
2:1 7 17 10 12 ~ 15 
C + anti- 20:1 25 38 3) ID 42 43 
Thy-1.2 7:1 10 19 10 19 Z3 21 
2:1 7 8 6 11 16 12 
20:1 1 25 6 8 a} 9 
C+anti -as-GM1 e 7:1 0 13 4 4 8 3 
2:1 0 3 0 2 3 0 
20:1 31 ffi 32 40 00 49 
C+anti-CD8 7:1 14 32 17 Z3 44 23 
2:1 9 15 9 11 2) 18 
20:1 25 o7 JI 41 63 51 
C+anti-CD4 7:1 12 3) 1B Z3 45 24 
2:1 8 1B 9 9 24 10 
~ 
Table 7 cont. 
a Effector : target ratio. 
hResults shown are representative of 3 separate experiments. Assays were done in triplicate for each effector: target ratio 
and standard errors of means (SEM) were lower than 5% and are omitted for clarity. 
c Spleens harvested 3 days after immunization i.p. with 107 PFU of virus. 
d Spleens harvested 3 days after immunization i.p. with 106 PFU of virus. 
e The lysis of YAC-1 targets by VV-HA-IL2-induced effectors in nude or normal mice could be further reduced by 
increasing the concentration of anti-as-GM1 antisera (used in the above experiment at a 1:50 dilution) to a 1:10 dilution. 
Table 8. 
Resitance to lysis by complement and antiserum treatment by 
VV-HA-IL2-induced cytolytic effectors can be overcome with 
increasing concentration of anti-as-GM1. 
% specific lysis c 
Treatment a E:Th Splenocytes from d 
(antiserum 3-day-immune 3-day-immune 5-day-immune dilution) 
normal CBA/H outbred nude outbred nude 
Conly 20:1 49 56 00 
7:1 28 31 44 
2:1 13 17 21 
C + anti-as-GM1 20:1 31 40 49 
(1:50) 7:1 15 a) 25 
2:1 8 12 15 
C + anti-as-GM1 20:1 17 23 2.8 
(1:25) 7:1 9 11 17 
2:1 4 6 8 
C + anti-as-GM1 20:1 8 13 a) 
(1:10) 7:1 3 5 9 
2:1 1 3 5 
a Six day immune splenocytes were treated with antibody+ C as described 
in Materials and Methods. 
b Effector : target ratio. 
c SEM were less than 5%. 
d Splenocytes were obtained from female CBA/H or outbred nude mice that 
had been infected i.v. with 107 PFU of VV-HA-TK or VV-HA-IL2. 
Table 9. 
Lysis ofYAC-1 targets by spleen cells from outbred nude mice infect.ed 
with VV-HA-IL2 or VV-HA-TK. 
% specific lysis c 
Day(s) 
after VV-HA-IL2-immune VV-HA-TK-immune 
Immunization a E:Th 
effectors effectors 
1 20:1 ;I) 28 
7:1 22 12 
2:1 9 5 
2 20:1 48 33 
7:1 Z7 15 
2:1 12 6 
3 20:1 54 36 
7:1 34 19 
2:1 16 9 
4 20:1 58 34 
7:1 :E 18 
2:1 18 7 
5 20:1 65 28 
7:1 48 14 
2:1 a) 9 
6 20:1 62 31 
7:1 45 13 
2:1 17 6 
8 20:1 ffi 25 
7:1 35 11 
2:1 13 4 
Unimmunized 20:1 22 
control 7:1 9 
2:1 3 
Table 9 cont. 
a Six- to 8-week old female outbred nude mice were infected i.v. with 107 
PFU of VV-HA-IL2 or VV-HA-TK. 
b Effector :target ratio. 
c SEM were less than 5%. 
Table 10. 
Phenotype of 5-day immune splenocyt.e effectors from nude mice infected 
with VV-HA-IL2 orVV-HA-TK. 
% specific lysis c 
Treatment a E:Th 
3-day immune 5-day immune 
splenocytes d splenocytes e 
VV-HA-IL2 VV-HA-TK I VV-HA-IL2 VV-HA-TK 
Conly 20:1 ffi 2) 68 36 
7:1 31 18 45 18 
2:1 17 8 23 9 
C + anti-Thy-1.2 20:1 3) ID 36 23 
7:1 14 11 19 12 
2:1 6 4 8 5 
C + anti-as-GM1 20:1 13 3 20 5 
7:1 5 0 9 2 
2:1 3 0 5 0 
C + anti-CD4 20:1 5.9 3) 70 35 
7:1 32 16 46 16 
2:1 15 7 25 9 
C + anti-CDS 20:1 55 28 65 33 
7:1 3) 17 43 17 
2:1 17 7 20 8 
C + anti-Thy-1.2 9 1 15 3 
+ anti-as-GM1 20:1 4 0 7 1 
7:1 2 0 3 0 
2:1 
Table 10 cont. 
a Splenocytes were treated with antibody+ C as described in Materials and 
Methods. Anti-as-GM1 antisera was used at a dilution of 1:25. 
h Effector : target ratio. 
c SEM were less than 5%. 
d,e Splenocytes were obtained from 3- and 5-day immune female nude 
mice that had been infected with 1Q7PFU of VV-HA-IL2 or VV-HA-TK 
. 
1.V. 
CHAPTER4 
Analysis of the role of NK cells in rapid viral clearance using NK-cell 
deficient mice 
INTRODUCTION 
Host defense mechanisms, both specific and non-specific, have been 
implicated as antiviral effectors in protection and recovery from infection 
but the relative importance of any particular mechanism appears to 
depend on the type of virus, immune status of the host and the severity of 
infection (reviewed in Chapter 1). The non-specific effectors like 
macrophages, IFNs and NK cells limit spread of virus early during 
infection before the induction of specific immune responses like _antibody 
and effector T cells. While macrophages and IFN s have known antiviral 
functions (Zisman et al. 1970; Blanden, 1971b; Gresser et al., 1976) the role 
of NK cells has remained obscure. However, recent reports have provided 
conclusive evidence for a role of NK cells in mediating protection against 
development of fatal viral disease (Rager-Zisman et al., 1987) and limiting 
the severity and duration of acute viral infection (Bancroft et al., 1981; 
Shellam et al., 1981; Bukowski et al., 1983; Bukowski et al., 1984). The 
relative importance of NK cells in contributing to antiviral mechanisms 
during some viral infections was demonstrated in the above studies/\ the 
use of specific antisera to deplete NK cells, adoptive transfer of NK cells or 
by the use of NK cell deficient beige mice. 
The results presented in Chapter 3 indicated a possible role for NK cell-
mediated antiviral mechanism(s) in contributing to the rapid clearance 
of VV-HA-IL2 in normal and nude mice. However, a causal relationship 
between virus-encoded IL-2-activated NK cells and antiviral function in 
vivo was not established. Moreover, it was also shown that not all the 
cytolytic activity on YAC-1 targets by splenocytes from VV-HA-IL2-
infected mice was mediated by as-GM1+ NK cells. 
The present study was designed to investigate the causal relationship 
between the IL-2 induced NK cell activation and antiviral effects in vivo 
using NK deficient mouse models. Nude or normal mice, depleted of NK 
cells using specific antisera/Mab, and NK deficient beige mice were 
inoculated with the IL-2-encoding or control viruses to study the immune 
responses and viral replication. 
MATERIAIS AND l\'1ETH0DS 
Mice. 
Beige mice of the CBA background (Cabg/bg) were purchased from the 
Animal Resources Centre, Perth. Normal CBA/H and C57BL/6 mice and 
athymic Swiss outbred mice were obtained from the Animal Services 
Section of the John Curtin School of Medical Research. All mice, bred 
under specific pathogen free conditions, were used between 6-10 weeks of 
age and in individual experiments age- and sex-matched mice were used. 
Viruses. 
As in Chapter 2. 
Antisera. 
The following antisera were used at the indicated dilutions for cell 
surface analysis by cytofluorometry: anti-as-GM1 at a 1:20 dilution, F4/80, 
which is a rat-antimouse-macrophage Mab (Austyn and Gordon, 1981), 
kindly provided by Dr. W. Allen (JCSMR) as culture supernatant, was 
used undiluted. Biotinylated anti-Thy-1.2 (Becton Dickson, Mountain 
View, CA, USA) at a 1:1000 dilution, anti-CD4 and anti-CDS (both 
described in Chapter 3) and anti-NK-1.1, clone PK136 (Koo and Peppard, 
1984; Koo et al., 1986) obtained from the American Type Culture Collection 
(Rockville, MD, USA) were used as undiluted culture supernatants. 
FITC-conjugated sheep anti-rabbit IgG, sheep anti-rat IgG and sheep 
anti-mouse IgG (Silenus Laboratories, Victoria, Australia) at 1:20 
dilutions and streptavidin R-phycoerythrin conjugate (Serotec Ltd., 
Blackthorn Bicester, England) at a 1:30 dilution were all used as 
secondary antibodies. Sheep IgG (Silenus Laboratories) was used at a 
1:20 dilution to block Fe receptors. The working dilutions of all the above 
reagents were chosen from staining titration data. 
In vitro cell depletion with antibody and complement 
The panel of antisera/Mab used and the method for cell depletion in vitro 
has been described in Chapter 3. 
In vivo NK cell depletion in nude mice. 
Outbred Swiss nude mice were depleted of NK (as-GM1+) cells in vivo 
using the method described by Habu et al. (1981) with modifications. Anti-
as-GM1 was administered i.v. followed by the i.n. route after light 
anaesthesia with ether, to effectively deplete NK cells and to promote lung 
VV titres. The procedure involving antibody administration via two 
routes is based on the findings of Stein-Streilein and Guffee (1986), that 
treatment with anti-as-GM1 by the two routes was superior to the i.v. 
route alone. This was particularly essential for the depletion of NK cells 
in the lung. Stock antiserum was diluted 1:5 in PBS prior to use. Mice 
were given 150 µl of antiserum i.v. and 50 µl i.n. on days -5, -3, -1, 0, 1, and 
2 where day O was the day of infection with virus. Control mice were 
similarly treated with PBS or normal rabbit serum (NRS). Treatment 
was continued everyday after the day of infection since preliminary 
depletion experiments showed the rapid reemergence of as-GM1 + cells 
(assessed by flow ·cytometry and lysis ofYAC-1 targets) in spleens of mice 
infected with VV-HA-IL2. Anti-as-GM1 antiserum treatment does not 
deplete as-GM1- NK cell precursors and IL-2 is known to give rise to as-
GM1+ cells from precursors which lack the marker .. (Hasui et al., 1989). 
A Mab that recognizes the NK-1.1 marker (only expressed by some strains 
of mice) on murine NK cells was available but appropriate C57BU6 nude 
mice were not available. Therefore, the use of the NK-1.1- nude mouse 
model for this study was not possible. 
Depletion of NK cells in normal mice. 
Although the as-GM1 marker is expressed predominantly on NK cells in 
normal mice, there have been reports that it is also expressed on some T 
cells (Suttles et al., 1986) and macrophages (Wiltrout et al., 1985). Si?ce 
as-GM 1 was also found on murine ovarian cells ( unpublished 
observations; see Chapter 6), it was not possible to demonstrate the effect 
of as-GM1 + cell depletion on VV replication in ovaries. Therefore, NK cell 
depletion in normal mice was achieved by the use of the anti-NK-1.1 Mab 
(Koo et al., 1986), which recognizes the NK-1.1 marker. C57BL/6J mice 
which express this marker were selectively depleted of NK cells using a 
modified method, originally described by Koo et al. (1986). Female 
C57BL/6J mice aged 5-6 weeks were given approximately 1 mg antibody in 
0.2 ml of PBS i.v. and 250 µgin 50 µl of PBS i.n. at 7 day intervals over a 
m 
three week period. Three days after the last treatment, mice were given 
the antibody again 1 day prior to immunization with virus. Antibody 
treatment was continued on the day of infection and everyday thereafter 
except on the day the mice were sacrificed. Efficiency of the depletion was 
assessed by cytolytic activity of the splenocytes on YAC-1 targets and flow 
cytometry. 
Fluorescent staining of cells for flow cytometry. 
For single colour staining, aliquots of cells (lx1Q6 splenocytes or 3x1Q5 
leucocytes in complete EMEM) that had been depleted of erythrocytes and 
B cells (see below), were pelleted by gentle centrifugation, the medium 
removed and cells were resuspended in 100 µl of Mab appropriately 
diluted in EMEM or undiluted and incubated for 30 min at 4°C. Samples 
were centrifuged through 0.5 ml ofFCS and resuspended in 100 µl of the 
appropriate second stage reagent and incubated for a further 30 min at 
40c. After a final centrifugation through FCS, samples were 
resuspended in 0.5ml of complete EMEM for flow cytometry. 
Macrophages were incubated with sheep IgG to block Fe receptors prior to 
primary antibody staining. At times when flow cytometry was performed 
a day after staining, the cells were fixed in 1 % gluteraldehyde in PBS. 
F1ow Cytometry. 
Fluorescent labelled samples were analyzed on a FACS 440 flow cytometer 
(Becton Dickinson Immunocytometry System, CA, USA) using 100 mW of 
488 nm laser light to excite FITC and phycoerythrin (PE). Fluorescence 
emissions of FITC and PE were detected fallowing passage trough a 560 
nm dichroic mirror and a 535/15 nm band pass filter for PE-fluorescence. 
For single colour analysis, 20,000 events were collected from each sample. 
Gating of dead cells and red cells was performed using forward light 
scatter. Analysis of data was performed on a Consort 40 computer 
(Becton Dickinson) using the DISP4 program. The percentage of 
positively stained cells was calculated by subtracting control cells stained 
with the fluorochrome-conjugated reagents, from those stained with 
primary antibodies and fluorochrome-conjugated reagents. 
61 
B cell depletion in splenocyte and liver leukocyte populations. 
Splenocyte and liver leukocyte preparations were depleted of B cells before 
staining for the cell surface analysis by cytofluorimetry. Sheep red blood 
cells (SRBC) were coupled to sheep anti-mouse Ig in 0.1 % CrCl3. B cells 
were rosetted with sheep anti-mouse lg-coupled SRBC and removed by 
Ficoll-Paque separation. This method generally resulted in more than 
95% depletion of B cells. 
Isolation of leukocytes from ovaries for cytotoxicity assays. 
Ovarian effector cells were prepared from pooled ovaries obtained from 
30-40 mice per group. Ovaries were carefully minced and incubated in 
EMEM containing 2mg/ml of collagenase (Boehringer Manheim, 
Indianapolis, IN., USA) at 37°C for 30 min before gently pressing through 
a stainless steel mesh. The resulting cell suspension was washed once in 
EMEM containing 5% heat-inactivated FCS. Enrichment for NK cells 
was carried out by either passage through nylon wool columns, Ficoll-
Paque density gradient separation or Percoll (Pharmacia, Uppsala, 
Sweden) gradient separation as described elsewhere (Patel and Linna, 
1984). 
Isolation of liver leukocytes. 
Liver leucocytes were isolated from uninfected control or virus infected 
mice after in situ perfusion with enzyme (McIntyre and Welsh, 1986). 
Mice were anaesthetized with sodium pentobarbital (1mg, i.p.) prior to 
catheterizing the portal vein with polyethylene tubing. Perfusion 
(2.5ml/min for 5 min) was carried out initially with Ca2+_ and Mg2+_ free 
Hanks balanced salt solution (HESS) at 37°C to flush peripheral blood 
from the liver. The perfusate was then changed to prewarmed (37°C) 
HBSS containing 0.05% (wt/vol) collagenase and perfusion was continued 
for a further 10 min. After that, the liver was excised and teased apart 
with fine forceps in HBSS. The resulting suspension was aspirated 
several times, clumps were removed by passage through nylon mesh and 
pelleted at 1,000 g. The parenchymal cells were removed by Ficoll-Paque 
density gradient separation and the leucocytes were removed from the 
interphase, washed 3 times in EMEM and resuspended in complete 
EMEM. Liver leucocytes obtained this way were used in cytotoxicity 
assays and cell surface analysis by cytofluorimetry. 
Cytotoxicity assays. 
The standard chromium release assay was performed as described in 
Chapter 3. 
In experiments using VV-HA-TK- or VV-HA-IL2-infected targets , L929 
cells were infected with either virus for 3 hand then labelled with 51Cr for 
1 h, washed 3 times and resuspended in complete EMEM. Samples were 
assayed in triplicate (2xl04 target cells plus the appropriate number of 
splenocyte effector cells or lxl03 target cells plus the appropriate number 
of ovarian or liver effector cells in 200 µl per well) for 4 h with YAC-1 
targets, 6 h for L929 and EIA targets and 8 h for macrophage targets at 
37°C in a humidified atmosphere of 5% CO2 and 95% air. 
Preparation of macrophage targets for cytotoxicity as.says. 
Resident peritoneal macrophages were isolated from C57BI16 female 
mice by peritoneal lavage with ice-cold Pucks A saline. Pooled 
macrophages were pelleted by centrifugation and resuspended in 
complete EMEM. The desired number of cells were added to each well 
and allowed to adhere for 1 h at 37°C after which non-adherent 
(approximately 50% of the total cells) cells were washed off with medium. 
Macrophages were labelled with 2 µCi 51Cr per well and simultaneously 
infected with VV-WR at 40PFU/cell. Control macrophage targets were 
left uninfected. After a further incubation for 1 hat 37°C, plates were 
washed 3 times with EMEM before addition of the appropriate number of 
effectors. Spontaneous 51Cr release for uninfected macrophages was 
between 10-15% and for infected macrophages was between 18-22%. 
Histology. 
Organs removed from mice after cervical dislocation were fixed in 10% 
neutral buffered formalin before being processed for embedding in 
paraffin. Sections of tissue ( 4 µm thick) were stained with haematoxylin 
and eosin and mounted in mounting fluid. 
VIrUS titration. 
As in Chapter 2. 
RESULTS 
The effect ofNK (as-GM1+) cell depletion in nude mice on recombinant 
VV replication. 
In order to establish that NK. (as-GM1+) cells contributed to the control of 
viral replication and recovery from infection with VV-HA-IL2, outbred 
nude mice were depleted of as-GM1 + by repeated injections with anti-as-
GM1 antiserum. The procedure described in Materials and Methods 
resulted in the elimination of more than 98% of splenic as-GM1 + cells, as 
assessed by flow cytometry and completely abolished the cytolytic activity 
on YAC-1 targets (data not .shown). Control mice were treated using a 
similar regime with either PBS or normal rabbit serum (NRS) diluted in 
PBS. Groups of NK cell depleted mice and control mice infected i.v. with 
107 PFU ofVV-HA-IL2 or VV-HA-TK were sacrificed 5 days later for the 
determination of splenic NK. activity (YAC-1 target lysis) and virus titres 
. 1n organs. 
Control nude mice inoculated with VV-HA-IL2 had elevated splenic NK. 
activity which was about 3-fold higher than the activity induced by VV-
HA-TK, 3 and 5 days after infection as described in Chapter 3 (data not 
shown). Splenocytes obtained from virus infected mice which had been 
treated with anti-as-GM1 antiserum had virtually no cytolytic activity on 
YAC-1 or L929 targets (data not shown). 
NK cell depletion in nude mice infected with VV-HA-TK resulted only in 
marginal and insignificant (p>0.05) increases in the mean viral titres of 
ovaries and lungs, 3 and 5 days after infection compared to control mice 
(Table 1). On the other hand, depletion of NK. cells had marked effects on 
VV-HA-IL2 replication in lungs and to a lesser extent in ovaries of nude 
mice. Three days after infection, the mean lung VV-HA-IL2 titre 
increased by 1.2 log10 and the ovarian titre was higher by 0.8 log10 and, by 
5 days after infection, the titres increased by 1.6 log10 and 1.0 log10 
respectively, compared to control mice. Despite a satisfactory depletion of 
NK cells, ovarian VV-HA-IL2 titres were never as high as levels of VV-
HA-TK. In contrast, VV-HA-IL2 titres in lungs of NK cell-depleted mice 
attained levels that were similar to the mean lung VV-HA-TK titre in 
control mice. These results demonstrated that the strong NK response 
induced by VV-HA-IL2 played an important role in control of virus 
replication in ovaries and lungs. In addition, they implied that some 
other mechanism(s), independent of NK cell-mediated cytotoxicity, may be 
involved in viral clearance in infected ovaries. Although depletion of the 
as-GM1+ NK cells did not promote VV-HA-TK replication to a statistically 
significant extent (p>0.05 ), increased viral titres were apparent. 
Separate groups of nude mice that were infected with 107 PFU ofVV-HA-
IL2 or VV-HA-TK and treated with anti-as-GM1 antiserum, were 
monitored for signs of morbidity and mortality. All mice that were 
infected with VV-HA-TK died within 14 days after infection, and NK cell 
depletion did not accelerate the MTD (Table 2). In contrast, no mortality 
was recorded in NK cell-depleted nude mice that had been infected with 
VV-HA-IL2 although morbidity was noted. 
NK cell depletion in normal mice: Effect on YAC-1 target lysis and viral 
replication. 
The procedure described for NK cell depletion with the NK-1.1 Mab was 
very efficient since the cytolytic activity of normal splenocytes on YAC-1 
targets was completely abolished (Fig. 1) and NK-1.1 + cells were absent 
from the C57BU6 splenocyte population when assessed by flow cytometry 
(data not shown). Lysis ofYAC-1 targets by 3-day immune effectors from 
VV-HA-IL2-infected mice was about 3-fold higher than the VV-HA-TK-
induced splenic NK activity. Treatment with the Mab in mice infected 
with VV-HA-TK resulted in a 9-fold reduction in levels of YAC-1 target 
lysis (Fig. 1) and was comparable with levels of lysis mediated by 
unimmunized controls. On the other hand, despite a 9-fold reduction in 
levels of NK activity in mice given Mab and VV-HA-IL2, levels of cytolytic 
activity above control levels was still present (Fig. 1) although no NK-1.1 + 
cells could be detected by flow cytometry. This cytolytic activity could have 
been due to some other category of effectors which were presumably 
expanded in the presence of IL-2. 
Ovaries and lungs from groups of 4 mice that had been treated or 
otherwise with the NK-1.1 Mab and infected with 107 PFU virus i.v. 3 days 
previously were used to determine viral titres. Titres of VV-HA-TK in 
ovaries and lungs of NK cell-depleted mice were increased marginally 
above levels in control mice but the increases were statistically 
insignificant (p>0.05) compared to mean lung and ovarian titres in 
control mice (Table 3). In contrast, the mean VV-HA-IL2 titre was more 
than 2 log10 PFU higher in ovaries and increased by 1.3 log10 PFU in 
.... 
ffi 
lungs of Mab-treated mice in comparison with untreated controls. 
However, the increased VV-HA-IL2 titres in ovaries of NK cell-depleted 
mice were not elevated to the level of ovarian VV-HA-TK titres. While it is 
likely that activated NK cells could have been largely responsible for the 
clearance of VV-HA-IL2 from the lungs of normal mice, other factors 
besides NK cells appear to have been involved in viral clearance in 
ovaries. Although no evidence has been obtained, the non-NK cytolytic 
effectors (obtained from NK cell-depleted, VV-HA-IL2-infected mice) (Fig. 
2) are candidates for further investigations. 
The replication of VV-HA-IL2 in CBNH mice (non-NK-1.1 expressing 
strain) was not significantly (p>0.05) affected after treatment with the NK-
1.1 Mab (Table 3). 
Tc cell responses in NK cell-depleted mice. 
The data presented above established that NK cell depletion resulted in 
enhanced VV-HA-IL2 replication. It may be expected that the Tc cell 
response in these mice would be elevated due to the increased viral 
antigen load. The lysis ofVV-WR-infected C57BL/6 macrophages 6 days 
after infection in NK cell-depleted C57BU6 mice was almost 3-fold higher 
than in control mice (Table 4) and the lysis of uninfected, syngeneic 
macrophage targets was insignificant. Interestingly, the cytolytic 
effectors obtained from antibody-treated mice exhibited high levels of lysis 
of uninfected H-2-compatible EL-4 targets whereas the lysis by effectors 
from untreated mice was minimal (Table 4). This finding suggested 
further that the depletion of NK cells resulted in the emergence of at least 
one other cytolytic population that was presumably expanded and/or 
activated in the presence of IL2. 
Although no virus was recovered from the lungs of antibody treated or 
untreated mice, about 104 PFU of virus was recovered from ovaries of 
mice depleted of NK cells 6 days after infection (Table 4). VV-HA-IL2 was 
not recovered from ovaries of untreated mice. 
Studies with beige mice. 
Beige mice lack functional cytolytic NK cells (Roder and Duwe, 1979). 
They possess the phenotypically "NK-like" cells which are defective at the 
level of postbinding trigger of target cell lysis. The relative importance of 
cytolytic NK cells, especially in VV-HA-IL2 clearance, was investigated 
using beige mice since NK cells are thought to mediate antiviral activity 
by direct cytolysis of virus infected cells as well as by the secretion of 
antiviral factors. NK and Tc cell responses as well as viral replication 
kinetics were compared in beige and normal CBA mice following 
infection with VV-HA-TK or VV-HA-IL2. 
Comparison of NK and Tc cell responses in beige and normal CBA mice. 
Groups of 4 age-matched female CBA normal and beige mice were 
infected i.v. with 107 PFU of VV-HA-TK or VV-HA-IL2. On days 1, 2, 3, 4, 
6 and 9 after infection, splenocytes were tested for NK and Tc activity 
while ovaries were used to measure virus titres. 
Splenocytes obtained from VV-HA-IL2 or VV-HA-TK-infected beige mice 
had no cytolytic activity on YAC-1 targets on any of the days after infection 
(data not shown). Cytolytic activity on the classical NK targets observed 
using effectors from 2-day immune beige and normal mice is shown in 
Table 5. While VV-HA-IL2 induced about a 3-fold higher splenic NK 
activity above the VV-HA-TK induced response in normal mice, the IL-2-
encoding virus did not induce any such activity in beige mice. 
The kinetics of Tc cell generation in beige and normal mice after 
inoculation with VV-HA-TK or VV-HA-IL2 were similar although not 
identical (data not shown). Peak responses were observed using 6 day 
immune splenocytes (Table 6). Tc cell activity induced by either virus in 
beige mice was slightly higher than activity in normal mice 6 days post 
infection (Table 6). 
Comparison of the kinetics of viral replication in beige and normal mice. 
One day after infection with 107 PFU virus, titres of VV-HA-TK and VV-
HA-IL2 in ovaries of beige and normal mice were comparable but from 
the second day onwards, VV-HA-TK titres were always higher than VV-
HA-IL2 in both beige and normal mice (Figure 2). This difference was 
more marked in normal mice, VV-HA-IL2 titres reached a peak of 5.6 
log10 PFU on day 2 and declined to become undetectable by day 6. In beige 
mice VV-HA-IL2 titres peaked at 6.4 log10 on day 4 and declined 
thereafter, but 4.8 log10 persisted on day 6 and 2.0 log10 remained on day 9. 
.... 
The control virus, VV-HA-TK, behaved similarly (though not identically) 
in beige and normal mice, reached a peak of around 8 log10 on days 3 and 
4 and declined to about 4 log10 on day 9, but clearance of virus was slightly 
delayed in beige mice compared to normal mice, after peak titres were 
reached. 
The above data is compatible with the idea that a strong NK cell response 
induced by VV-HA-IL2 contributed to rapid clearance of this virus from 
ovaries of normal mice. Nevertheless, beige mice clearly derived benefit 
from IL-2, even though they produced no detectable cytolytic NK activity in 
spleens. Since the generation of Tc cell response was similar to normal 
mice> this benefit was presumably mediated by mechanisms as yet 
undefined, possibly by activation of the NK-like cells to secrete cytokines 
which contributed to antiviral mechanisms. 
NK cells lyse VV-HA-IL2-infected L929 cells more efficiently than VV-
HA-TK-infected cells. 
Data from the above experiments established that depletion of NK cells 
(as-GM1 antiserum or NK-1.1 Mab treatment) or a lack of cytolytic NK 
cells (beige mice) resulted in enhanced VV-HA-IL2 replication. NK cells 
could contribute to control of vaccinia replication in vivo either by lysing 
infected cells or by secreting anti-viral factors. NK cells were able to lyse 
vaccinia-infected L929 cells (Chapter 3, Tables 1 and 3). They also killed 
VV-HA-IL2-infected targets more efficiently than VV-HA-TK-infected 
targets (Table 7). The mechanism of enhanced lysis could be due to 
augmentation of NK cell activity by IL-2 secreted by the VV-HA-IL2-
infected L929 cells during the 6 h 51Cr release assay. Addition of 
exogenous recombinant murine IL-2 to the NK assay or pulsing effector 
cell suspensions with IL-2 for 1-4 h before the cytotoxicity assay also 
resulted in enhanced lysis of L929 or YAC-1 targets (data not shown). The 
enhanced killing was not due to increased target cell susceptibility to lysis 
since pulsing target cells with IL-2 prior to the assay did not affect the 
levels of lysis (data not shown). 
Liver lesions caused by VV-HA-IL2 contain more infiltrating 
mononuclear cells than lesions caused by VV-HA-TK. 
The above data suggest that NK cells could contribute to inhibition of virus 
replication in vivo by lysing infected cells, providing that they were 
present at the site of infection. The recent report (Natuk and Welsh, 1987) 
that recombinant human IL-2 is chemotactic for murine large granular 
lymphocytes, including NK cells, suggests a mechanism whereby this 
could occur. Therefore, the possibility that infected foci produced by VV-
HA-IL2 may attract NK cells more efficiently than VV-HA-TK was 
investigated by histologically examining liver lesions of CBA/H mice 12, 
24, 48 and 72 h after i.v. infection with 107 PFU virus. The lesions caused 
by VV-HA-IL2 (Figure 3a) consistently contained more infiltrating 
mononuclear cells than lesions caused by VV-HA-TK (Figure 3b). 
Similar observations were also made in athymic nude mice 3, 6, 9 and 12 
days after i.v. infection with 107 PFU of VV-HA-TK or VV-HA-IL2 (data 
not shown) 
Phenotypic analysis of liver leukocyt.es. 
Cytofluorimetric analysis of liver leukocytes isolated from euthymic 
CBA/H mice 3 days after infection revealed that there were more as-GM1+ 
and Thy-1.2+ cells in the infiltrate caused by VV-HA-IL2 than that due to 
VV-HA-TK (Table 8). In addition, the liver infiltrates caused by both 
viruses also contained macrophages (F4/80+ cells), CD4+ and CDS+ T 
cells. In athymic nude mice, infiltrates caused by VV-HA-IL2 also 
contained more as-GM1+ and Thy-1.2+ cells than VV-HA-TK induced 
infiltrates. However, no CD4+ or CDS+ T cells were detected in liver 
infiltrates of VV-HA-TK and VV-HA-IL2-infected nude mice which 
otherwise contained macrophages. 
Cytolytic activity of liver leukocytes. 
The ability of liver leucocytes to lyse the NK sensitive YAC-1 targets was 
tested. Liver leucocyte effectors obtained from either normal CBA/H or 
athymic Swiss outbred nude mice 3 days after i.v. infection with 107 PFU 
of VV-HA-TK or VV-HA-IL2 lysed YAC-1 targets (Fig. 4). Lysis was 
consistently higher using effector cells from VV-HA-IL2-infected mice 
than from VV-HA-TK-infected mice but the difference was more marked 
in nude mice than in normal mice. 
Isolation of leukocytes from ovaries of VV infected mice: 
Functional and phenotypic charact.eri7.ation. 
In Chapter 2, data on VV replication in mouse ovaries was presented. 
While VV-HA-TK grew to between 1os-109 PFU in ovaries of normal 
CBA/H of Swiss outbred nude mice, VY-HA-IL2 was rapidly cleared ( 
Chapter 2, Figures 3 and 4). The highly productive infection made the 
ovary a potentially sensitive indicator of changes in the virus-host 
relationship caused by IL-2. Histological examination of infected ovaries 
(Chapter 6, Figure lb) suggested that VY-HA-TK replicated rapidly in 
ovarian stroma and destroyed many stromal cells by day 3 after infection. 
Damage caused by VV-HA-IL2 was barely detectable (Chapter 6, Figure 
la), consistent with the low levels of virus recovered. 
Since IL-2 does not directly inhibit virus replication in vitro (unpublished 
observations), the ·inhibition of VY-HA-IL2 replication in ovaries of 
infected mice could be attributed in part to local cell-mediated 
mechanisms induced by the expression of this lymphokine in foci of 
infection. The nature of VY-induced histopathology in ovarian stroma 
did not permit clear evaluation of inflammatory infiltration as was 
possible in the liver, therefore attempts were made to isolate and 
characterize infiltrating leukocytes from ovaries of VY-infected mice. 
Leukocytes were isolated from ovaries of 30 mice per group which had 
been infected i.v. with 107 PFU of VY-HA-TK or VV-HA-IL2, 3 days 
previously and enriched for NK cells by Ficoll-Paque density gradient 
separation, Percoll density gradient separation or by passage through 
nylon wool columns. 
Irrespective of the method used for enrichment, ovarian effector cells 
obtained from mice infected with VY-HA-IL2 had a 9-fold greater cytolytic 
activity on YAC-1 targets (Table 9) than cells induced by VV-HA-TK. The 
ovarian effector cells mediating lysis of YAC-1 targets were Thy-1.2±, as-
GM1+, CD4- and CDS- (Table 10). Treatment ofVV-HA-IL2-induced 
ovarian cytolytic cells with anti-as-GM1 and C completely abrogated the 
capacity for lysis ofYAC-1 targets, but the lysis of L929 targets was only 
partially reduced. Furthermore, treatment of these effectors with anti-
Thy-1.2 and C did not abrogate the lytic activity on L929 targets. This 
suggested the existence of two different populations of effector cells, one 
..... 
being as-GM1+ and largely Thy-1.2+ which could lyse both YAC-1 and 
L929 targets, and a second being as-GM1- and Thy-1.2- which could lyse 
only L929 targets. Whether these as-GMl- and Thy-1.2- cytolytic effectors 
are mutually exclusive is not known. 
Interestingly, no NK activity could be demonstrated in ovaries ofVV-HA-
IL2-infected beige mice (data not shown). The clearance of VV-HA-IL2 
from ovaries of these mice was delayed in comparison with clearance 
from ovaries of normal mice (Fig. 2). 
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DISCUSSION 
The evidence presented earlier unequivocally demonstrated a crucial role 
for IL-2-activated NK cells in mediating antiviral mechanisms. Depletion 
of NK cells in nude or normal mice resulted in enhanced VV-HA-IL2 
titres but increases in VV-HA-TK titres were marginal (Tables 1 and 3), 
suggesting that NK cells were probably not an obligatory requirement for 
the control of VV-HA-TK growth early during the course of infection. 
This finding, however, is not consistent with a previous report (Bukowski 
et al., 1983) which indicated that the wild type virus, VV-WR, replicated to 
significantly higher levels in spleens and livers of NK cell-depleted 
normal mice. The reduced virulence of VV-HA-TK compared to VV-WR 
(Chapter 2, Table 1), and the inability ofVV-HA-TK to replicate as 
efficiently as the wild type virus in spleens or livers (Chapter 2, Fig. 4 and 
Chapter 6, Table 1) of normal mice may have contributed to the difference. 
Comparison of viral replication kinetics in ovaries of beige and normal 
mice suggested that the elevated NK cytolytic activity induced by VV-HA-
IL2 in normal mice, but not in beige animals, may have made a 
significant contribution to control of VV replication in ovaries. Whereas 
normal mice were able to clear VV-HA-IL2 by the sixth day after 
infection, virus persisted until at least day 9 post-infection in ovaries of 
beige mice. This data is consistent with a role for NK-cell-mediated 
cytolytic activity in viral clearance. 
Nonetheless, beige mice did clearly benefit from virus encoded IL-2 
because VV-HA-IL2 titres were consistently lower than control VV-HA-
TK throughout the course of infection from days 2-9. This implied that 
some other mechanism, independent of NK cell-mediated cytolytic 
activity, also contributed to clearance of VV-HA-IL2 in beige mice. Since 
the defect in the NK cells of beige mice is limited to an absence of cytolytic 
activity (Roder and Duwe, 1979), it remains possible that the NK-like cells 
in these animals helped to clear infection by release of antiviral factors 
such as IFN-y or TNF-a which are known to be triggered by IL-2. Apart 
from a lack of cytolytic NK cells, beige mice are reported to have both 
defective macrophage-mediated anti-tumour activity (Mahony et al., 1980) 
and alloreactive Tc cell responses (Saxena et al., 1980). Data presented in 
this Chapter clearly established that beige could mount strong anti-VV Tc 
cell response. However, it is not clear if the defective macrophage-
mediated anti-tumour activity of beige mice may extend to antiviral 
activity. 
Absence of cytolytic NK cells in beige mice or the depletion of NK cells in 
normal mice resulted in enhanced Tc cell responses to VV-HA-IL2, 
compared to control normal mice. While the enhanced response, 
presumably due to an increase in viral antigen load, is to be expected, 
depletion of NK cells in normal mice also resulted in the emergence of an 
unidentified population of cytolytic effectors which efficiently lysed 
uninfected EL-4 targets 6 days after infection. In addition, VV-HA-IL2 
but not VV-HA-TK, induced cytolytic cells in NK cell-depleted C57BU6J 
mice which had substantial levels of lysis of YAC-1 targets 3 days post-
infection. It is relevant to note that, in the presence of IL-2, spleen- and 
liver-derived macrophage precursors develop into typical granula-
containing cells in vitro and acquire the capability to lyse YAC-1 targets 
(Baccarini et al., 1988). While the antiviral efficacy of these non-NK 
effectors is not known, the data suggests that virus-encoded IL-2 
predominantly activates NK cells, but in their absence, other IL-2 
responsive lymphoid (or myeloid) cells are activated. 
In order for NK cells to mediate antiviral activity, their presence within 
foci of infection may be essential. This would allow their cytolytic activity 
to operate against virus-infected cells, thus preventing further viral 
replication in those cells. It would also result in local production of 
potentially effective concentrations of antiviral factors. NK activity was 
demonstrated in the ovary and liver. Elevated NK activity coincided with 
the rapid clearance of VV-HA-IL2 from ovaries of infected normal mice 
but not from ovaries of beige mice which had no detectable NK activity in 
ovaries or spleens. Clearance of VV-HA-TK which induced only low 
levels of NK activity in ovaries of normal mice was significantly delayed 
compared to VV-HA-IL2. Furthermore, histology of infected livers 
indicated that VV-HA-IL2 induced more rapid mononuclear cell 
infiltration into foci of infection than VV-HA-TK. Infectious foci due to 
VV-HA-IL2 also contained more mononuclear cells which included NK 
cells as well. These results are consistent with the idea that NK cells are 
attracted to foci of infection and that IL-2 may be an important 
chemotactic influence (Natuk and Welsh, 1987). 
Since VY-infected L929 targets were lysed in vitro by the NK-like activity 
generated during infection in vivo, it is possible that virus-infected cells 
are subjected to NK-mediated lysis during infection in vivo. The finding 
that VV-HA-IL2 infected targets were lysed more efficiently than control 
virus infected targets suggests further that NK cells attracted to foci of 
infection may be activated by the virus-encoded IL-2, hence resulting in 
efficient viral clearance. 
While an important role for NK cells in contributing to control of VV-HA-
IL2 replication has been established above, there is sufficient evidence 
which suggests that non-NK-mediated antiviral mechanisms are also 
involved. Firstly, NK cell-deficient beige mice cleared VV-HA-IL2 more 
efficiently than VV-HA-TK as discussed earlier. These mice derived 
benefit from virus-encoded IL-2, despite the lack of cytolytic NK cells. 
Secondly, at least two distinct populations of cytolytic effector cells were 
isolated from ovaries of VV-HA-IL2-infected normal mice. The first had 
a phenotype of NK cells and was as-GM1+, Thy-1.2±, CD4- and CDS-. The 
second population lacked any of the above markers. It app~ars very likely 
that both these populations contributed to antiviral mechanisms in vivo. 
This is because titres of VV-HA-IL2 in ovaries of NK cell-depleted normal 
mice were always lower than titres of VV-HA-TK in control or NK cell-
depleted mice, although VV-HA-IL2 titres increased 100-fold in ovaries of 
NK cell depleted mice. 
Finally, although as-GM1+ NK cell-depletion in nude mice resulted in 
enhanced VV-HA-IL2 replication, no mortality was recorded. While this 
finding may be further construed as supportive of the above contention 
that non-NK mediated antiviral mechanisms are also important, survival 
of NK cell-depleted nude mice from infection with VV-HA-IL2 may have 
been a result of other contributory factors. It is possible that 
compensation for NK cell depletion may have occurred by the emergence 
or expansion of other cell types with antiviral activity, especially after 
exposure to IL-2. IL-2 is also known to induce the maturation of as-GM1 + 
cells from as-GM1- progenitors (Hasui et al., 1989), indicating the 
possibility that as-GM1 + cells can re-emerge in NK cell depleted nude 
mice after infection with VV-HA-IL2. 
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Figure 1. NK cell depletion and YAC-1 target lysis. 
C57BL/6J mice were treated with anti-NK.1.1 Mab as described earlier and 
infected i.v. with 107 PFU of VV-HA-IL2 or VV-HA-TK. Control mice 
treated with only PBS were given the similar dose of virus or left 
uninfected. The capacity for splenocytes from Mab-treated or untreated 
mice and infected with virus or otherwise to lyse YAC-1 targets was tested 
3 days after infection. 
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Figure 2. lunetics of virus replication in ovaries of nonnal, or beige mice. 
Normal and beige CBA mice were infected i.v. with 107 PFU ofVV-HA-IL2 or VV-HA-TK. Data shown are means of log10 
PFU/pair of ovaries + SEM in groups of 4 female mice. The sensitivity of virus detection in the assay system employed is 
above 100 PFU indicated by the horizontal dotted line. 
Figure 3. Mononuclear cell infiltration in livers of recombinant 
VV-inf ected mice. 
Haematoxylin and eosin-stained histological sections of livers 
from normal CBA/H mice taken 72 h after i.p. injection with 107 
PFU of VV-HA-IL2 or VV-HA-TK. More infiltration with 
mononuclear cells was typically seen in liver lesions caused by 
VV-HA-IL2 (a) than in lesions caused caused by VV-HA-TK (b) 
[magnification x250]. 
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Figure 4. Lysis ofYAC-1 targets by liver leukocytes from CBAJH mice (a) and athymic nude mice (b). 
Eight week old female CBA/H and athymic nude mice were infected i.v. with 107 PFU of VV-HA-TK or VV-HA-IL2 and 3 
days later leukocytes were isolated from livers of mice after in situ perfusion with collagenase as described earlier. 
Table 1. 
The effect of as-GM1 antisernm treatment in nude mice on recombinant 
VV replication. 
Virus and 
Treatmenta 
Geometric means oflog10 virus titres+ SEMh 
Ovaries Lungs 
Experiment 1 - Day 3 p.i. 
VV-HA-TK + PBS 7.5 +0.3 6.3+0.2 
VV-HA-TK + anti-as-GM1 7.8+0.1 6.7+0.4 
VV-HA-IL2 + PBS 5.0+0.2 5.2+0.1 
VV-HA-IL2 + anti-as-GM1 5.8+0.1 6.4+0.4 
Experiment 2 - Day 5 p.i. 
VV-HA-TK + NRS 8.3 +0.3 6.2+0.2 
VV-HA-TK + anti-as-GM1 8.6+0.1 6.5+0.1 
VV-HA-IL2 + NRS 4.3+0.1 4.2+0.1 
VV-HA-IL2 + anti-as-GM1 5.3+ 0.2 5.8+0.1 
Table 1. - continued 
a Six to 9 week old female outbred nude mice were given 150 µI i.n. 
antiserum to as-GM1 (diluted 1:5 in PBS) on days -5, -3, -1, 0, 1 and 2 for 
Experiment 1 and similarly for Experiment 2 with additional 
treatments on days 3 and 4. Control mice were given only PBS 
(Experiment 1) or normal rabbit serum (NRS) (Experiment 2). On day 
0, mice were injected i.v. with 107 PFU virus, and on the days indicated 
for each experiment, organs were removed for determination of viral 
titres. 
b Data shown are the geometric means of titres of organs from 4 
individual mice + the standard errors of means (SEM). 
Table 2. 
The effect of as-GM1 antiserum treatment on the mortality of nude mice 
after virus infection. 
Noof 
. 
mice 
5 
4 
5 
4 
Virus and % mortality 
treatmenta 
VV-HA-TK + 100 
PBS 
VV-HA-TK + 
anti-as-GM1 
VV-HA-IL2 + 
PBS 
VV-HA-IL2 + 
anti-as-GM1 
100 
nil 
nil 
MTD 
(death on days p.i.)b 
12.0 (9, 12, 12, 13, 14) 
11.3 (9, 11, 12, 13) 
a Eight week old female outbred nude mice were given 150µ1 i.v. and 50µ1 
i.n. antiserum to as-GM1 (diluted 1:5 in PBS) on days -5, -3, -1, 0, 1, 2 
and 3. Control mice were given only PBS. On day 0, mice were injected 
i.v. with 107 PFU virus and mortality was recorded. No mortality was 
observed in mice given antiserum alone (data not shown). 
b Mean time to death is based on the average of the days individual mice in 
groups died after infection. 
Table 3. 
The effect ofNK (NK-1.1) cell depletion in normal mice on recombinant 
VV replication. 
Virus and 
Treatmenta 
Geometric means of 10~10 virus titres+ SEMb 
Ovaries Lungs 
C57BU6Jmice CNK-1.1+2 
VV-HA-TK +PBS 7.0+0.2 4.8+0.l 
VV-HA-TK + NK-1.1 Mab 7.2+0.3 5.2+0.3 
VV-HA-IL2 + PBS 2.9+0.1 3.1 + 0.3 
VV-HA-IL2 + NK-1.1 Mab 5.1 +o.1c 4.4+0.3C 
CBA/H mice (NK-1.1-2 
VV-HA-IL2 + PBS 4.4+0.2 4.0+0.1 
VV-HA-IL2 + NK-1.1 Mab 4.6+0.1 4.3+0.3 
a Mice were treated with anti-NK-1.1 Mab as described in the materials 
and methods section, while controls were similarly given PBS only. 
Virus titres in organs were determined 3 days after infection with 107 
PFU. 
b Data shown are the geometric means of titres of 4 individual organs + 
SEM. 
c significant, p < 0.01 
Table 4. 
The effect of NK (NK-1.1 +) cell depletion in normal C57BLJ6J mice on 'fc cell response and VV-HA-IL2 titres 
Infection and/or 
treatment a 
VV-HA-IL2 
VV-HA-IL 
+ NK-1.1 Mab 
E:T 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
% 51U~~ifi~ ly5i~ Qf targ~t~ b 
Uninfected 
macrophages 
5 
4 
4 
4 
3 
2 
VV-WR Infected 
macrophages 
00 
70 
45 
ffi 
00 
74 
EL-4 
11 
4 
2 
46 
Z3 
12 
log1ovirus titres 
in ovaries + SEMc 
< 2.0 
4.0+0.5 
Table 4. cont. 
a Six week old female C57BU6 mice were given 107 PFU VV-HA-IL2 i.v. and treated with anti-NK-1.1 Mab as described in 
Materials and Methods and the assays were carried out six days post-infection. 
b Peritoneal macrophages from C57BU6 mice were used as infected or uninfected targets. 
c Data shown are the geometric means of 4 individual titres for each group. 
Table 5. 
NK cell responses in normal and beige mice after infection with 
VV-HA-TK or VV-HA-IL2a 
Splenocytes 
VV-HA-TK-
. immune 
VV-HA-IL2-
. immune 
Unimmunized 
controls 
E:T 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
% ~Ilf~ifiQ l:Y~i~ Qf Y AC-1 targ~t~ 
CBA/H Normal mice 
~ 
ID 
8 
56 
32 
17 
15 
9 
3 
CEA Beige mice 
2 
2 
1 
3 
1 
2 
2 
2 
0 
a Splenocyte effectors (pooled from 4 individual spleens) were obtained 
from 8 week old female normal or beige mice of the CEA background 2 
days after i.v. infection with 107 PFU virus. 
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Table 6. 
Comparison of Tc cell responses to VV-HA-TK and VV-HA-IL2 in normal 
and beige CBAmice.a 
Effectors 
CBA/H 
Normal 
. 
mice 
Cabg/bg 
Beige 
. 
mice 
E:Th 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
% s12ecific l:x:sis Qf L929 targets 
Uninfected targets VV-WR Infected targets 
VV-HA-TK VV-HA-IL2 VV-HA-TK VV-HA-IL2 
-immune -immune -immune -immune 
5 6 65 57 
2 2 42 
2 0 22 
2 1 70 
1 1 58 52 
0 0 32 
a Splenocyte effectors (pooled from 4 individual spleens) were obtained 
from 8 week old female normal or beige mice of the CBA background 6 
days after i.v. infection with 107 PFU virus. 
b Effector : target ratio. 
Table7 
Enhanced killing of L929 cells infected with VV-HA-IL2 by splenic NK 
cells. 
Effectors a 
Normal 
control 
VV-HA-IL2 
. 
-immune 
E:Th 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
L.929 
5 
2 
0 
18 
9 
3 
% sEecific lisis c 
L929 
+ 
VV-HA-IL2 
13 
7 
2 
44 
' 
11 
L929 
+ 
VV-HA-TK 
9 
5 
1 
17 
8 
a Effector cells were either splenocytes of uninfected CBA/H mice or 
splenocytes from CBA/H mice infected i.v. with 107 PFU ofVV-HA-IL2 3 
days previously. 
b Effector : target ratio. 
c Results shown are representative of 4 separate experiments. 
SEM of triplicates were lower than 3% and are omitted for clarity. 
Table 8. 
Phenotype of liver leukocytes8 isolat.ed from normal and nude mice infected with VV-HA-IL2 or VV-HA-TK. 
% positive cells 
Cell surface Normal CBA/H mice Outbred Swiss nude mice 
marker 
uninfected VV-HA-IL2 VV-HA-TK uninfected VV-HA-IL2 VV-HA-TK 
control infected infected control infected infected 
Thy-1.2 18 :r7 25 1.4 8.0 2.6 
CD4 9 12 15 0.7 1.1 0.5 
CD8 6 5 7 0.5 0.9 1.0 
as-GM1 ~ 49 34 34.0 58.0 40.0 
t 
F4/80 16 21 18 22.0 31.0 34.0 
a Liver leukocytes were isolated from uninfected controls 3 days after i.v. infection with 107 PFU of virus. Isolated 
leukocytes from 2 mice per group were pooled before staining for flow cytometric analysis. A total of 20,000 fluorescence-
activated cell sorting events were analysed for each population and cell surface marker. 
Table 9. 
Lysis ofYAC-1 targets by leucocyt.es isolated from ovaries of infect.ed 
mice.a 
Effectors a 
Normal 
control 
VV-HA-TK 
. 
-immune 
VV-HA-IL2 
. 
-immune 
E:Th 
10:1 
3:1 
1:1 
.10:1 
3:1 
1:1 
10:1 
3:1 
1:1 
% specific lysis c 
Ficoll-Paque 
2 
0 
0 
5 
3 
1 
2.8 
15 
Percoll 
NDd 
4 
2 
1 
'Zl 
17 
7 
Nylon Wool 
ND 
3 
2 
2 
11 
6 
4 
a Ovarian leucocytes were isolated from normal uninfected female CBA/H 
IID:Ce and CBA/H mice infected i.v. with 107 PFU of virus 3 days earlier. 
Results are representative of 2 separate experiments. 
b Effector: target ratio. 
c SEM of triplicates were less than 5%. 
d Not done. 
Table 10. 
Phenotype of ovarian effect.or! cells from CBMI mice infected with 
VV-HA-IL2 or VV-HA-TK. 
Effector E:Th 
cells plus 
treatment 
C 10:1 
3:1 
1:1 
C+anti-CD8 10:1 
3:1 
1:1 
C+anti-CD4 10:1 
3:1 
1:1 
C+anti-as- 10:1 
GM1 3:1 
1:1 
C+anti- 10:1 
Thy-1.2 3:1 
1:1 
YAC-1 
VV-HA-
IL2-
immune 
25 
a) 
12 
a) 
19 
15 
25 
22 
17 
0 
3 
0 
5 
9 
2 
VV-HA-
TK-
immune 
4 
1 
1 
5 
2 
1 
4 
2 
0 
1 
1 
0 
1 
1 
1 
% specific lysis 
L929 
VV-HA-
IL2-
immune 
21 
16 
14 
25 
19 
16 
27 
a) 
15 
10 
8 
5 
17 
13 
10 
VV-HA-
TK-
immune 
4 
2 
1 
6 
3 
2 
5 
.4 
2 
0 
0 
0 
5 
3 
2 
L929+VV-WR 
VV-HA-
IL2-
immune 
25 
21 
18 
31 
25 
21 
3) 
26 
22 
13 
11 
8 
24 
20 
14 
VV-HA-
TK-
immune 
4 
2 
2 
5 
3 
4 
6 
5 
3 
1 
1 
0 
6 
4 
3 
a CBA/H female mice were infected i.p. with 107 PFU virus 3 days before 
harvesting cells and enriching leucocytes with Ficoll-Paque. 
b Effector : target ratio. 
CHAPIER5 
The role of soluble mediators in viral clearance 
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INTRODUCTION 
The specificity and mechanism of cytotoxicity of antiviral Tc cells have 
been studied extensively in vitro, but their physiological effector function 
in vivo has remained unclear. In this regard, the classical studies by 
Blanden (1970; 1971a, b) using the mousepox model not only established 
the importance of Tc cells in mediating recovery from a generalized viral 
infection but also provided a basis for understanding the mechanisms 
involved. In response to ectromelia virus infection, the generation of 
antiviral Tc cells is followed by their migration from the circulation into 
infectious foci where blood monocytes are recruited through the release of 
leucotactic factors. The antiviral Tc cells eliminate virus-infected cells by 
direct or indirect cytolytic mechanisms before progeny virus are produced 
whereas the recruited monocytes ingest virus or virus-infected cells by 
virtue of their phagocytic capability. The specifically sensitized Tc may 
also produce IFN locally which could protect uninfected cells within and 
around the lesion~ increase resistance of monocytes to infection and 
enhance their virucidal capacity. However, the precise role of soluble 
mediators such as IFN-y, produced by antiviral Tc cells, in contributing to 
antiviral mechanisms is not clearly understood. 
Zinkernagel and Althage (1977) suggested two possible mutually exclusive 
mechanisms which could account for Tc cell-mediated antiviral function 
in vivo. The mechanisms are: (i) Tc cells lyse virus-infected cells before 
assembly and release of infectious virus progeny; (ii) Tc cells do not lyse 
infected cells, but release antiviral soluble mediators upon recognition of 
the relevant viral plus MHC class I antigens. In the same report, 
evidence was provided in favour of the first mechanism using a mouse-
VV-inf ection model. Virus-immune Tc cells were shown to effectively 
inhibit replication ofVV in acutely infected target cells in vitro by 
destroying infected target cells before assembly and release of progeny 
virus. These findings, together with the fact that anti-VV Tc cells are 
demonstrable early in infection (after 3 days), and strong circumstantial 
evidence for the antiviral activity of Tc from adoptive transfer models in 
vivo led them to suggest that T cells may act cytolytically in vivo in some 
viral infections. Further evidence in support of the first mechanism 
comes from the work of Lukacher et al (1984). They had used murine Tc 
lymphocyte clones directed to type A influenza virus to examine their in 
vivo antiviral effector activity after adoptive transfer into syngeneic mice 
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lethally infected with influenza A virus. In a dual-infection model, mice 
were simultaneously infected with lethal doses of two different subtypes of 
influenza A virus (HlNl and H2N2). When cloned Tc cells of H2N2 
specificity were transferred to the infected mice, the pulmonary viral 
titres of the strain recognized by the Tc cell clone only was reduced. The 
high level of specificity exhibited by Tc cells led these investigators to 
conclude that Tc cells mediate antiviral protective effects in vivo by direct 
cytolysis of virus-infected cells in an antigen-specific manner and not by 
non-specific host defense mechanisms such as the release of soluble 
factors. 
The above studies seem adequately convincing, but they fail to 
accommodate the possibility that both cytolysis of infected cells and 
release of antiviral factors are not mutually exclusive. Furthermore, 
such soluble factors produced by T cells are secreted locally into a limited 
space between interacting cell types (Pao et al., 1987). 
Based on their findings that clones of murine antigen-specific, H-2-
restricted, Tc cells released high levels of IFN-y when co-cultured with 
allogeneic cells pr~senting antigen, Klein and others ( 1982) suggested that 
Tc cells, on binding to antigen complexed with class I MHC, secreted 
IFN-y in addition to cell lysis. Tc cells that recognized and killed virus-
infected cells would help prevent spread of infection if in addition they 
released IFN-y at the local site of infection. IFN-y-induced upregulation 
of class I MHC expression could enhance recognition of virally infected 
target cells by Tc cells (Bukowski and Welsh, 1985; Schiltknecht and Ada, 
1985c) and, furthermore, IFN-y may activate macrophages and enhance 
their ability to destroy virus (Blanden, 1971b). The demonstration by 
Morris et al (1982) that an anti-influenza Tc cell clone that conferred 
protection against lethal influenza infection in mice also produced IFN-y 
when exposed to histocompatible, virus-infected targets in vitro led them 
to speculate that both direct cytolysis of virus-infected cells and secretion 
of IFN-y may be important in the control of an infection. 
The mechanism by which NK cells mediate antiviral function in vivo is 
still not entirely known. Moreover, the recognition element(s) for NK cells 
have not been characterised although a recent report (Mtillbacher and 
King, 1989) indicated that MHC class 1-unassociated ~2-m may serve as a 
ligand for NK cell-mediated lysis of targets. 
The murine cytomegalovirus (MCMV) infection of the mouse is presently 
the most convincing virus system in which NK cells have been 
demonstrated to contribute to antiviral mechanisms (reviewed in Welsh, 
1986). Evidence that cytolytic NK cells may be important in control of 
MCMV infection is essentially based on the findings that mice with 
genetically high levels of NK activity are more resistant than those with 
genetically low levels (Bancroft et al., 1981). Mice bearing the beige 
mutation (Roder and Duwe, 1979), and therefore deficient in cytolytic NK 
cells, are also highly susceptible (Shellam et al., 1981). Furthermore, an 
NK-cell like clone with in vitro cytolytic activity protected baby mice from 
MCMV infection (Bukowski et al., 1985) but the in vivo protective effect 
was lost when the clone failed to lyse target cells in vitro after long term 
culture (quoted in Welsh, 1986). Whether NK cells contribute to antiviral 
mechanisms in vivo by cytolytic activity and/or secretion of antiviral 
factors is still unclear. 
NK cells may secrete all 3 species of IFNs. However, the type of IFN 
produced appears to depend on the stimulus. F~r example, cloned 
murine NK cells produce IFN-a or -P on stimulation with Sendai virus 
(Randa et al., 1983) but otherwise produce IFN-y following stimulation 
with IL-2 (Randa et al., 1983; Young and Ortaldo, 1987). In at least two 
independent reports on the evaluation of toxicity and therapeutic efficacy 
of high dose IL-2 using mouse models, the toxic effects were in part 
attributed to the preferential secretion of IFN-y and/or TNF-a by IL-2-
activated NK cells (Gately et al., 1988; Peace and Cheever, 1989). These 
reports have 2 important implications. Firstly, they indicate that IL-2 can 
trigger NK cells to produce cytokines with known antiviral and 
antitumour activities. Secondly, while IL-2-activated NK cells can play an 
important role in orchestrating beneficial effects such as control of viral 
infection (Weinberg et al., 1986; Bukowski et al., 1988) and antimetastatic 
activity (Hinuma et al., 1987), they can also induce toxic manifestations. 
The undesirable effects of NK cell-mediated toxicity appear to be related to 
the high dose of IL-2 used (Cotran et al., 1987). 
The fact that resting NK cells, but not T cells, respond to IL-2 and produce 
IFN-yis most probably due to the constitutive expression of the p75 
subunit of the IL-2R on NK cells (Siegel et al., 1987; Tsuda et al., 1987). 
Resting T cells do not express the p55 subunit of the IL-2R. Although 
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some T cells do express the p75 subunit of the IL-2R, they require 
antigenic or other mitogenic stimuli to respond to IL-2. These 
observations may perhaps explain why NK. cells are more rapidly 
activated in mice infected with VV-HA-IL2 compared to VV-HA-TK. 
Evidence presented in the preceding chapter from studies using nude, 
beige and normal mice infected with VV-HA-IL2 suggested both NK cell-
dependent and -independent mechanisms contributed to viral clearance 
and survival of nude mice. Control of the virus infection by NK cells could 
either be mediated by direct cytolysis of infected cells and/or through the 
release of antiviral factors which directly or indirectly prevent virus 
spread. The release of IFN-y or cytokines that activate macrophages and, 
hence, increase their virucidal capacity could be involved in this process 
(Blanden, 1971b; Blanden, 1982; Blanden et al., 1976). It is also likely that 
expression of IL-2 during infection with VV-HA-IL2 induced other 
leukocytes (non-NK cells) to produce potentially effective concentrations of 
antiviral factors such as IFN-y or TNF-a. These cytokines are known to 
synergise with IFN-a and/or -~ ('/'/ ong et al., 1986), both of which are 
normally produced during-virus infections, to exert potent antiviral 
activity. 
Therefore, the roles of host-derived cytokines such as IFN-y, TNF-a and 
IFN-~ in the recovery from VV-HA-IL2 infection was investigated. The 
approach taken to evaluate the relative importance of these soluble 
mediators was by the use of specific Mab/antisera to inhibit their activity 
in vivo during infection with VV-HA-IL2. Viral titres, morbidity and 
mortality were assessed in animals treated with these antibodies. In 
addition, the role of mononuclear phagocytes in the process of recovery of 
nude mice from VV-HA-IL2 infection was investigated. 
MATERIAI.S AND l\1ETH0DS 
Mice. 
As described in Chapter 2 
Viruses. 
As described in Chapter 2 
Antisera/Mab 
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Purified rat anti-mouse IFN-y, a neutralizing Mab (5,700 U/mg) was 
obtained from Lee Biomolecular Research Inc., San Diego, CA. One U of 
this antibody neutralised IOU of the antiviral activity of murine IFN-y in 
vitro. 
A polyclonal anti-human TNF-a antibody (HT-2 4/14/88), originally raised 
in rabbits by Drs. ·s. Kunkel and D. Remick, was kindly provided by Dr. R. 
Marks, University of Michigan Medical School, Ann Arbor, Michigan. 
This antibody neutralised the biological activity of murine TNF-a in vitro 
and in vivo: 
Rabbit antiserum to mouse IFN-~ (neutralizing antibody with activity of 
10,000 unit/ml) was obtained from Lee Biomolecular Research Inc., San 
Diego, CA. 
Hybridoma cell lines, clone GKl.5 (anti-CD4) (Dialynas et al., 1983b) and 
clone 49.11.1 (anti-CD8/Ly2.1) (Hogarth et al., 1982) were kindly provided 
by Dr. R. Ceredig (John Curtin School of Medical Research). These 
antibodies were obtained as ascites, grown in pristane-primed outbred 
nude mice and used after partial purification as described in Chapter 2. 
In mvo cell depletion with Mabs. 
Normal CBA/H mice were depleted of CD4+ or CDS+ T cells using the 
appropria~e Mabs described above. Mice were given i.p. 500 µI of anti-CD4 
or 500 µI of anti-CDS Mabs 3 times on alternate days prior to infection 
(days -5, -3, -1), on the day of infection (day 0), and for 2 consecutive days 
after infection (days 1 and 2). This procedure is based on titrations for the 
depletion of T cells, perfomed with either Mab. Efficiency of depletion was 
assessed by flow cytometry as described in Chapter 4. 
Treatment with antisera/Mab t.o cyt.okines. 
The rat-anti-mouse IFN-a. Mab was diluted in PBS and a 200 µI volume 
was given Lp. (varying concentrations, depending on the experiment) to 
nude or normal mice on the days indicated in the Results section. 
Generally, mice were given the Mab one day prior to infection, on the day 
of infection and thereafter everyday except for the day of sacrifice. In 
experiments where mortality in nude mice was assessed, the Mab was 
given one day prior to infection, on the day of infection and for 3 
consecutive days after infection. 
A 100 µl volume of the anti-human TNF-a. antibody, sufficient to 
neutralize the in vivo biological activity of murine TNF (Dr. R. Marks, 
personal communication) was administered i.v. to nude mice one day 
prior to infection, on the day of infection and thereafter for 3 consecutive 
days p.i .. 
The rabbit antiserum to mouse IFN-~ was given i.p. to mice as follows: 
500U on days O (day of infection), 1 and 2, and 400U on days 3 and 4 post-
infection. 
Recombinant IL-2 and IFN-y. 
Affinity column purified recombinant (r) murine IL-2, with a specific 
activity of 64,000U/ml, was kindly provided by Dr. P. Hodgkin, DNAX 
Research Institute of Molecular and Cellular Biology, Palo Alto, CA., · 
USA. Recombinant murine IFN-y (300,000U/inl) was a kind gift of 
Boehringer Ingelheim, Vienna, Austria. 
Nude mice that had been infected 1 h earlier with VV-HA-TK were given 
i.p. 600U of recombinant murine rIL-2 or rIFN-y and thereafter every 8 h 
for a period of 5 days. Uninfected controls were treated similarly to assess 
the toxicity of the lymphokines. 
Macrophage depletion in vivo with silica. 
Silica (silicon dioxide), particle size between 0.5 to 10 µ (more than 80% 
between 1 and 5 µ) was obtained from the Sigma Chemical Company, St 
Louis, MO, USA. · Mice were depleted of macrophages with silica based on 
methods reported elsewhere (Allison, 1976). 
Nude mice were given silica (suspended in PBS and sonicated at 50 watts 
for 3x5 second) i.p. (5 mg) and i.v. (5 mg) on days -1, 3, 6 and 9. Treatment 
via the two routes is effective for the depletion of blood monocytes, 
peritoneal and organ associated macrophages (Allison, 1976). 
Assay for IL-2. 
The presence of IL-2 in sera, peritoneal fluids or ascites of mice was 
assessed by CTL-L cell proliferation and uptake of 3H-thymidine as 
described in Chapter 2. 
Virus titration. 
As described in Chapter 2. 
Cytotoxic assays. 
As described in Chapter 3. 
Assay for IFN-yin nude mouse splenocyte culture supernat.ant.s. 
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Splenocytes from outbred nude mice were cultured in the presence of rIL-
2 to determine whether as-GM1+ and as-GM1- cells produced IFN-y. 
Whole splenocytes (5xl06 cells treated with C only) were cultured in 1ml of 
complete EMEM containing 5xl04 M 2-mercaptoethanol and lOOU rIL-2 
for 3 days at 37°C in a humidified atmosphere containing 5% CO2 in air. 
Similarly, splenocytes depleted of as-GM1+ (5xl06 cells treated with anti-
as-GM1 + C) were cultured under the same conditions and controls were 
not exposed to IL~2. Presence of IFN-y in the culture supernatants was 
determined using a commercial sandwich ELISA (Holland Biotechnology 
bv, Leiden, Netherlands). The ELISA was performed according to the 
manufacturers' instructions. IFN-y activity (U/inl) was calculated from 
optical density values using a standard curve. 
RESULTS 
Enhanced VV-HA-IL2 replication in vivo after treatment with IFN-y Mab 
in nude mice. 
Nude mice infected i.v. with 107 PFU VV-HA-TK or VV-HA-IL2 were 
treated with a neutralising Mab to IFN-y and virus titres were determined 
in organs 3 and 5 days after infection. 
Three days after infection, VV-HA-TK titres in ovaries and lungs of anti-
IFN-y Mab-treated mice were 0.8 log10 PFU and 0.9 logio PFU higher than 
in PBS-treated controls respectively (Table 1). On the other hand, Mab 
treatment resulted in increases of 2.5 log10 PFU in ovaries and l.8 log10 
PFU in lungs of VV-HA-IL2-infected mice. 
Five days after infection, treatment with the Mab caused 0.4 logio increase 
in VV-HA-TK titres in ovaries and lungs compared to controls given PBS 
(Table 1). In contrast, VV-HA-IL2 titres were higher by 4.8 log10 in 
ovaries and 2.3 log10 in lungs of nude mice that had received the Mab to 
IFN-y. Furthermore, titres of VV-HA-IL-2 in Mab-treated mice were now 
comparable to the titres reached by VV-HA-TK. 
These data indicate that in nude mice early during an infection with VV-
HA-TK, IFN-y exerted antiviral function but the effect was lower on day 5 
than on day 3. During infection with VV-HA-IL-2, treatment with anti-
IFN-y Mab resulted in greater enhancement viral replication than with 
VV-HA-TK, suggesting that virus-encoded IL-2 may have induced the 
secretion of IFN-y. 
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The ability of nude mice t.o survive infection with VV-HA-IL2 is inhibited 
by anti-IFN-yMab. 
The above data suggested that IFN-y induced by virus-encoded IL-2 played 
an important role in virus clearance. Experiments were therefore 
undertaken to assess the effect of anti-IFN-y Mab treatment on the 
survival of nude mice infected with VV-HA-IL2. 
The results of a representative experiment are shown in Table 2. 
Treatment with 500U of anti-IFN-y Mab in VV-HA-TK-infected mice did 
not significantly (p > 0.05) affect the mean time to death (MTD) of about 15 
days compared to mice given VV-HA-TK only. However, nude mice 
infected with VV-HA-IL2 and treated with the antibody died from the fifth 
day onwards after infection, with a MTD of 9.6 days. This is in sharp 
contrast to the group of mice given VV-HA-IL2 only, where no mortality 
was recorded. The MTD was dependent upon the dose of anti-IFN-y Mab 
administered. Mice infected with VV-HA-IL2 and treated with several 
doses of lOOU Mab had a MTD of 11 days whereas treatment with 500U 
- Mab resulted in a MTD of 6 days (Table 3). 
IL-2-mediat.ed toxicity in mice infected with VV-HA-IL2 and treated with 
anti-IFN-y Mab. 
Some nude mice that had been infected with VV-HA-IL2 and treated with 
anti-IFN-y Mab died very rapidly, between days 5 to 8 p.i., with signs of 
erythematous eruptions all over the body and no distinct pox lesions. 
Mice that died after 9 to 10 days p.i. had obvious signs of vaccinial disease 
with pox lesions on tail and feet but with no erythematous eruptions. It is 
likely that the enhanced replication of VV-HA-IL2 after treatment with 
IFN-y Mab, resulted in the production of toxic levels of IL-2. 
Apart from exhibiting erythroderma, nude mice that appeared to suffer 
from the toxic effects of IL-2 had ascites and massive accumulation of 
mononuclear cells in the peritoneal and pleural cavities. These 
pathological findings are consistent with IL-2 toxicity which may be 
manifested in the form of vascular leak syndrome (Cotran et al., 1987). 
Evidence for vascular leakage was also sought by histologic examination 
of skin sections obtained from VV-HA-IL2 infected, antibody-treated mice. 
There was mild papillary oedema, some perivascular mononuclear cell 
infiltration and red blood cell extravasation in the dermal interstitial 
84 
spaces (Fig. la). There was occasional engorgement of capillaries with 
red blood cells. These findings suggested increased permeability of the 
capillary walls. Similar pathology was not seen in histological sections of 
skin from mice that had been infected with VV-HA-IL2 only (Fig. lb). 
Massive mononuclear cell infiltration was also noted in liver sections, 
with large areas of necrosis, in mice infected with VV-HA-IL2 and 
treated with the Mab (Fig. le), but not in livers of mice that had been 
infected with VV-HA-TK and treated with Mab (Fig. ld). 
Varying levels of IL-2 were demonstrable in sera, ascites and peritoneal 
fluids of mice that displayed the pathology described above (data not 
shown). No IL-2 was detected in sera or peritoneal fluids from mice that 
had been infected with VV-HA-IL2 only or mice infected with VV-HA-TK 
and treated with anti-IFN-y Mab. There was a 5-10-fold increase in the 
number of peritoneal cells in mice with obvious pathology . About 1-2xl06 
mononuclear cells were obtained from the peritoneal cavity of mice that 
had been infected with VV-HA-IL2. However, in mice that were infected 
with VV-HA-IL2 and treated with anti-IFN-y Mab, up to 107 peritoneal 
cells were recovered. These cells had potent cytolytic activity on YAC-1 
targets which was more than 9-fold higher than activity induced by 
infection with VV-HA-IL2 only (Table 4). They were as-GM± and Thy-
1.2±. Although treatment with anti-as-GM1 and C reduced the cytolytic 
activity on YAC-1 targets by more than 9-fold, substantial lytic activity still 
remained (Table 4). 
Effect of treatment with anti-IFN-y Mab ofVV-HA-IL2-infected nude mice 
on splenic NK cell activity. 
Investigations were carried out to determine if treatment with the anti-
IFN-y Mab in VV-HA-IL2-infected nude mice inhibited NK cell activation, 
thereby preventing NK cell-mediated antiviral function in vivo. Five days 
after i.v infection with 107 PFU ofVV-HA-TK, levels of NK activity (lysis of 
YAC-1 targets) in Mab-treated mice were slightly lower than untreated 
controls given virus only (Fig. 2). In contrast, the splenic NK activity in 
mice that had been infected i.v. with 107 PFU ofVV-HA-IL2 and treated 
with the Mab was more than 3-fold higher than activity induced by 
infection with VV-HA-IL2 alone (Fig. 2). These data indicate that 
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treatment with the anti-IFN-y Mab in VV-HA-IL2-infected mice did not 
prevent NK cell activation. 
Splenocytes from VV-HA-TK-infected mice mediating lysis of YAC-1 
targets were as-GM1+, Thy-1.2±, CD4- and CD8-. Lysis of YAC-1 targets 
by splenocytes from VV-HA-IL2-infected mice was mainly due to as-
GM1+, Thy-1.2±, CD4- and CD8- effectors and to a lesser extent by effectors 
that were as as-GM1-, Thy-1.2±, CD4- and CD8- (data not shown). 
Splenocytes obtained from VV-HA-IL2-infected mice that had been treated 
with anti-IFN-y Mab were as-GM1+, Thy-1.2±, CD4- and CDS- and were not 
completely lysed by treatment with anti-as-GM1 and C (data not shown) as 
was noted for the peritoneal cells (Table 4). 
Effect of administration of rllr2 or rIFN-y on mortality and survival time 
of nude mice infected with VV-HA-TK. 
The above data clearly established that in VV-HA-IL2-infected mice IFN-y 
is involved in the rapid clearance of virus and recovery of nude mice. 
Therefore it was of interest to determine whether administration of 
exogenous rIL-2 or rIFN-y during infection with VV-HA-TK contributed 
to recovery of nude mice. 
Groups of 3 - 5 outbred nude mice infected i.v. with 107 PFU VV-HA-TK 
were given 600U of rIL-2 or rIFN-y i.p. every 8 h for a period of 5 days. The 
rationale for this protocol was based on the kinetics of VV-HA-IL2 
clearance reported in Chapter 2. Morbidity and mortality in these and 
other groups given virus alone or the recombinant cytokines alone were 
assessed. 
No morbidity or mortality was recorded in groups of mice given only rIL-2 
or rIFN-y. All mice given VV-HA-IL2 alone survived with no overt 
disease. Nude mice infected with. VV-HA-TK alone showed signs of 
disease by 6 days p.i. and all mice died with a MTD of 12.2 days (Table 5). 
Treatment with exogenous rIL-2 or rIFN-y delayed the onset of disease 
signs which appeared between 11-16 days p.i., and significantly (p < 0.001) 
prolonged survival of nude mice. Nevertheless, all mice that had been 
infected with VV-HA-TK and treated with either rIL-2 or rIFN-y 
succumbed to disseminated disease and died with MTD of 23.4 and 25.8 
days, respectively. 
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TNF-a or IFN-P may not be cru.cial for the recovery of nude mice from 
VV-HA-IL2 infection. 
While the data presented above convincingly indicate that IFN-y is an 
important component in the recovery of nude mice from an infection with 
VV-HA-IL2, it is possible that other soluble factors could have contributed 
to antiviral mechanism(s), either on their own or in synergy with IFN-y. 
In this regard, the most likely known participants are TNF-a, which can 
be triggered by IL-2 or IFN-y, and IFN-a and IFN-P which are normally 
produced during a virus infection. Since the antisera to TNF-a and IFN-P 
were only available in limited amounts, preliminary experiments were 
carried out to determine if these reagents inhibited the recovery of nude 
mice from an infection with VV-HA-IL2. Groups of 4 nude mice treated 
with anti-TNF-a or anti-IFN-P were infected i.v. with 107 PFU VV-HA-IL2 
and were observed for morbidity and mortality. Although some morbidity 
was recorded in the group that had been treated with anti-IFN-P antibody, 
all mice that had .been infected with VV-HA-IL2 and treated with anti-
TNF-a or anti-IFN-P recovered from the infection. No virus persisted in 
organs of these mice at 20 days p.i. While these studies are not backed up 
by data on virus titres in organs early in the infection, they nevertheless 
suggest that TNF-a or IFN-P may not be crucial~ mediating the recovery 
of nude mice. 
The role of IFN-a was not investigated. 
The role of mononuclear phagocytes in the recovery mechanism(s). 
Monocytes and macrophages have a well defined antiviral role in vivo 
Since IFN-y has been shown to be crucial for the recovery of nude mice 
from an infection with VV-HA-IL2, it is possible that IFN-y-mediated 
antiviral mechanism(s) were in part due to activated 
monocytes/macrophages. IFN-y is a potent monocyte/macrophage 
activating factor and anti-IFN-y Mab can abrogate the antiviral and 
antitumour activities of these mononuclear phagocytes (Spitalny and 
Havell, 1984). To investigate the possible involvement of this class of cells, 
nude mice were treated with silica, a procedure known to deplete or 
inactivate macrophages (Allison, 1976). Groups of 5 nude mice that had 
been treated with silica were infected i.v. with 107 PFU VV-HA-TK or VV-
HA-IL2. Controls were treated with silica only or infected with viruses 
only. Morbidity and mortality were assessed. 
Treatment with silica, did not acccelerate the MTD of nude mice that had 
been infected with VV-HA-TK (Table 6). Two of the 5 mice that had been 
infected with VV-HA-IL2 and treated with silica died 30 days after 
infection with obvious signs of a disseminated vaccinial disease. The 
remaining 3 mice in the group were sacrificed 32 days after infection in 
order to determine if virus had been cleared. About 3.8 log10 PFU virus 
was recovered from the lungs and 4.4 log10 PFU was recovered from the 
brains of these mice (Table 6). Treatment with silica also resulted in 
lower splenic NK cell activity in uninfected or virus-infected mice (data 
not shown). 
Both as-GM1+ and as-GM1· nude mouse splenocytes produce IFN-yin 
vitro. 
In the previous Chapter, depletion of as-GM1 + (NK) cells in nude mice 
was shown to result in enhanced VV-HA-IL2 replication (Chapter 4, 
Table 1), plus signs of morbidity but no mortality. As discussed in 
Chapter 4, a possible explanation for the failure of NK cell-depleted nude 
mice to die from VV-HA-IL2 infection was that both as-GM1+ (NK) and 
as-GM1- (NK precusors and non-NK) cells may have contributed to virus 
clearance, either by cytolysis of virus-infected cells or secretion of 
antiviral factors. It was therefore of interest to determine if as-GM1+ and 
as-GM1- splenocytes from nude mice produced IFN-y on stimulation with 
IL-2. Nude mouse splenocytes, either whole or depleted of as-GM1 + cells, 
were cultured in media containing lOOU/ml rIL-2 for 3 days following 
which the presence of IFN-y in cultures was assayed using an ELISA. 
More than 40U/ml of IFN-y was detected in whole splenocyte culture 
supernatants, whereas between 26-30U/ml of the lymphokine was 
detected in cultures depleted of as-GM1+ cells. No IFN-y was detected in 
control cultures that had been maintained in the absence of IL-2. 
The role of IFN-y in the clearance of virus in normal mice. 
Bas£•:i on the data obtained in studies with nude mice, it was likely that 
IFN-y, induced by virus-encoded IL-2, mediated the rapid clearance of 
VV-HA-IL2 in normal mice. Therefore experiments were carried out 
using normal CBA/H mice to assess the role of IFN-y in rapid viral 
clearance. 
Groups of female CBA/H mice were treated with the IFN-y Mab one day 
prior to infection (day -1), on the day of infection (day 0) and for 2 
consecutive days after infection. Three days after i.v. infection with 107 
PFU virus, mice were sacrificed to determine viral titres in organs and 
splenic NK activity. 
The antibody treatment resulted in enhanced VV-HA-TK and VV-HA-IL2 
replication in ovaries and lungs. Mean titres of VV-HA-TK increased 
significantly (p < 0.01) by 0.9 logio PFU in ovaries and l log10 PFU in lungs 
of antibody-treated animals (Table 7). The effect of IFN-y Mab treatment 
was more marked in the case of VV-HA-IL2 replication. The mean VV-
HA-IL2 titre increased by 3.7 logio in ovaries and 1.5 log10 in lungs 
compared to titres in control mice (Table 7). 
In normal mice infected with VV-HA-TK or VV-HA-IL2, treatment with 
anti-IFN-y antibody resulted in enhanced NK cell activity, but the effect 
was more marked in VV-HA-IL2-infected mice (Table 7). 
Six days after infection, the Tc cell responses to VV-HA-TK and VV-HA-
IL2 were elevated in mice treated with anti-IFN-y Mab and were at least 3-
fold higher than the responses in untreated animals (Table 8). Although 
by this time VV-HA-IL2 was undetectable in ovaries of control mice, in 
anti-IFN-yMab-treated mice, up to 5.6 logio PFU VV-HA-IL2 was 
recovered (Table 8). The mean VV-HA-TK titre also increased from 6.5 
log10 PFU in the control group to 7 .5 log10 in the Mab-treated mice (Table 
8). No virus was recovered from lungs at 6 days p.i. 
The above data clearly indicate that treatment with anti-IFN-y Mab in 
normal mice did not inhibit NK cell activation or the induction of antiviral 
Tc cell response. However, IFN-y, presumably secreted by NK and T cells, 
appears to be an important factor in viral clearance, especially in the case 
of VV-HA-IL2. 
The role of CD4+ and CDS+ T cells in rapid VV-HA-IL2 clearance by 
possible IFN-y secretion. 
In normal mice, both T cells and NK cells are known to produce IFN-y. 
In the previous Chapter, it was demonstrated that depletion of NK cells in 
normal mice led to enhanced VV-HA-IL2 replication. Based on the data 
presented in Chapter 4 and in this Chapter, there is sufficient evidence to 
suggest the NK cells could have contributed to antiviral mechanism(s) in 
vivo by cytolysis of virus infected cells and/or secretion of antiviral factors 
like IFN-y. Both CD4+ and CDS+ T cells were not represented in the 
cytolytic effector populations evident up to day 3 after infection (see 
Chapter 3, Tables 2 and 4). It was of interest, however, to determine if 
these two populations of T cells contributed to antiviral mechanisms in 
vivo, during the first 3 days after infection through secretion of IFN-y. 
Therefore normal CBA/H mice were depleted of CD4 + or CDS+ T cells by 
repeated injections with anti-CD4 and anti-CDS Mab, infected with 107 
PFU ofVV-HA-IL2 i.v. and 3 days later, the viral titres in organs were 
determined. 
While the depletion of CDS+ T cells had virtually no effect (p > 0.05) on 
viral titres, the mean VV-HA-IL2 titres in lungs and ovaries of anti-CD4 
antibody treated mice were significantly (p < 0.001) higher than control 
mice (Table 9). 
DISCUSSION 
The currently held view with regard to the role of Tc cells in host defense 
to viral infection is based on the capacity of these effectors to recognize 
viral peptide in association with the MHC Class I antigen on the surface 
of infected cells followed by cytolysis (Zinkernagel and Doherty, 1974; 
Zinkernagel and Althage, 1977; reviewed in Zinkernagel and Doherty, 
1979; Lukacher et al., 1984; Townsend et al., 1986a) and possibly, local 
release of IFN-y (Blanden, 1971a; Klein et al., 1982; Morris et al. 1982). 
The IFN-y, released in an antigen-specific and H-2-restricted manner, 
could control further spread of virus by a variety of mechanisms, but its 
relative importance is unclear. On the other hand, while NK cells have 
been implicated to mediate antiviral function in vivo (Bukowski et al., 
1984; reviewed in Welsh, 1986), the the relative importance of NK cell-
mediated cytolytic activity versus NK cell-secreted antiviral factors is not 
known. 
The results presented in this Chapter demonstrate very clearly that IFN-y 
played a crucial role in the efficient clearance of VV-HA-IL2 and the 
recovery of nude mice from an infection with this virus. The IL-2-induced 
IFN-y was also involved in efficient clearance of VV-HA-IL2, and to a 
lesser extent VV-HA-TK, in normal mice. IL-2 induces and regulates the 
production of IFN-y by T lymphocytes and NK cells (Farrar et al., 1981; 
Torres et al., 1982; Randa et al., 1983; Trinchieri et al., 1984; Young and 
Ortaldo, 1987). Since nude mice lack functional T cells which are the 
principal producers of IL-2, the virus-encoded IL-2 was essential for nude 
mouse lymphoid cell activation and IFN-y secretion. Although lymphoid 
cells from aged ( 4-6 month old) N :NIH(S) II nude mice were previously 
shown to be capable of secreting IL-2 in response to ConA (MacDonald et 
al., 1982), a quantitative analysis of the precursors of IL-2 producing· cells 
in that system showed a 5-to-10-fold deficiency in precursor frequency 
among nude lymphoid cells (MacDonald and Lees, 1984). Therefore, if IL-
2 is crucial for the induction and regulation of IFN-y production, then 
nude mouse lymphoid cells would be expected to produce only low levels of 
IFN-y which may be insufficient for the control of a virus infection. In 
normal mice, optimal levels of IL-2 production by T lymphocytes would 
ensure the induction and regulation of relevant concentrations of IFN-y 
secretion. 
...... 
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As-GM1 + NK cells are thought to be the major source of IFN-y production 
in T-cell deficient mice (Bancroft et al., 1989). The present data suggests, 
however, that as-GM1- cells, under appropriate conditions, may secrete 
IFN-y. Both as-GM1+ and as-GM1- nude mouse splenocytes were shown 
earlier (Chapter 3, Tables 7 and 8) to cause lysis ofYAC-1 targets. 
However, there is no evidence on the question of whether these cytolytic 
populations were also responsible for IFN-y secretion in vivo. It is also not 
clear if the as-GM1- nude mouse lymphoid cells are progenitors of NK 
cells or non-NK cells. 
Since both T cells and NK cells can produce IFN-y in normal mice, it is 
likely that both these populations contributed to IFN-y secretion after 
infection with VV-HA-IL2. Data presented in this and the preceding 
Chapters, from experiments in which Mabs were used to deplete specific 
cell subsets in normal mice, indicated that NK and CD4 + T cells may have 
contributed to inhibition ofVV-HA-IL2 replication by the secretion of IFN-
y. However, the enhanced VV-HA-IL2 replication in normal mice 
depleted of CD4 + T cells is by no means proof that this subset of T cells 
could have contributed to antiviral function in vivo only by secretion of 
IFN-y. The finding that CDS+ T cell depletion did not affect VV-HA-IL2 
titres is consistent with data presented earlier (Chapter 3, Table 7), which 
indicated that CDS+ T cells did not play a role in viral clearance during 
the first 3 days after infection. 
The anti-IFN-y Mab did not inhibit NK cell activation or Tc cell 
generation, indicating the possiblity that the antiviral function of these 
effector cells could have been impaired in vivo and also concurring with 
the report by Sayers and others (1986) that the potentiating effect of IL-2 on 
the cytolytic activity of NK cells is not mediated by IFN-y. In fact, the 
enhancement of NK cell cytotoxicity mediated by IL-2 is known to precede 
by several hours the appearance of detectable IFN-y in culture 
supernatants (Sverdersky et al., 1984; Trinchieri et al., 1984). 
The finding that a proportion of VV-HA-IL2-infected nude mice that had 
been treated with anti-IFN-y Mab died from IL-2 toxicity is consistent with 
increased IL-2 production due to enhanced VV-HA-IL2 replication. This 
is further evidence that IL-2 is produced in vivo during infection with VV-
HA-IL2. IL-2 was not detected in biological fluids of mice infected with 
VV-HA-TK, whether or not they had been treated with anti-IFN-y Mab . 
Although IL-2 could not be demonstrated in sera of mice infected with 
VV-HA-IL2 but untreated with ant-IFN-y Mab, this may reflect the fact 
that IL-2 is produced locally at sites of infection, at levels that are sufficent 
to mediate a cascade of immune mechanisms but not high enough to be 
detected systemically. In this regard, administration of exogenous rIL-2 
or r IFN-y did not allow recovery but prolonged survival of nude mice 
infected with VV-HA-TK. Because lymphokines are usually produced as 
paracrine (and autocrine) factors secreted into a limited space between 
interacting cell types (Poo et al., 1987), virus-encoded IL-2 produced locally 
would be expected to operate (in inducing antiviral immune mechanisms) 
more effectively and efficiently than the systemic administration of 
lymphokines which also have very short half lives in vivo. The data may 
reflect the fact that it is not possible to mimic, by administration of 
exogenous rIL-2 or rIFN-y, conditions under which VY-encoded IL-2 or 
the IL-2-induced IFN-y operate in vivo. It may also underscore the 
importance of local immune mechanisms which operate at the sites of 
virus infection. 
IL-2 in foci of infection may have induced the secretion of other cytokines 
which are believed to mediate, at least in. part, the toxic effects of IL-2 
(Cotran et al., 1987; Gately et al., 1988, Peace and Cheever, 1989). The 
presence of one such cytokine, TNF-a, could not be demonstrated in the 
biological fluids of mice that were suffering from IL-2 toxicity. 
IFN-y could have contributed in a number of ways to limit viral 
replication in vivo. First, it is possible that IFN-y may have had a direct 
antiviral effect on cells either through limiting viral replication or 
preventing infection of other cells. Recent evidence (Leist et al., 1989; 
Kohonen-Corish et al., 1990; Ruby and Ramshaw, submitted) is consistent 
with an antiviral role for IFN-y in vivo. 
Second, IFN-y, could have mediated antiviral funciton in vivo through 
monocyte/macrophage activation and data presented earlier is consistent 
with a role for these mononuclear phagocytes. While the complete 
depletion of monocytes/macrophages is unlikely to be achieved in vivo, the 
data provide sufficient evidence which supports the earlier suggestion 
that monocytes/macrophages (most likely activated by IFN-y) may have 
contributed, in part, to the IL-2-induced antiviral mechanisms which 
enabled nude mice to recover from infection with VV-HA-IL2. Nude mice 
treated with silica were unable to clear VV-HA-IL2. Therefore, 
mononuclear phagocytes seem essential for the full expression of IFN-y 
mediated antiviral function. The finding that silica treatment reduced 
NK activity supports the possibility that persistence ofVV-HA-IL2 in 
silica-treated mice could have been partly due to impaired NK cell 
function in vivo. 
The third mechanism by which IFN-y could have contributed to antiviral 
function in vivo is based on the ability of this lymphokine to regulate the 
induction or upregulation of the expression of class I and class II MHC 
gene products and P2-microglobulin (~2-m). The membrane-bound class I 
MHC glycoproteins serve as recognition elements for CDS+ Tc 
lymphocytes during immune elimination of virus-infected cells. 
Recently, class I MHC-unassociated P2-ni has been implicated as a ligand 
for NK cell recognition and lysis of target cells (Miillbacher and King, 
1989). Treatment with a neutralizing Mab to IFN-y in vivo could have 
interfered with the induction or upregulation of both the T- and NK-cell 
ligands, thus affecting the recognition, and triggering of lysis of virus 
infected cells. 
Finally, IFN-y could have contributed to antiviral mechanisms in vivo by 
synergizing with other host-derived antiviral factors like TNF-a (Wong 
and Goedde!, 1986) and/or IFN-a (Fleischman et al., 1984) and IFN-P 
(Zerial et al., 1982). The antiviral activities of these cytokines are 
synergistic when acting together. However, experiments using 
antibodies to TNF-a or IFN-P have provided no evidence to suggest an 
essential role for either of these factors in mediating recovery of nude 
mice from infection with VV-HA-IL2. 
Figure 1. Histologi,c changes in skins and livers of athymic, nude mice 
infected with recombinant VV and treated with anti-IFN-y Mab. 
Haematoxylin and eosin-stained histologic sections of skins and livers 
taken 5 days after i.v. injection with 107 PFU of VV-HA-IL2 or VV-HA-TK 
and treated with anti-IFN-yMab or otherwise. Red blood cell 
extravasation [arrows] was often observed in the dermal interstitial 
spaces in skin sections of mice inoculated with VV-HA-IL2 and treated 
with Mab (a), but not in sections from mice given VV-HA-IL2 only (b). 
[magnification x 100] Massive mononuclear cell [MN] infiltration and 
necrotic lesions [N] were typically seen in livers of mice infected with VV-
HA-IL2 and treated with the Mab (c). Livers from mice infected with VV-
HA-TK and treated with the Mab had significantly smaller numbers of 
mononuclear cells [MN] in the foci (d). [magnification x 80] 
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Figure 2. The effect of IFN-y Mab -treatment on splenic NK cell activi"ly . 
Six to 8-week old female nude mice were given 500U of anti-IFN-y Mab i.p. 
on days -1, 0, 1, 2 and 3. Mice were infected i.p. with 107 PFU virus on day 
0, and 5 days later the splenic cytolytic activity on YAC-1 targets was 
determined using pooled splenocytes. The assay was carried out in 
triplicate for each effector to target ratio and SEM were less than 5%. 
Table 1. 
The effect of anti-IFN-y Mab treatment in nude mice on the replication of 
VV-HA-TK or VV-HA-IL2 a. 
Virus infection 
and treatment 
Expt, 1. - 3 days post-infection 
VV-HA-TK + PBS 
VV-HA-TK + anti-IFN-y ab. 
VV-HA-IL2 + PBS 
VV-HA-IL2 + anti-IFN-y ab. 
Expt, 2 - 5 days post-infection c 
VV-HA-TK + PBS 
VV-HA-TK + anti-IFN-y ab. 
VV-HA-IL2 + PBS 
VV-HA-IL2 + anti-IFN-y ab. 
Log10 virus titres b 
. 
ovanes 
7.5+0.2 
8.3+0.3 
5.0+0.2 
7.5+0.3 
8.6+0.2 
9.0+0.1 
4.0+0.1 
8.8+0.1 
lungs 
6.3+0.2 
7.2+ 0.2 
5.1 + 0.3 
6.9+ 0.3 
6.5 +0.2 
6.9+ 0.2 
4.2 + 0.1 
6.5+0.2 
a Six week old female nude mice were given 500U of anti-IFN-y Mab i.p. on 
days -1, 0, 1 and 2. Mice were infected i.v. with 107 PFU virus on day 0, 
and 3 days later mice were sacrificed and virus titres in organs were 
determined. 
b Data shown are the geometric means of log10 virus titres + SEM of 4 
individual lungs or pairs of ovaries. 
c The regime of Mab treatment and infection with virus for Expt. 2 is as for 
a above except that mice were given the Mab on day 3 as well. 
.. 
Table 2. 
Mortality in nude mice treated with anti-IFN-y antibody and infected with 
VV-HA-IL2. a 
Virus and/or No. of mice % Mortality MTD b (death on days p.i.) 
antibody 
antibody only 3 nil 
VV-HA-TK 5 100 15.4 (12,14,15,18,18) 
VV-HA-TK 5 100 14.6 (13,13,14,16,17) 
+ antibody 
VV-HA-IL2 5 nil 
VV-HA-IL2 5 100 9.6 (5,6,7,13,17) 
+ antibody 
' 
a Ten week old female nude mice were given 500U of antibody i.p. on days 
-1, 0, 1, 2 and 3. Mice were infected i.v. with 107 PFU of virus on day 0. 
Control mice were left uninfected. One U of antibody neutralizes lOU of 
the anti-viral activity of IFN-y in vitro. 
b Mean time to death. 
Table 3. 
The effect of increasing anti-IFN-y antibody concentration on mortality of 
nude mice infected with VV-HA-IL2.a 
No of mice Ab. conc.b Infected/ MTD c (death on days p.i.) 
Uninfected 
4 lOOU VV-HA-IL2 11.00 (9,11,11,13) 
2 lOOU 
4 200U VV-HA-IL2 9.75 (7,9,10,13) 
2 200U 
4 300U VV-HA-IL2 8.50 (7,8,9,10) 
2 300U 
4 400U VV-HA-IL2 7.75 (6,7,8,10) 
2 400U .. 
4 500U VV-HA-IL2 6.00 (5,5,6,8) 
2 500U 
a Six week old female nude mice were given i.p. varying concentrations of 
anti-IFN-y on days -1, 0, 1, 2 and 3. Mice were infected on day O with 107 
PFU virus i.v. and controls were left uninfected. 
b One U of antibody neutralizes lOU of the antiviral activity of IFN-yin 
vitro. 
c Mean time to death. 
C 
Table 4. 
Phenotype of perit.oneal cyt.olytic effect.or cells from VV-HA-IL2-infected 
and anti-IFN-y Mab-treated nude mice. a 
% specific lysis of Y AC-1 targets 
Treatment E:T effectors from effectors from 
VV-HA-IL2- · VV-HA-IL2-
infected, antibody- infected mice 
treated mice 
10:1 78 21 
3:1 66 13 
1:1 49 6 
C + anti-Thyl.2 10:1 67 15 
C + anti-as-GM1 
(1:50 dilution) 
C + anti-as-GM1 
(1:5 dilution) 
3:1 
1:1 
10:1 
3:1 
1:1 
10:1 
3:1 
1:1 
43 
32 
ffi 
51 
38 
36 
24 
15 
8 
3 
17 
7 
5 
4 
1 
0 
a Six week old female nude mice were given 500U of anti-IFN-y Mab i.p. on 
days -1, 0, 1, 2 and 3, and infected i.v. with 107 PFU ofVV-HA-IL2 on day 
0. Peritoneal cells were harvested 5 days after infection from groups of 4 
mice, treated or untreated with anti-IFN-y Mab. Aliquots of lxl06 
peritoneal cells were treated with appropriate antibody and/or 
complement (C) and effectors were used in a cytotoxicity assay. Anti-as-
GM1 was used at 2 dilutions, and by increasing the concentration more 
of the cytotoxic activity on YAC-1 targets could be abrogated. 
Table 5. 
The effect of exogenous rIL-2 or rlFN-y administration on survival of 
nude mice infected with VV-HA-TK. 
No. of Virus a Treatment b % Survival MTDC 
. (Death on days p.i. ) mice 
3 nil rIL-2 100 
3 nil rIFN-y 100 
5 VV-HA-IL2 100 
5 VV-HA-TK 0 12.2 (9,11,12,14,15) 
5 VV-HA-TK rIL-2 0 23.4 (19,21,24,25,28) d 
5 VV-HA-TK rIFN-y 0 25.8 (18.,.23,27,28,33) d 
a Eight week old male nude mice were given 107 PFU virus i.v. 
b One hour after infection, mice were given i.p. 600U of rIL-2 or rIFN-y (+ ) 
and thereafter every 8 hours for a period of 5 days. Controls were given 
PBS only (-). 
c Mean time to death. 
d Significant, p < 0.001 - Students T-test, compared to group given 
VV-HA-TK only. 
Table 6. 
The effect of macrophage depletion on mortality and VV-HA-IL2 
clearance in nude mice. 
No of Virus a Macrophage b % Survival MTDC 
mice depletion (Death on days p.i. ) 
(i) Mortality 
5 VV-HA-TK 0 13.4 (10,13,14,15,15) 
5 VV-HA-TK + 0 14.0 (10,10,14,18,18) 
5 VV-HA-IL2 100 
5d VV-HA-IL2 + 6) 30 (30,30) 
(ii) Viral titres d Log10 virus titres + SEM 
Lungs Brain 
3.8 +0.4 4.4 + 0.4 
a Eight week old male nude mice were given 107 PFU virus i.v. 
b Mice were depleted(+) of macrophages as described earlier. Control 
mice were left untreated(-) with silica. 
c Mean time to death. 
d The 3 surviving mice were sacrificed on day 32 p.i. and virus titres in 
lungs and brain were determined. 
Table 7. 
Anti-IFN-y Mab treatment in normal CBA/H mice: Effect on NK cell 
responses and vhus titres. a 
% Specific lysis Infection and 
Treatment E:T of Log10 virus titres ± SEM b 
YAC-1 targets . ovanes lungs 
VV-HA-TK 20:1 37 7.9.+ 0.1 4.7+0.1 
7:1 19 
2:1 7 
VV-HA-TK+ 20:1 45 8.8 + 0.2 C 5.7+0.3C 
IFN-y Mab 7:1 25 
2:1 13 
VV-HA-IL2 20:1 52 3.9+0.1 3.8+0.1 
7:1 33 
2:1 17 
VV-HA-IL2 + 20:1 61 7.6 + 0.2 d 5.3 + 0.1 d 
IFN-yMab 7:1 49 
2:1 :I) 
a Six week old female CBA/H mice were treated with 300U anti-IFN-y Mab 
i.p. on days -1, 0, 1 and 2. Mice were infected with 107 PFU virus on day 
0, and 3 days later, splenocytes were used to measure NK activity while 
ovaries and lungs were used for determination of viral titres. 
b Data shown are the geometric means of log10 virus titres + SEM of pairs 
of ovaries and individual lungs from groups of 3 mice. 
c Significant, p < 0.01, Students T-test. 
d Significant, p < 0.001, Students T-test. 
Table 8. 
Anti-IFN-y Mab treatment~ normal CBA/H mice : Effect on Tc cell 
responses and virus titres a. 
Infection and 
Treatment 
VV-HA-TK 
VY-HA-TK + 
IFN-yMab 
VV-HA-IL2 
VY-HA-IL2 + 
IFN-yMab 
E:T 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
20:1 
7:1 
2:1 
% Specific lysis of 
VY-WR-infected 
L929 targets b 
00 
54 
~ 
82 
f57 
sg 
ro 
45 
21 
75 
65 
48 
Log10 virus titres 
+SEM 
in ovaries c 
6.5+0.2 
7.5+0.1 
< 2.0 
5.6+0.1 
a Six week old female CBA/H mice were treated with 300U anti-IFN-y Mab 
i.p. on days -1, 0, 1, 2, 3 and 4. Mice were infected with 107 PFU virus on 
day 0, and 6 days after infection, splenocytes were used to measure Tc 
activity, while virus titres in ovaries and lungs were determined. 
b The levels of lysis shown are lysis of virus-infected targets minus lysis of 
uninfected targets. Lysis of uninfected targets was between 5-10% of the 
levels of lysis seen on VY-WR-infected targets 
c Data shown are the geometric means oflog10 virus titres+ SEM of pairs 
of ovaries from 3 mice per group. 
Table 9. 
Depletion of CD4+ or CDS+ cells in normal mice: Effect on VV-HA-IL2 
replication. 
Virus infection and 
antibody treatment a 
VV-HA-IL2 
VV-HA-IL2 + anti-CD4 
VV-HA-IL2 + anti-CD8 
Geometric means of log10 virus titres+ SEM b 
. 
ovanes 
4.1 + 0.1 
5.5 + 0.1 C 
4.2+0.2 
lungs 
3.8+ 0.2 
5.1+0.2C 
4.1 + 0.2 
a Eight week old female CBA/H mice were treated with anti-CD4 or anti-
CD8 Mab to specifically deplete CD4 + and CDS+ T cells as described 
. 
under Materials and Methods. Three days after infection, mice were 
sacrificed for the determination of virus titres in organs. 
b The datd shown are the geometric means of log10 virus titres+ SEM of 
paired ovaries or indiviual lungs from 4 mice per group. 
c Significant, p < 0.001 Students T-test, when compared with VV-HA-IL2 
titres in untreated mice. 
CHAPrER6 
VV growth in murine ovaries: A functional and histological analysis. 
Il'ITRODUCTION 
Acceptance of a vaccine by any community is governed by a complex 
equation, balancing efficacy against safety, gain against risk and fear of 
disease against the potential side effects associated with vaccination. The 
incidence of encephalitis and other complications following vaccination 
with existing strains of VV (approximately 1:10,000) was judged to be 
unacceptable in the western countries in the final years before smallpox 
was eradicated (Mims and White, 1984d). Because the standards have 
changed for human vaccines, the smallpox vaccine, which has remained 
more or less unchanged for more than a hundred years, would never 
have been licensed if introduced a few years ago (Mims, 1987b). Since 
recombinant VV have been proposed as live virus vaccines for human 
and veterinary use, it is crucial that existing strains are improved with 
regard to safety. 
While the primary aim of inserting the IL-2 gene into the VV genome was 
to enhance the immune responses to VV and the co-expressed influenza 
HA in immunized mice, there is sufficient evidence to conclude that the 
expression of this lymphokine during infection with VV-HA-IL2 reduced 
virulence. Data presented earlier clearly indicated that in mice treated 
with anti-IL-2 (Chapter 2, Table 3) or anti-IFN-yMab (Chapter 5, Tables 1, 
3 and 5), titres of VV-HA-IL2 were increased significantly compared to 
growth in untreated controls, and sometimes comparable with titres of 
VV-HA-TK. 
This final experimental chapter addresses essential findings related to 
the safety and potential use of VV as a live virus vector to deliver foreign 
antigens of medical and verterinary importance. The first of these is the 
highly productive infection caused by VV in ovaries of mice described in 
the earlier chapters. Using normal mice, the effect of VV replication on 
the reproductive function of ovaries was investigated. Since VV-HA-TK 
had been constructed from VV-WR, the capacity for VV-WR to replicate 
in ovaries was studied. It was also of interest to determine if human 
vaccine strains of VV replicated in murine ovaries. After all, VV-WR is a 
mouse-adapted virus derived from the human vaccine strain VV-NYBH. 
Three human vaccine strains with varying degrees of pathogenicity 
(reviewed in Fenner et al., 1988c) were used in the study. 
The second important finding relates to the fact that VV-HA-IL2 was 
cleared more rapidly than VV-HA-TK from ovaries and other organs of 
normal ~ce without affecting immunogenicity. The use of recombinant 
VY-encoding immunomodulatory molecules such as IL-2 may serve to 
make vaccines safer. The effect of IL-2-induced mechanisms of rapid 
viral clearance on the reproductive function of ovaries was investigated 
histologically and functionally. 
Finally, during the course of this work, an unexpected finding was made. 
In order to show the causal relationship between VV-HA-IL2-induced NK 
cells and their antiviral function in vivo, normal mice were depleted of 
NK (as-GM1 +) cells with anti-as-GM1. Instead of exacerbating the 
infection, treatment with anti-as-GM1 reduced significantly VV-HA-TK 
and VV-HA-IL2 titres in ovaries of infected mice. However, lung viral 
titres in antiserum treated mice increased significantly (data not shown). 
Evidence for the role of NK cells in contributing to antiviral function in 
vivo was nevertheless obtained using a specific Mab (anti-NKl.1) to NK 
cells. In an attempt to understand the mechanism behind lower viral 
titres in ovaries of anti-as-GM1-treated mice, some preliminary work was 
carried out. The results are discussed in the context of viral tropism and 
how knowledge of the passage history of any strain being considered as a 
candidate vaccine may be crucial to its selection. 
MATERIALS AND METIIODS 
Mice. 
Specific pathogen-free mice were used at 6-8 weeks of age. The strains 
used in the present study, i.e., BALB/c, C57BU6J, C3H/HeJ, CBA/H, 
DBN2J and SJUJ were all obtained from the Animal Services Section, 
JCSMR. 
Viruses. 
The mouse brain passaged VY-WR and the recombinant viruses VV-HA-
TK and VY-HA-IL2 have been described in Chapter 2. Three human 
vaccine strains ofVV were also used. The New York City Board of Health 
strain (VV-NYBH), also known as the Wyeth strain, and the Lister 
(Elstree) strain (VY-Lister or VY-Elstree) were obtained from Dr. D. B. 
Boyle, Australian Animal Health Laboratory, Geelong, Victoria, 
Australia. The Copenhagen strain (VY-Copenhagen) was kindly 
provided by Dr. M.-P. Kieny, Transgene, Strasbourg, France. The 3 
strains may be classified in terms of pathogenicity in mice, rabbits and 
irradiated rats as follows: mildly pathogenic - VY-NYBH; moderately 
pathogenic - VY-Lister; and highly pathogenic - VY-Copenhagen 
(reviewed in Fenner et al., 1988c). This classification also reflected the 
frequency of complications after vaccination with any one of the 3 strains. 
Treatment of normal mice with antiserum to as-GM 1. 
Female CBNH mice were given the anti-as-GM1 antiserum i.v. in a 150µ1 
volume (stock antiserum diluted 1:5) on 2 alternate days prior to 
immunization (day 0), and thereafter everyday except on the day when 
mice were sacrificed for determination of viral titres. 
Establishment of primary and secondary murine ovarian cell culture 
Paired ovaries from 20 CBNH or C57BU6J mice were aseptically removed 
and minced with sharp surgical scissors. Minced tissue was incubated 
in 2ml of HBSS containing collagenase (2mg/ml) (Boehringer-
Mannheim, Tutzig, FRG) at 370c. After 20 min, the digested ovarian 
tissues were gently pressed through stainless steel mesh using syringe 
plungers, clumps removed by passage through nylon mesh and the 
resulting cell suspension was washed once with HBSS and then with 
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RPMI 1640 (Gibco Laboratories, Grand Island, NY., USA) containing 5% 
FCS. After the final wash, 3xl06 viable cells were seeded into 175 cm2 
Nunclon tissue culture flasks in 50ml of RPMI 1640 containing 20% FCS 
and maintained at 37°C in a humidified atmosphere containing 5% CO2. 
After 24h, dead cells were removed by gentle aspiration and fresh RPMI 
1640 containing 15% FCS (complete RPMI) was added to the primary 
cultures. Ovarian cells were used after a further passage (secondary 
culture). By this time, most of the cells had a fibroblast-like morphology. 
The cells were used for virus replication studies in vitro and flow 
cytometry. 
Flow cytometry. 
As described in Chapter 4. 
( 
Preferential growth of VV in ovaries. 
In Chapter 2, both VV-HA-TK and VV-HA-IL2 were shown to replicate in 
murine ovaries. Since both these recombinants were constructed from 
VV-WR, it was of interest to investigate whether the wild type virus also 
caused a productive infection in ovaries. Normal CBA/H mice were 
therefore infected i.v. with 107 PFU of VV-WR in order to compare virus 
replication in ovaries versus growth in other visceral organs. Groups of 4 
mice were sacrificed on days 1, 2 and 3 after infection and virus titres 
were determined in the ovaries, lungs, liver and spleen. Liver and spleen 
had the lowest titres, reaching 105.3 PFU by day 3. The mean lung viral 
titre was 106.4 PFU on day 3 but ovaries had the highest mean titres on all 
3 days of assay, rising from 105.0 PFU on day 1 to 107.3 PFU on day 2 and 
reached 108.6 PFU on day 3 (Table 1). Since ovaries weigh approximately 
14 times less than lungs, virus titre per gram of tissue was about 2,000-
fold higher in ovaries than in lungs. The preferential growth of VV-WR 
in ovaries suggested tissue-specific tropism and/or extremely productive 
infection of ovarian cells. 
The ability of other VV strains t.o replicat.e in ovaries. 
VV-WR is a mouse brain passaged, mouse-adapted, neurovirulent virus 
derived from VV-NYBH. The human vaccine strain VV-NYBH had been 
widely used during the smallpox eradication campaign. Therefore a 
study to test the ability of 3 human vaccine strains, VV-NYBH, VV-
Elstree and VY-Copenhagen to replicate in ovaries was undertaken. 
Virus titres of paired ovaries from groups of 3 CBA/H mice inoculated i.v. 
3 days previously with 107 PFU of either VV-WR, VV-NYBH, VV-Elstree 
or VY-Copenhagen were determined. The mean VV-WR titre was 4-5 
log10 higher than the other three strains (Table 2). The ability of the 3 
human vaccine strains to replicate in ovaries correlated with the 
pathogenicity of these strains for mice and rabbits (Table 2, and Fenner et 
al. 1988b). VV-WR also replicated efficiently in ovaries after i.p. 
inoculation but not after s.c. inoculation into the foot-pad (data not 
shown). 
VV replication in ovaries of various mouse strains. 
The ability ofVV-HA-TK and VV-HA-IL2 to replicate in ovaries of various 
mouse strains was next tested. Groups of 4 female BALB/c, C3H/HeJ, 
C57BU6J, CBA/H, DBA/2J and SJUJ mice were given i.v. 107 PFU virus 
and 3 days later virus titres in ovaries were determined. VV-HA-TK was 
recovered from ovaries of all mouse strains tested with mean titres 
ranging from 107.0 to 1os.2 PFU (Table 3). On the other hand, mean VV-
HA-IL2 titres ranged from 103.9 to 105.1 PFU. 
Histologic changes associated with VV replication in ovaries. 
The effect of VV replication in ovaries was investigated histologically. 
Haematoxylin and eosin stained sections of ovaries were obtained from 
CBA/H mice 1, 2, 3, 6 and 12 days after inoculation with 107 PFU of either 
VV-HA-TK, VV-HA-IL2 or VV-WR. Histological examination of infected 
ovaries indicated· that VV-HA-IL2 had hardly replicated (Fig. la) and no 
damage was detectable, consistent with the low levels of virus recovered 
(Chapter 2, Fig. 4). In contrast, VV-HA-TK initially infected ovarian 
stroma, not follicle~, and had destroyed many stromal cells by day 3 after , 
infection. By day 6 post-inoculation with VV-HA-TK, the ovarian stroma 
had been largely destroyed (Fig. le) but by day 12, VV-HA-TK had 
completely destroyed the stroma and ovarian follicles (fig. ld). Histologic 
changes in ovaries after infection with VV-WR was comparable to that 
caused by VV-HA-TK (data not shown). 
Ovarian damage and sterility in mice. 
In order to determine whether the ovaries of mice infected with VV-WR 
or VV-HA-TK were functionally impaired, female CBA/H mice that had 
been inoculated 30 days previously with any one of the wild type or 
recombinant VV were individually mated with a male mouse and 
observed for 60 days or until they produced a litter. 
All mice that had been infected either i.p. or i.v. with VV-WR did not 
produce litters over the 60 day observation period (Table 4). In the group 
that had been inoculated with VV-HA-TK, only 30% produced litters and 
these were delayed well beyond the normal gestation period of 20-21 days. 
Infection with VY-Copenhagen also reduced fertility; 70% of the mice 
produced litters and some of the mice that did become pregnant took 
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longer to do so (Table 4). In contrast, all mice that had been infected with 
VV-HA-IL2, VV-NYBH or VV-Elstree produced litters within the normal 
gestation period. These results indicate that obvious functional 
impairment of ovaries occurs when the VV strain has the capacity to 
replicate to high titres (e.g. 8 log10) in these organs. Because VV-HA-IL2 
reaches maximal titres of only 4-5 log10 in infected ovaries (Chapter 2, 
Fig. 4), functional impairment is not detectable. 
Treatment with anti-as-GM1 reduces the capacity for VV t.o replicat.e in 
• ovanes. 
The antiserum to as-GM1 was initially used in an attempt to deplete as-
GM1+ NK cells in normal mice but was found to be unsuitable (see 
Chapter 4). Although the antiserum treatment resulted in enhanced 
viral titres in lungs of normal mice (data not shown), ovarian VV titres 
were markedly reduced. The results from a representative experiment 
are shown in Table 5. In that experiment, normal CBA/H mice treated 
with anti-as-GM1 were infected i.v. with 107 PFU of VV-HA-IL2 and 3 
days later, virus titres in ovaries were determined. 
While the mean VV-HA-IL2 titre in ovaries of untreated CBA/H mice 3 
days after infection was 4.5 log10, virus was below the level of detection ( < 
2 log10 PFU) in antiserum-treated mice. Treatment with anti-as-GM1 
also resulted in a 1.5 log10 reduction in VV-HA-TK titre in ovaries (Table 
5). Using a specific Mab to NK cells (anti-NK-1.1), evidence was presented 
in Chapter 4 which indicated that NK cell depletion in normal mice 
resulted in enhanced ovarian and lung VV-HA-IL2 titres (see Chapter 4, 
Table 3). Further investigation of the phenomenon whereby anti-as-GM1 
reduced capacity for VV to replicate in ovaries using cultured ovarian 
fibroblasts in vitro was unsuccessful. Although VV-WR, VV-HA-TK and 
VV-HA-IL2 replicated successfully in cultured ovarian cells, treatment of 
the cells with antiserum prior to infection with VV was found to be toxic 
to the cells at the various concentrations used (data not shown). The 
toxicity may not, however, have reflected the in vivo phenomenon since 
histological examination of ovaries from anti-as GM1 treated mice that 
had been infected with VV-HA-TK indicated that the ovarian stroma was 
not as badly damaged as was apparent in mice that had been inoculated 
with VV-HA-TK but not treated with antiserum. In vitro, incubation of 
101 
VV-HA-TK or VV-HA-IL2 with high concentrations of anti-as-GM1 for 1 
h prior to titration had no effect on viral titres (data not shown). 
Murine ovarian cells express as-GM1 or a closely relat.ed epitope. 
The above findings suggested that anti-as-GM1 prevented VV infection of 
the ovarian cells. One possible explanation was that the ovarian cells 
expressed a cell surface epitope identical to or cross-reactive with as-GM1, 
and following treatment with anti-as-GM1 in vivo, binding of the antibody 
to the ovarian cell surface may have impeded virus binding or entry to 
target cells. The presence or absence of "as-GM1" on ovarian cells was 
tested by flow cytometry. Freshly prepared ovarian cells had low viability 
and were therefore unsuitable for cytofluorometry. Cultured CBA/H 
ovarian cells were stained with anti-as-GM1 as the primary antibody 
followed by FITC-conjugated secondary antibody. Flow cytometric 
analysis revealed that more than 90% of CBA/H ovarian cells expressed 
varying levels of 'as-GM1' (Fig. 2). Similar findings were also made with 
cultured C57BU6J ovarian cells (data not shown). The possibility that 
levels of as-GM1 on the ovarian cells could have increased after culture 
cannot be excluded. 
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DISCUSSION. 
VV replication in murine ovaries has not been documented previously. 
Data presented in this chapter and Chapter 2 show that in normal mice 
VV-WR and VV-HA-TK, a recombinant virus constructed from VV-WR, 
replicated to substantially higher titres in ovaries than in lungs, liver and 
spleen. VV-WR also replicated more efficiently in ovaries than the 
vaccine strains VV-NYBH, VV-Elstree and VY-Copenhagen. The 
recombinant viruses, VV-HA-TK and VV-HA-IL2 also seeded and 
successfully replicated in ovaries of 6 different mouse strains tested 
although VV-HA IL2 titres were consistently lower. 
Histological examination indicated that infection with VV-WR or VV-HA-
TK led to the destruction of ovarian stroma and eventually follicles. 
Consistent with histological evidence, infection with VY-WR i.p. or i.v. 
resulted in 100% sterility, thereby indicating the functional impairment of 
ovaries. VY-HA-.TK infection resulted in a 70% sterility· in mice and this 
may be a reflection of the reduced virulence ofVV-HA-TK compared to 
VV-WR discussed in Chapter 2. 
Of the 3 vaccine strains tested, only VY-Copenhagen caused any 
infertility (30%) in infected mice. VY-Copenhagen grew to higher titres 
in ovaries than VY-NYBH or VY-Elstree and has been reported (Fenner 
et al., 1988c) to be associated with post-vaccination complications in 
human vaccinees. The inability of the human vaccine strains to replicate 
as efficiently as VY-WR in ovaries and the finding that s.c. inoculation 
did not result in infection of ovaries may perhaps explain why no adverse 
effects on fertility of vaccinees immunized against smallpox were 
reported during the smallpox eradication program. However, viraemia 
has been noted after primary vaccination and virus was recovered from 
tonsillar and pharyngeal swabs (Fenner et al., 1988d), thus providing the 
opportunity for virus to spread to ovaries. It is possible that the ovarian 
tissue-specific tropism seen in mice does not exist in humans. 
Interestingly, VY-WR was found to replicate in ovaries of rats 
CD.Willenborg, personal communication) and rabbits (unpublished 
observations). 
As stated earlier, VV-WR was derived from VY-NYBH by mouse brain 
passage and selected for its neurovirulence (neurovaccinia). The 
adaptation to mouse could explain, at least in part, the efficient 
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replication of VV-WR but not VV-NYBH in mouse ovaries. In this 
regard, it is interesting to note that the glycosphingolipid, as-GM1 (or a 
cross-reacting epitope), is expressed on at least 2 strains of mouse ovarian 
cells and that the antiserum, anti-as-GM1, reduced the capacity for VV to 
replicate in ovaries. The anti-as-GM1 used in the present study had been 
prepared by immunisation of rabbits with purified as-GM1 (Kasai et al., 
1980), which itself had been prepared from the naturally occuring 
ganglioside, GM1, in bovine brain. Antiserum to as-GM1 prepared in this 
way has been reported to exhibit a small degree of cross-reactivity with 
GM1 (Kasai et al., 1980; Jacquemart et al., 1988). GM1 and related 
glycosphingolipids occur in high concentration in the central nervous 
system (CNS) (Svennerholm, 1972). Since repeated mouse brain passage 
of VV-NYBI;I, which is a dermotropic strain, allowed the derivation of 
VV-WR, a neurovaccinia virus, and since anti-as-GM1 impeded VV 
infection of ovaries, it may be possible that tropism for both the CNS and 
ovaries was acquired by adaptation of the virus to bind to as-GM1 or a 
closely related ganglioside or cell surface glycoproteins that have the 
same carbohydrate chain as those found on gangliosides (Tonegawa and 
Hakamori, 1977). 
It is likely that viral tropism for any particular tissue is influenced by 
multiple surface markers expressed by cells that make up the tissue. 
Obviously, the receptor will be a major determinant of the characteristic 
viral tropism. However, additional factors are also believed to be involved 
in viral tropism and the expression of the relevant receptor may not make 
a target cell permissive to infection (Mims, 1989). The receptor for VV is 
thought to be the epidermal growth factor receptor (EGF-R) (Eppstein et 
al., 1985) but reports by others (Stroobant et al., 1985; Buller et al., 1988) 
suggest that this may not be the only receptor. VV can successfully infect 
and replicate to comparable levels in EGF-R+ and EGF-R- cells (Stroobant 
et al., 1985) suggesting a lack of any absolute requirement for EGF-R for 
the growth of VV in tissue culture. Possible mechanisms by which anti-
as-GM1 reduces the capacity for VV to infect murine ovaries could be by 
impeding viral binding to the cell surface or via co-capping of the EGF-R 
with as-GM1 (or a cross-reactive epitope), thereby removing the viral 
receptor. Although further investigations are necessary, there is a 
distinct possibility that as-GM1 or the cross-reacting epitope serves as an 
additional receptor for VV. In this regard, it relevant to note that rabies 
virus, which is also a neurotropic virus, may bind to acetylcholine 
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receptors at the neuromuscular junction (site of initial infection), but at a 
later stage to ganglioside receptors on neural cells (Conti et al., 1988). 
Data presented in this chapter underscore 3 important points with regard 
to the use of VV as a live virus vaccine vector in humans or animals. 
Firstly, VV has been shown to replicate in mouse ovaries and cause 
infertility. Secondly, inclusion of the IL-2 gene markedly reduced the 
extent of viral replication and ovarian damage and prevented infertility. 
The third point relates to the choice of appropriate VV strains for use as 
recombinant vaccines. The passage of history of the strain being 
considered will have to be thoroughly investigated to avoid any 
undesirable side effects caused by tissue tropism. It must be stressed 
however, that sterility in mice was only observed when virus was 
inoculated i.v. or i.p. but not s.c. Vaccination against smallpox using VV 
had been carried out only s.c. by scarification, presumably reducing the 
risk of spread to ovaries, even if the tropism existed. 
11111""""" 
Figure 1. Histologi,c changes in ovaries of normal, CBAJH mice infected 
with recombinant VV. 
Haematoxylin and eosin-stained histological sections of ovaries from 
normal CBA/H mice taken at various times after i.p. injection with 107 
PFU of VV-HA-IL2 or VV-HA-TK. Histologic changes in ovaries of VV-
HA-IL2-infected mice were hardly noticeable at day 3 post-infection and 
look normal (a). The rapid replication of VV-HA-TK had damaged the 
ovarian stroma [S] partially at day 3 post-infection (b). Six days after 
infection, VV-HA-TK had destroyed large areas of the stroma (c) but by 
day 12 post-inoculation, the ovarian stroma [SJ and follicles [F] were 
completely destroyed (d). [magnification xlOO]. 
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Figure 2. Expression of as-GM 1 on CBAIH ovarian fibroblast cells detected by flow cytometry. 
One million cells were incubated either with the secondary FITC-conjugated antibody alone 
(continuous line) or with anti-as-GM1 as primary antibody followed by secondary FITC-conjugated 
antibody (broken line). A total of 20, 000 fluorescent activated cell sorting events were analysed. 
Table 1. 
Kinetics ofVV-WR replication in various organs of CBAIH mice. a 
Day(s) after Log10 virus titres in organs+ SEM b 
infection ovanes lungs spleen liver 
1 5.0+0.l 4.2+0.3 3.8+0.3 4.0+0.4 
2 7.3 +0.3 5.9+0.4 5.0+0.3 4.8+ 0.2 
3 8.6+0.2 6.4+0.2 5.3+0.3 5.3+0.2 
a Group of 4 female CBA/H that had been infected i.v. with 107 PFU of 
VV-WR 1, 2 and 3 days previously were sacrificed and their organs 
were removed for determination of virus titres. 
-
h Data shown are geometric means of 4 individual organ titres + SEM. 
Table 2. 
Effect of VV strain on the ability to replicat:e in murine ovaries. 
Virus strain Description a Log10 virus titres + SEM b 
i) VV-WR mouse brain passaged 8.5+0.2 
neurovirulent 
ii) VV-Copenhagen human vaccine highly 4.5 +0.7 
pathogenic 
iii) VV-Elstree human vaccine 3.9+0.4 
moderately pathogenic 
iv) VV-NYBH human vaccine mildly 2.8+0.2 
pathogenic 
a The passage history and description ofVV-WR is based on Wokatsch 
(1972). The classification of the 3 human vaccine str?-ins with regards 
to pathogenicity in mice and which also reflects the severity of 
complications associated with vaccination using any of these strains is 
based on Fenner et al. (1988c). 
b Data shown are geometric means of titres of paired ovaries from 3 
individual animals + SEM. 
Table 3. 
VV replication in ovaries of various mouse strains. 
Mouse strain a Log10 virus titres + SEM b 
VV-HA-IL2 VV-HA-TK 
BALB/C 4.9+0.3 7.8+0.1 
C3H/HeJ 4.5+0.5 8.1 + 0.1 
C57BU6J 3.9+0.2 7.0+0.1 
CBA/H 4.7+0.3 8.0+0.1 
DBA/2J 4.3 +0.3 8.2+0.2 
SJL/J 5.1 + 0.3 7.7+0.2 
a Six to 8 week old female mice of the indicated strains were infected i.v. 
with 107 PFU virus and 3 days post-inoculation, pairs of ovaries we.re 
removed from groups of 4 mice for determination of virus titres. 
b Data shown are the geometric means of titres of paired ovaries from 
groups of 4 mice + SEM. 
Table 4. 
Effect of VV replication in ovaries on fertility of CBAfH mice. 
Virus a No. Pregnant/rota.I(%) b Time to Delivery c 
Nil 10/10 (100%) 20- 21 d 
VV-WR 0/20 (0%) 
VY-Copenhagen 14/20 (70%) 20 - 28 e 
VV-Elstree 10/10 (100%) 20- 21 d 
VV-NYBH 10/10 (100%) 20- 21 d 
VV-HA-TK 6/20 (30%) 26- 33 e 
VV-HA-IL2 20/20 (100%) 20 - 21 d 
a Six week old CBA/H mice were inoculated i.v. with 107 PFU virus, except 
for VV-WR which was inoculated i.v. into 10 mice and i.p. into the 
remaining 10 mice. 
b Thirty days after inoculation, mice were individually mated with a 
CBA/H male mouse and observed for a further 60 days or until they 
produced a Ii tter. 
c Time in days from exposure to male mouse to delivery of litter. 
d Normal gestation period. 
e Delay in gestation period. 
Table 5. 
The effect of treatment with anti-as-GM1 antisenun on VV replication in 
ovaries of CBNII mice. 
Treatment with 
anti-as-GM1 a 
+ 
Log10 virus titres+ SEM b 
VV-HA-IL2 
4.5+0.3 
< 2.0 
VV-HA-TK 
7.3 +0.2 
5.8 +0.2 
a Paired ovaries were obtained 3 days after infection with VV-HA-IL2 or 
VV-HA-TK from groups of 4 mice that had been treated(+) or untreated 
(-) with anti-as-GM1. 
b Data shown are geometric means of titres of paired ovaries from groups 
of 4 mice + SEM. 
CHAPTER7 
DISCUSSION AND CONCLUDING REMARKS 
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Athymic nude mice lack mature T cells and are therefore unable to 
mount T-dependent immune responses. T cells are the principal 
producers of IL-2 which is pivotal for the generation and regulation of an 
immune response. Apart from its direct stimulatory effects on lymphoid 
and myeloid cells, IL-2 also regulates the production of other lymphokines 
like IFN-y. The nude mouse model therefore provided an opportunity to 
study the function of VY-encoded IL-2 in vivo by analysis of the immune 
mechanisms induced by IL-2 that allowed their recovery from VV 
infection. 
The highly 'attenuated' phenotype of VV-HA-IL2 in mice was due to 
antiviral mechanisms induced by virus-encoded IL-2. Data from 
experiments in vivo using Mabs to IL-2 or IFN-y clearly established that 
VV-HA-IL2 could replicate to high titres in mouse tissues and therefore 
the reduced virulence did not result from the insertion of a foreign gene 
into the VV genome. Furthermore, the consequences of IL-2 production 
and subsequent activation of antiviral mechanisms following an infection 
with VV-HA-IL2 cannot be mimicked by the administration of exogenous 
IL-2 to mice infected with VV-HA-TK. It is the localized production of IL-
2, at sites of viral infection, which makes VV-HA-IL2 a unique virus-
infection model. 
Evidence presented earlier suggested that the mechanisms operative 
between days 1-4 after infection in both nude and normal mice and which 
led to the rapid elimination of VV-HA-IL2, are similar. Data from 
studies using nude, normal and beige mice indicated clearly that 
multiple antiviral mechanisms were involved. A number of different 
classes of cytolytic cells, mononuclear phagocytes and IFN-y were 
implicated as potential participants in the process of rapid viral 
elimination and recovery of nude mice but the relative importance of any 
one of these components was not easy to define. 
Several lines of evidence suggested that NK cells contributed to clearance 
of virus early in infection. First, the kinetics of enhanced NK cell cytolytic 
activity in spleen, liver and ovary of nude and/or normal mice coincided 
with the rapid clearance of VV-HA-IL2 from these organs. Second, the 
clearance of VV-HA-IL2 in NK-cell deficient beige mice was significantly 
delayed compared to normal mice. Third, infiltration of mononuclear 
cells into foci of VV-HA-IL2 infection in the liver occurred more rapidly 
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than in VV-HA-TK-infected livers, with increased numbers of as-GM1 + 
cells in the former. Finally, VV-HA-IL2-induced cytolytic NK cells lysed 
VV-HA-IL2-infected targets more efficiently than VV-HA-TK-infected 
targets. These observations suggested that virus-encoded IL-2 activates 
and attracts NK cells to sites of viral replication where they exert their 
antiviral activity. That NK cells contributed to viral clearance was clearly 
demonstrated in experiments in which host NK cells were depleted with 
specific antisera or Mab. 
In nude and normal mice, depletion of as-GM1 + or NKl.1 + cells, 
respectively, resulted in enhanced VV-HA-IL2 titres, although no deaths 
were recorded in the former. As discussed in Chapter 4, it is possible that 
as-GM1+ cells were regenerated from as-GM1· progenitors in the 
presence of IL-2 or that other populations of IL-2 responsive antiviral 
effectors were expanded as a consequence of NK cell depletion. In normal 
mice, depletion of NKl.1 + cells resulted in the emergence of an 
unidentified population of cytolytic cells which lysed both uninfected 
syngeneic and allogeneic targets in vitro. Whether this effector 
population, which apparently was expanded in the absence of NK cells, 
contributed to antiviral mechanisms is unclear. If this and other 
lymphoid or myeloid populations that were expanded and/or activated by 
virus-encoded IL-2 contributed to antiviral mechanisms, the relative 
contribution of NK cells in viral clearance becomes difficult to estimate. 
In nude mice, a small proportion of splenocytes that lysed the classical 
NK targets, YAC-1, were as-GMl ·. There is a possibility that this 
population (presumably precursors of NK cells and/or T cells) contributed 
to the antiviral function. 
Of the cytolytic cell populations obtained from ovaries ofVV-HA-IL2-
infected mice, one bore the phenotype of conventional NK cells and a 
second was as-GM1 · and Thyl.2·. The identity of the latter is not known 
but there is a distinct possibility that this cell type contributed to the 
process of virus elimination. 
Data presented in Chapter 5 clearly established that IFN-y played a 
crucial role in the clearance of VV-HA-IL2 both in nude and normal 
mice. Treatment of nude mice with a Mab to IFN-y resulted in enhanced 
VV-HA-IL2 growth and inhibited recovery from infection. In normal 
mice, the Mab treatment also prevented the clearance of VV-HA-IL2. 
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However, the finding that this Mab also prevented clearance of VV-HA-
TK further suggested that IFN-y may play an important role in the 
normal antiviral mechanisms operative during VV infection. These 
findings suggested that virus-encoded IL-2 induced the secretion of IFN-y 
by lymphoid cells in both nude and normal mice. In vitro analysis of 
nude mouse splenocytes indicated that both as-GM1 + and as-GM1- cells 
produced IFN-y after exposure to IL-2. Since IFN-y is a major 
contributor to antiviral mechanisms, its production by as-GM1- cells in 
nude mice depleted of as-GM1+ cells could explain why they survived 
infection with VV-HA-IL2. The as-GM1- cells could have represented 
precursors of NK and/or T cells. 
In normal mice, the classes of lymphoid cells likely to have been triggered 
to secrete IFN-y by virus-encoded IL-2 are T cells and NK cells. NK cells 
are known to produce IFN-y after stimulation with IL-2 whereas T cells 
require antigen in addition to IL-2. In this regard, the in vivo depletion of 
NK-1.1 + and CD4+ T cells, but not CDS+ T cells, resulted in enhanced 
levels of VV-HA~IL2 replication, as assessed three days after infection . 
.. The precise contribution of CD4+ T cells to the clearance ofVV-HA-IL2 is 
not known but there is a possibility that they were induced to produce 
IFN-y by virus-encoded IL-2 and antigen. 
IFN-y could mediate antiviral activity in a number of ways which are not 
mutually exclusive. Firstly, IFN-y produced early during the course of 
infection with VV-HA-IL2 may have induced an antiviral state in 
uninfected cells and thereby limited viral spread. Secondly, IFN-y could 
have contributed to antiviral mechanisms by upregulating class I MHC 
and ~2-m resulting in more efficient action of effector cells which 
recognize these molecules. As the class I MHC molecules complexed 
with viral peptides are recognized by CDS+ Tc cells, this mechanism 
would only be applicable to normal mice. At 3 days post-infection, anti-
VV Tc cell activity in VV-HA-IL2-infected mice was not detectable and 
depletion of CDS+ T cells at this time did not affect viral titres in normal 
mice. Therefore, the concentration of class I antigens-on target cells up 
to 3 days after infection with VV-HA-IL2 may not have influenced the 
efficiency of Tc cell recognition and elimination of infected cells. On the 
other hand, levels of expression of class I MHC-unassociated ~2-m (a 
possible ligand for NK cells) could have influenced NK cell recognition 
and effector function (Mullbacher and King, 1989) in both nude and 
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normal mice. Treatment with a Mab to IFN-y could potentially inhibit 
up-regulation of expression of the ligand and subsequently prevent 
binding and triggering of lysis of virus-infected cells. Indeed, treatment 
with the Mab in both nude and normal mice prevented the elimination of 
virus, although NK cell responses were higher than in control mice, 
thereby indicating that the effector function of NK cells was inhibited. 
Thirdly, IFN-y could have mediated antiviral function through the 
activation of monocytes/macrophages. While the complete depletion of 
mononuclear phagocytes is not likely to be achieved in vivo, the data 
provided sufficient evidence which indicated that 
monocytes/macrophages (most likely activated by IFN-y) contributed to 
the IL-2-induced antiviral mechanisms which enabled nude mice to 
recover from infection with VV-HA-IL2. The finding that silica 
treatment reduced NK activity allows the possibility that persistence of 
VV-HA-IL2 in silica-treated mice could have been partly due to impaired 
NK cell function in vivo. IFN-y can only limit viral spread by virtue of its 
ability to protect uninfected cells from infection (apart from up-regulation 
of ~2-m and class I MHC expression). On the other hand, macrophages 
(actjvated by IFN-y ) can phagocytose infectious virus particles released 
from infected cells or following NK cell-mediated lysis. Taken together, 
these findings imply that monocytes/macrophages are essential for the 
full expression of IFN-y -mediated antiviral activity. However, because of 
the pleiotropic activity of this cytokine, the precise contribution to antiviral 
function in vivo cannot be established but it should be emphasized that 
IFN-y acts in concert with other components of the immune system. 
The mechanism(s) of recovery of athymic nude mice from VV-HA-IL2 
infection can thus be summarised as follows. Virus-infected cells produce 
IL-2 which rapidly activates as-GM1 + (NK cells) and as-GM1 · cells 
(precursors of NK and/or T cells; possibly precursors of spleen- and liver-
associated macrophages). Indeed, elevated NK-like activity is detectable 
as early as 1 day post-infection. The chemotactic effect of IL-2 on NK cells 
(and possibly non-NK cells) allows recruitment of these effectors into sites 
of viral replication and this recruitment would precede activation if it 
were mediated by IL-2 from the foci of infection. Both as-GM1 + and as-
GM1 · cells are triggered by virus-encoded IL-2 to produce IFN-y. IFN-y 
activates mononuclear phagocytes (and presumably recruits blood 
monocytes). Activated NK cells, non-NK cells and the mononuclear 
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phagocytes, together with IFN-y, contribute to the rapid elimination of 
VV-HA-IL2 and recovery of nude mice. 
The need for antiviral CDS+ Tc for recovery from a primary poxvirus 
infection is well established (Hirsch et al., 1968; Blanden, 1970; 1971a, b; 
Buller et al., 1987). The demonstration (Ruby and Ram.shaw , submitted) 
that CDS+ Tc cell fuction in vivo is dependent on IFN-y further illustrates 
the importance of IFN-y in antiviral immunity. The mechanisms of 
recovery described above involve 'non-specific' components of the immune 
system which can clearly be activated to mediate efficient antiviral 
functions to compensate for the absence of T-cell mediated mechanisms 
in nude mice. 
Recovery from a generalized primary viral infection, e.g. mousepox, in 
normal mice and from VV-HA-IL2 infection in nude mice appear to 
involve similar but obviously not identical mechanisms. The roles of 
antiviral Tc cells, mononuclear phagocytes and IFN in the process of 
recovery from primary ectromelia virus infection were discussed by 
Blanden (1971b) and have been addressed in Chapters 1 and 5. I have 
presented evidence that recovery of athymic nude mice from VV-HA-IL2 
infection is dependent on cytolytic NK-like or non-NK cells, mononuclear 
phagocytes and IFN-y. Thus, a general model, based on that proposed by 
Blanden (1971b), encompassing three closely interacting components of 
the immune system may accomodate the data presented in this thesis. 
The model requires a cytolytic effector component (Tc cells in normal 
mice and NK and non-NK cells in nude mice) which produces IFN-y 
(second component) and recruits mononuclear phagocytes (third 
component) to sites of viral replication. The cytolytic effectors lyse infected 
cells to prevent further viral replication (Tc cells can lyse infected targets 
before progeny virus is assembled, but this is not formally established for 
NK cells). IFN-y -activated monocytes/macrophages phagocytose 
infectious virus particles and infected cell debris resulting from action of 
the cytolytic cells. IFN-y induces an antiviral state in uninfected cells to 
prevent further viral spread and increases the expression of ligands 
(class I MHC for Tc cells and ~2-m for NK cells) on target cells. It ought 
to be emphasised that in normal mice, antiviral Tc cells secrete IFN-y 
after binding, via the TCR, to their ligands on virus-infected cells, 
whereas in nude mice, virus-encoded IL-2 triggers production of IFN-y by 
NK and non-NK cells. Furthermore, for the former, secretion of IFN-y by 
110 
antiviral Tc cells takes place only after Tc cell activation (a time-
dependent process) whereas for the latter, IFN-y secretion triggered by 
virus-encoded IL-2 (which itself is produced within a few hours after 
infection) occurs rapidly. The rapid activation of NK cells and secretion of 
IFN-y influence the rapid elimination of VV-HA-IL2. 
Inclusion of the IL-2 gene into the VV genome may provide a potentially 
safe vaccine vector which can be engineered to deliver foreign antigens of 
medical and verterinary importance. The virus is highly 'attenuated' 
and was shown to prevent undesirable side-effects in normal mice. Rapid 
elimination of virus did not result in reduced anti-VV Tc cell responses, 
although antibody titres to VV and influenza HA were lower in mice 
immunized with VV-HA-It2 than in mice given VV-HA-TK (Andrew et 
al., 1989). Nevertheless, immunization of normal mice with VV-HA-IL2 
conferred levels of protection against challenge with the wild type, HA-
homologous influenza virus comparable with the level of protection 
afforded by priming with VV-HA-TK (unpublished observations). 
Further investig·ations in this area should provide a better understanding 
of the effects of virus-encoded IL-2 on B- and T-cell memory which are 
relevant to long-term protection after vaccination. 
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